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Abstract 
Biocides are chemical compounds with antimicrobial properties and they are widely used for 
disinfection, antiseptic and preservation purposes. Biocides have been applied for centuries due to 
early empirical approaches, such as cleansing of wounds with wine, vinegar and honey and salting 
of fish and meat. Today, large amounts of biocides are used for disinfection to achieve a satisfactory 
level of hygiene in various settings and use of biocides has become an integrated part of the 
industrialized world.  
Despite the widespread use and application of biocides knowledge about their exact mechanisms of 
action, especially at sub-inhibitory concentrations, and the bacterial response to such exposure, is 
relatively limited. The increasing use of biocides has within recent years lead to concerns about 
development and emergence of biocide resistant microorganisms that might make the task of 
eradication of pathogenic bacteria more difficult. Furthermore, it has been suggested that use of 
biocides may contribute to the development of resistance in bacteria to antimicrobial agents used in 
human and animal therapy. So far, it is evident that cross- and co-resistance mechanisms to 
antimicrobials agents and biocides exist. However, much less is known about the potential effect of 
biocides on development of antimicrobial resistance in bacteria by promoting the horizontal transfer 
of resistance genes or by inducing the mutation rate. Even though biocides are commonly used at 
working concentrations way above the lethal bacterial dose, the efficacy of these compounds can be 
significantly reduced by incorrect use or the presence of residual concentrations hence, bacterial 
exposure to sub-inhibitory concentrations of biocides is likely to occur.  
The overall objective of this study was to examine if natural bacterial isolates become less 
susceptible to biocides used in their environment and if this can lead to spread of antimicrobial 
resistant clones due to co-selection. Furthermore, the objective was to examine if exposure to sub-
inhibitory concentrations of biocides induce development of resistance to antimicrobial agents. 
So far, only few studies have investigated the susceptibility of livestock-associated isolates to 
biocides used in their environment. Pigs are increasingly recognised as a potential reservoir of 
community-acquired methicillin resistant Staphylococcus aureus (CA-MRSA), especially clones 
belonging to clonal complex (CC) 398. Recently, methicillin resistant S. aureus (MRSA) isolates 
belonging to CC30 was for the first time detected among Danish pigs. The susceptibility of 79 
porcine S. aureus isolates belonging to CC398 or CC30 to commonly used biocides in pig farming 
was therefore determined (Manuscript III). The biocides comprised benzalkonium chloride (BC), 
hydrogen peroxide (HP), sodium hypochlorite (SH), formaldehyde (FH), and caustic soda (NaOH). 
S. aureus isolates did in general not show reduced susceptibility to the biocides tested. However, a 
quaternary ammonium compound (QAC) resistance gene, qacG, was detected in MRSA CC30 
isolates. The presence of qacG in MRSA CC30 is worrying, since use of QACs may contribute to 
the selection and spread of these isolates. MRSA CC30 is often associated with MRSA types giving 
rise to clinical infections in Denmark and porcine MRSA CC30 may be prone to adapt to humans.  
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Residues or inaccurate use of biocides may lead to bacterial exposure to sub-inhibitory 
concentrations. The bacterial response to such exposure is however unclear. It has been suggested 
that the SOS response contribute to antimicrobial resistance development in bacteria by inducing 
mutagenesis. Therefore, the effect of sub-inhibitory concentrations of the five common biocides; 
BC, CHX, HP, PAA, and SH on the SOS response, indicated by the use of a recA-lacZ expression 
assay, and mutagenesis in S. aureus isolates was studied (Manuscript II). BC, CHX, and HP was 
found to induce the SOS response. In addition, HP and PAA were found to significantly (p ≤ 0.05) 
increase the mutation rate by 5-15 and 3-8 fold, respectively. These results suggest that exposure to 
sub-inhibitory concentrations of HP and PAA may contribute to emergence of antimicrobial 
resistance in S. aureus. This may be of potential risk for human health, since these disinfectants are 
widely used at hospitals and in the food industry. 
Mobile genetic elements such as conjugative transposons are important vectors in the dissemination 
of antibiotic resistance determinants. Tn916 including the tetracycline resistance gene tet(M) is a 
conjugative transposon and the prototype of a large family of related elements. They have an 
extremely broad host range and have been found in both pathogenic and commensal bacteria. In the 
study of Manuscript I, the effect of sub-inhibitory concentrations of ETOH, HP, CHX, and SH on 
the conjugative transposition of the mobile genetic element Tn916 was investigated. ETOH was 
found to significantly (p < 0.05) increase transfer of Tn916 by an average of 5-fold, whereas an 
increase of 4-fold on Tn916 conjugation frequency was observed (p = 0.12) when donors were 
exposed to hydrogen peroxide. These results suggest that exposure to sub-inhibitory concentrations 
of ETOH and HP may induce the spread of Tn916-like elements and their resistance genes, which is 
clinically important since these biocides are frequently used in hospitals. 
 
In conclusion, no widespread selection for reduced susceptibility to commonly used disinfectants in 
pig farming was detected in porcine S. aureus isolates. However, a biocide resistance gene, qacG, 
was identified in several of the MRSA isolates, which has also been found in other animal related 
staphylococci. Surveillance of the occurrence and emergence of reduced susceptibility to biocides 
in bacteria are however, still encouraged, since this will provide important data to determine if 
decreased susceptibility to biocides happen over time. Importantly, the data from this thesis 
demonstrated a potential of certain biocides to contribute to antimicrobial resistance development 
and emergence in bacteria through increased mutagenesis and transfer of the antimicrobial 
resistance gene tet(M). On the short term these results emphasises that correct use of biocides are of 
outmost importance and should not be compromised. On the long term, more studies are needed to 
elucidate the actual risk of biocide use on generating antimicrobial resistant bacteria in practice. 
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Dansk sammendrag 
Biocider er kemiske stoffer med antimikrobielle egenskaber og bruges i vid udstrækning til 
desinfektion, antisepsis og til konservering. Biocider er blevet anvendt i århundreder til eksempelvis 
rensning af sår med vin, eddike eller honning og til saltning af fisk og kød på grund af tidlige 
empiriske tilgange. I dag, bliver store mængder af biocider anvendt til desinfektion for at opnå et 
tilfredsstillende niveau af hygiejne i forskellige miljøer og anvendelsen af biocider er blevet en 
integreret del af den industrialiserede verden.  
Selvom biocider anvendes i vid udstrækning er viden omkring deres nøjagtige virkningsmekanisme 
relativt begrænset især ved sub-inhiberende koncentrationer. Det øget forbrug af biocider har inden 
for de seneste år ledt til bekymring om udviklingen og spredningen af biocid resistente bakterier, 
som muligvis kan besværliggøre bekæmpelsen af patogene bakterier. Endvidere er det blevet 
foreslået, at anvendelse af biocider kan bidrage til udviklingen af resistens hos bakterier over for 
antimikrobielle stoffer, der anvendes til behandling af mennesker og dyr.  Indtil videre er det 
tydeligt at kryds- og co-resistens resistensmekanismer over for antimikrobielle stoffer og biocider 
findes, derimod er viden omkring biociders potentielle effekt på udviklingen af resistens overfor 
antimikrobielle stoffer i bakterier, forårsaget af den horisontale overførsel af resistensgener eller 
ved at øge mutations rate meget mindre kendt.  
Selvom biocider almindeligvis anvendes ved koncentrationer, som langt overstiger den dødelige 
dosis for bakterier, kan virkningsgraden af disse stoffer betydeligt blive reduceret ved forkert brug 
eller ved tilstedeværelsen af restkoncentrationer og dermed kan bakterier blive eksponeret til lave 
ikke dødelige koncentrationer. 
Det overordnet formål med dette projekt er at undersøge om naturlige bakterie isolater bliver 
mindre følsomme over for biocidstoffer, der anvendes i deres miljø og om dette kan lede til 
spredning af resistens overfor antimikrobielle stoffer i bakterier pga. co-selektion. Derudover, er 
formålet at undersøges effekten af eksponeringen af bakterier overfor sub-inhiberende 
koncentrationer på udviklingen af resistens overfor antimikrobielle stoffer.   
Hidtil har kun få studier undersøgt følsomheden af husdyr-relaterede bakterie isolaters overfor 
biocider, som anvendes i deres miljø. Svin bliver i stigende grad anerkendt som et potentielt 
reservoir for samfundserhvervet methicillin resistente Staphylococcus aureus (MRSA), specielt 
kloner, som hører til det klonale komplex (CC) 398. For nyligt blev den første MRSA tilhørende 
CC30 identificeret i danske svin, som desuden også blev fundet i landmænd. Følsomheden i 79 
svine S. aureus isolater overfor almindelige anvendte biocider i svine produktionen blev bestemt 
(Manuscript III). Biociderne bestod af benzalkonium klorid (BC), hydrogen peroxid (HP), natrium 
hypoklorit (SH), formaldehyd (FH) og kaustisk natron NaOH). S. aureus isolater udviste i 
almindelighed ikke nedsat følsomhed over for de testede biocider. Imidlertid blev et kvaternær 
ammoniumforbindelse (QAC) resistensgen, qacG, påvist i MRSA CC30 isolater. Tilstedeværelsen 
af qacG i MRSA CC30 er bekymrende, da brugen af QAC'er muligvis kan bidrage til selektionen 
og spredningen af disse isolater. MRSA CC30 er ofte forbundet med MRSA typer, der giver 
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anledning til kliniske infektioner i mennesker i Danmark og svine MRSA CC30 kan derfor muligvis 
være tilbøjelig til at tilpasse sig til mennesker. 
 
Biocidrester eller ukorrekt anvendelse af biocider kan føre til at bakterier bliver eksponeret overfor 
sub-inhiberende koncentrationer. Cellens reaktion på en sådan eksponering er uklar. Det er blevet 
foreslået, at SOS responset i bakterier kan bidrage til udviklingen af resistens overfor 
antimikrobielle stoffer ved at øge forekomsten af mutationer i bakterien. Derfor blev effekten af 
sub-inhiberende koncentrationer af de fem almindelige biocider BC, CHX, HP, PAA og SH på SOS 
responset, indikeret ved brug af et recA-lacZ ekspressions assay, samt mutationsfrekvensen i S. 
aureus isolater undersøgt (Manuscript II). BC, CHX og HP øgede SOS responset. Desuden blev det 
påvist at HP og PAA øgede mutationsfrekvensen signifikant (p ≤ 0,05) med 5-15 og 3-8 gange. 
Disse resultater tyder på, at eksponeringen overfor sub-inhiberende koncentrationer af HP og PAA 
kan bidrage til udviklingen af antimikrobiel resistens i S. aureus. Dette kan være af potentiel risiko 
for menneskers sundhed, da disse desinfektionsmidler i vidt omfang anvendes på hospitaler og i 
fødevareindustrien. 
 
Mobile genetiske elementer såsom konjugative transposoner er vigtige vektorer i udbredelsen af 
antimikrobielle resistensdeterminanter. Tn916, som indeholder tetracyklinresistensgenet tet(M) er et 
konjugativt transposon og prototypen på en stor familie af beslægtede elementer. De har et ekstremt 
bredt spektrum af bakterieværter og er blevet fundet i både sygdomsfremkaldende og kommensale 
bakterier. I studiet, som udgør Manuskript I blev effekten af sub-inhiberende koncentrationer af 
ETOH, HP, CHX og SH på overførslen af Tn916 undersøgt. ETOH blev fundet til signifikant (p 
<0,05) at øge overførsel af Tn916 5 gange i gennemsnit, hvorimod en gennemsnitlig øgning i 
overførslen af Tn916 på 4 blev observeret (p = 0,12), når donor bakterier blev udsat for HP. Disse 
resultater tyder på, at eksponering overfor sub-inhiberende koncentrationer af ETOH og HP kan 
fremkalde udbredelsen af Tn916-lignende elementer og deres resistensgener, hvilket er af klinisk 
betydning da disse biocider ofte anvendes på hospitaler.  
 
Afslutningsvis blev der ikke fundet udbredt nedsat følsomhed over for dedinfektionsmidler, som 
oftest anvendes i svineproduktionen i S. aureus svine isolater. Imidlertid blev biocidresistensgenet, 
qacG, konstateret i flere af MRSA CC30 isolaterne. Dette gen er også fundet i andre dyre-relaterede 
stafylokokker. Overvågning af forekomst af nedsat følsomhed over for biocider i bakterier 
opmuntres dog stadig, da dette vil give vigtige data til at afgøre, om nedsat følsomhed overfor 
biocider sker over tid. Vigtigere er det, at data fra denne afhandling har vist at visse biocider har 
potential til at bidrage til udviklingen af resistens overfor antimikrobielle stoffer i bakterier via øget 
mutationsfrekvens og ved øget overførsel af resistensgenet tet(M). På kort sigt understreger disse 
resultater, at korrekt anvendelse af biocider er af allerstørste betydning. På lang sigt er flere 
undersøgelser nødvendige for at belyse den faktiske risiko ved anvendelse af biocider på 
udviklingen af antibiotikaresistente bakterier i praksis. 
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Objective of study and outline of thesis 
Biocides are chemical compounds with antimicrobial properties and they are widely used for 
disinfection, antiseptic and preservation purposes 1. Biocides have been applied for centuries due to 
early empirical approaches, such as cleansing of wounds with wine, vinegar and honey and salting 
of fish and meat 2. Today, large amounts of biocides are used for disinfection to achieve a satisfactory 
level of hygiene in various settings and use of biocides has become an integrated part of the 
industrialized world 1. At hospitals, biocides are widely used for disinfection of inventory and 
equipments and for hand disinfection to prevent transmission of pathogens and they have become 
an important part of infection control strategies 3. In the food industry, biocides are extensively used 
in animal husbandries to prevent emergence and dissemination of disease among livestock animals 
and in food processing to prevent food contamination 4.  
Despite the widespread use and application of biocides knowledge about their exact mechanisms of 
action, especially at sub-inhibitory concentrations, and the bacterial response to such exposure, is 
relatively limited 5. The increasing use of biocides has within recent years lead to concerns about 
development and emergence of biocide resistant microorganisms that might make the task of 
eradication of pathogenic bacteria more difficult. Furthermore, it has been suggested that use of 
biocides may contribute to the development of resistance in bacteria to antimicrobial agents used in 
human and animal therapy. So far, it is evident that cross- and co-resistance mechanisms to 
antimicrobials agents and biocides exist 5. However, much less is known about the potential effect 
of biocides on development of antimicrobial resistance in bacteria by promoting the horizontal 
transfer of resistance genes or by inducing the mutation rate. Recently, stress in bacteria caused by 
sub-inhibitory concentrations of antimicrobial agents has been shown to induce transfer of 
resistance genes 6 and to induce the mutation rate in bacteria 7–10. Even though biocides are 
commonly used at working concentrations way above the lethal dose of bacteria, the efficacy of 
these compounds can be significantly reduced by e.g. the presence of organic matters, insufficient 
exposure time, and inappropriate dilution. In addition, low concentrations may be obtained in niches 
with large number of bacterial species, such as human and animal skin and on production lines after 
some time. Hence, bacterial exposure to sub-inhibitory concentrations of biocides is likely to occur. 
Knowledge is therefore urgently needed to shed light on the potential unintended consequences of 
the widespread use of biocides.  
Such knowledge may contribute with information on which compounds that are more likely to 
contribute to unwanted traits in bacteria such as antimicrobial resistance development. On the long 
term this will ensure that the use of biocides remains competent of retaining the high level of 
hygiene developed in the medical and industrial settings, which is of outmost importance for patient 
and consumer safety.  
The overall objective of this PhD study was to investigate whether different selected biocides may 
have unwanted effects. The objective, with specific research hypotheses and specific studies 
conducted is outlined in Figure 1.  
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Research approach and limitations 
It was not possible to cover all potential biocides or biological systems in this project. Thus, a 
number of biocides and model systems have been selected. Biocides prioritized in this PhD study 
constitute biocidal active substances of disinfectants commonly used in the medical setting and/or 
in the food industry.  
Staphylococcus aureus isolates of porcine origin was selected for the study of reduced susceptibility 
to and detection of known biocide resistance genes in natural isolates because research primarily 
has been focused on human clinical isolates and only few studies have been carried out on livestock 
associated isolates. Furthermore, pigs are increasingly recognised as a potential reservoir of 
community-acquired methicillin resistant S. aureus (CA-MRSA) 11 . Biocides selected for that 
study comprised benzalkonium chloride, hydrogen peroxide, sodium hypochlorite, formaldehyde, 
and caustic soda. The selection of biocides was based on a report published by the Danish Zoonosis 
Centre, National Food Institute, where the most used biocidal groups for disinfection in stables of 
finisher herds were presented 12. Compounds representing the various biocidal groups were selected 
based on prior working experience with these compounds within the research group.  
14 
 
S. aureus isolates from human and porcine origin were selected for the SOS response/mutagenesis 
study. This bacterial species constitute a growing and important human pathogen in which 
increasing resistance to multiple antimicrobial agents cause increased morbidity and mortality in 
humans. Porcine S. aureus isolates were selected based on the above mentioned reasons and to 
include S. aureus from different reservoirs. Biocides selected for this study comprised ethanol and 
chlorhexidine digluconate, because they are the most widely used antisepsis compounds at hospitals 
1,4. Furthermore, peroxygens (peracetic acid and hydrogen peroxide), and sodium hypochlorite are 
widely used for disinfection in animal husbandries and in food processing in addition to hard 
surface disinfection at hospitals 4,12. 
The conjugative transposon Tn916 was included as a model system for transfer of the tetracycline 
resistance gene tet(M) because it has an extremely broad host range 13. Furthermore, a regulatory 
mechanism for the transfer of this element has been suggested, which could be used in the set-up of 
the Tn916 transfer protocol 13. Biocides selected for this study comprised chlorhexidine 
digluconate, ethanol, hydrogen peroxide, and sodium hypochlorite due to their usage in the health 
care setting where increasing resistance in human pathogens constitute a major problem 1,3,4.   
Outline of thesis 
The thesis is divided into three main chapters. Chapter I gives an overview of the different groups 
of biocides, their mechanism of action and their application areas. In addition, current knowledge 
on mechanisms giving rise to reduced susceptibility to biocides in bacteria and co- and cross-
resistance mechanisms to antimicrobial agents are presented. In Chapter II a summary of own 
results are presented and discussed. Chapter III includes the three manuscripts produced during this 
study: 
I. M. A. Seier-Petersen, A. Jasni, F. M. Aarestrup, H. Vigre, P. Mullany, A. P.  Roberts, Y. 
Agersø. Effect of sub-inhibitory concentrations of four commonly used biocides on the 
conjugative transfer of Tn916. Manuscript submitted to Journal of Antimicrobial 
Chemotherapy. 
II. M. A. Seier-Petersen, A. S. Haugaard, F. M. Aarestrup, and Y. Agersø.  Effect of sub-
inhibitory concentrations of biocides on the SOS response and mutagenesis in 
Staphylococcus aureus. Manuscript in preparation. 
III. M. A. Seier-Petersen, L. N. Nielsen, H. Ingmer, F. A. Aarestrup, Y. Agersø. 
Characterization of Staphylococcus aureus CC398 and CC30 isolates from pigs and 
identification of the biocide resistance gene qacG. Manuscript submitted to Journal of 
Antimicrobial Chemotherapy. 
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CHAPTER I 
1 Introduction to biocides 
Biocides are chemical compounds capable of killing or inhibiting microorganism 1. They are 
defined as active substances and preparations containing one or more active substances intended to 
destroy, deter, render harmless, prevent the action of, or otherwise exert a controlling effect on any 
harmful organism by chemical or biological means 14. Biocidal compounds have been used for 
centuries due to early empirical approaches. For instance, natron, oils and balsams were used by the 
Egyptians in mummification of the dead and Persians used copper or silver vessels for storage of 
potable water. In addition, salting and natural spices have been used for preservation of foodstuffs 
and vinegar, wine, honey and mercuric chloride have been used in wound dressings 2,15. Along with 
the industrial revolution a range of new compounds became available and the antibacterial effect of 
a number of compounds began to be utilized 16. By the mid-1900s, many biocidal compounds were 
in common use both as industrial preservatives and in the medical field 15,16. Since then, the number 
of biocidal compounds, their use and applications have increased dramatically 1615. Today, biocides 
have become an integrated part of the industrialized world and are invaluable compounds for the 
control of human and animal pathogens and for management of unwanted microorganisms causing 
damage to various products, such as foods and cosmetics 14. Large amounts of biocides are 
therefore consumed within the medical, industrial and domestic environment where they are used 
for disinfection, antisepsis, preservative, and cleaning purposes 1 (the different use practices of 
biocides are defined in Box 1). 
 
The consumption of pesticides used in agriculture has been stagnant over the last 10 years 
representing an annual market value of 27 billion euros within the European Union (EU). In 
comparison, biocides represent nearly 11 billion euros in EU and the market has been growing by 5 
% per annum in the last 15 years and the market of biocides has been predicted to expand during the 
next years 17. The use of biocides is much less restricted in comparison to the use of therapeutically 
antimicrobials for which surveillance of the consumption in some EU countries exists and the 
consumption of biocides in various fields is therefore largely unknown. However, a Directive 
(98/8/EC) of the European Parliament and of the Council on placing biocidal products on the 
market was adopted in 1998. The purpose of this Directive was to harmonize the European market 
Box 1 | Definition of use practices of biocides 1,3,130:  
Cleaning is the physical process by which dirt, dust, and microorganisms are removed 
from surfaces. In this case microorganisms are removed to inhibit propagation.  
In disinfection, microorganisms are inhibited or destroyed to a safe level on inanimate 
objects; a load that will not give rise to infection.  
The purpose of sterilization is to completely eradicate any form of living microorganism, 
including spores.  
In antisepsis biocide compounds are used in or on living tissue to inhibit or destroy growth 
of microorganisms.  
Biocides are used as preservatives to inhibit growth of microorganisms in various 
formulated products such as foods, cosmetics, toothpaste, and pharmaceuticals. 
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for biocidal products and their active substances in addition to provide a high level of protection for 
humans, animals and the environment 18. In relation to the Biocide Directive the yearly 
consumption of biocidal product in Denmark was estimated and found to comprise up to 5,500 
tonnes per year 4. This was without including biocide used for e.g. cosmetics, human hygiene 
products, toys and medical products that are regulated by other directives 4. In comparison less than 
160 tonnes are annually consumed for antimicrobial agents used for therapy in humans and animals 
19. Table 1 illustrates some of the largest application areas within the estimated consumption in 
Denmark.  
 
As can be seen from the table, biocides are used in a range of application. A short description of the 
application of biocides in the health care setting, in the food industry, in animal husbandry, and in 
consumer care products is giving below. 
1.1 Application of biocides in the health care setting 
In the 1860s it was demonstrated that implementation of simple hand washing among physicians 
delivering babies reduced the post delivery infection rate in women. It was subsequent shown that 
application of carboxylic acid spray (a biocidal agent) to the skin of patients and to surgical 
instruments lead to a dramatic decrease in the rate of post operative infections 20. The role of 
microorganisms in the transmission of infectious diseases was increasingly realized and lead to the 
introduction of official procedures for sterilization of medical and surgical materials 21. In the mid 
twentieth century several biocidal compounds were common use in clinical practice. Today, the use 
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of biocides has become an essential part of infectious control strategies in preventing and 
controlling healthcare-associated infections 3. The worldwide increase in antimicrobial resistance in 
bacterial pathogens leading to increased mortality and morbidity in humans emphasizes the 
significance of infection control practices and the important role of biocides in the health care 5. 
Biocides are widely used for antisepsis in hand disinfection to avoid transmission of pathogens via 
the hands of the personnel thereby preventing and controlling spread of disease among patients 3,5. 
Biocides are used for chemical sterilization or disinfection of heat sensitive devices where 
sterilization by steam under high pressure is not possible 5. Sterilization is particular important for 
devices used for penetration of the skin, such as surgical instruments, urinary catheters, and 
implantable devices were the risk of infection is greatest. In addition, biocides are used for chemical 
disinfection of “non-critical” devices, such as blood pressure cuffs and stethoscopes that only come 
into contact with intact skin and environmental surfaces, which includes floors, walls, tables, and 
bedrails 5. Furthermore, medical devices, such as catheters and sutures, are available with biocidal 
compounds to reduce the risk of infections and biofilm formation 22.   
 
1.2 Applications of biocides in the food production industry 
The high-tech agriculture and the increasing demands for foods of animal origin have contributed to 
the development of intensive live-stock production. The increase in animal concentration has led to 
challenges within and demands for more effective disease control programs to withhold a 
satisfactory level of hygiene 23. Disinfection is an essential part of preventing and controlling 
transmission of disease among animals. Biocides are widely used for cleaning and disinfection of 
areas associated with live-stock animals including farm buildings, beddings, equipments and 
transportation vehicles. In addition, biocides are used directly on animals e.g. in hoof baths to 
control infectious skin disease and for cleaning of udder and teats 4,5,23. Large amount of biocides 
are also used in areas of food production and processing including disinfection of equipment, 
machinery, containers, floors, walls, and decontamination of carcasses to eradicate and prevent 
spread of unwanted microorganisms. Biocides are also used for preservative purposes to prolong 
shelf-life of products and to inhibit food contamination or spoilage 4,5.   
1.3 Applications of biocides in consumer products 
Biocides are used as preservatives in a range of products including personal care products; 
cosmetics, to prevent growth of microorganisms. Cosmetics include products that are intended for 
use on the human body to cleanse, perfume, protect, or to correct body odour 22. Biocidal 
compounds are added to cosmetics to prevent contamination of the product by the consumer during 
use. The demand for preservatives in cosmetics and improvement of manufacturing practices 
became apparent in the 1960s and 1970s where up to 24% of unopened and up to 49% of used 
products were contaminated with microorganisms. The application of contaminated products 
including pathogens or opportunistic pathogens can result in infections at sites such as the eye or in 
wounds 22.  
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In addition, to the different areas of application mentioned above, biocides are used for a variety of 
other purposes contributing to human health and welfare, such as disinfection of waste water, 
swimming pools and as preservatives in paints and textiles 4. Furthermore, with the public 
awareness of hygiene and transmission of bacteria a number of consumer products have become 
available with an “antimicrobial effect” and comprise chopping boards, clothing, linen, carpets, 
computer keypads and many more 24.  
1.4 Chemical groups of biocides and mode of action 
Biocides are generally broad-spectrum in activity and they are often applied in various settings. 
They are believed to have multiple and unspecific target sites within microorganisms constituting 
the cytoplasmic membrane, proteins, DNA, RNA and other cytosolic components (Figure 2).  
 
 
 
In this section, an overview of commonly used biocides of different chemical groups and their 
general field of application is presented with focus on their use within the health care setting, food 
production and animal husbandry. Furthermore, the mode of action of each compound on bacteria is 
described. Biocides included in this PhD study are denoted in bold.  
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1.4.1 Alcohols 
In the group of alcohols ethanol (EtOH), isopropanol, and n-propanol are the most frequently used 
compounds 4. The activity of alcohols is rapid and broad-spectrum; they are effective against 
bacteria, viruses, and fungi; however they are in-effective toward spores 1,25. Alcohols are widely 
used for hand, skin, and hard surface disinfection in the health care setting 3.  
Knowledge about the specific mode of actions of alcohols is limited however, the primary mode of 
action is considered to be denaturation and coagulation of proteins. This affects membrane structure 
and function resulting in release of intracellular constituents, interference with cell metabolism and 
cellular functions, and subsequent cell lysis 1,25.  
1.4.2 Aldehydes 
The major aldehydes used as biocides are formaldehyde (FH) (monoaldehyde) and glutaraldehyde 
(dialdehyde). They are very active compounds and have a broad spectrum of activity including 
bacteria, bacterial spores, fungi, and viruses 1. At hospitals they are used for disinfection of 
equipment such as endoscopes. Formaldehyde is also used in veterinary hygiene for disinfection of 
areas where animals are housed and kept e.g. stables and for disinfection of animal transportation 
vehicles 4. 
Formaldehyde can interact with DNA, RNA, and proteins by cross-linking of free amino groups. 
Glutaraldehyde also causes cross-linking of amino groups in proteins, and inhibits transport 
processes into the cell 1.  
1.4.3 Chlorine and iodine compounds 
1.4.3.1 Chlorine releasing agents (CRAs) 
The most important compounds within the group of CRAs constitute sodium hypochlorite (SH), 
chlorine dioxide, and to a lesser extent chloramine-T. These compounds are highly oxidative and 
have a broad-spectrum of activity including bacteria, viruses and spores. Their primary use is in 
hard surface disinfection 1. Of these compounds, SH is one of the most widely used chemical 
disinfectants and is extensively applied in the food industry as well as for disinfection of surfaces 
and instruments at hospitals 4,26. 
The specific antimicrobial action of CRAs are not well understood however, due to their strong 
oxidizing potential these compounds are believed to react with proteins and enzymes (thiol groups 
are especially regarded as targets), and DNA causing disruption of the cytoplasmic membrane and 
interference with cell metabolisms 2,26.   
1.4.3.2 Chlorhexidine  
Chlorhexidine is a divalent cationic compound belonging to the biguanides. Because of its low 
solubility in water this compound is often produced as an inorganic salt e.g. chlorhexidine 
digluconate (CHX), to increase the solubility of the compound. Chlorhexidine is bactericidal, 
fungicidal, and active against some viruses, but not effective against spores 27. Chlorhexidine 
constitutes one of the most widely used biocides for skin and mucosa disinfection in the health care 
sector 1,4. It is also used in agriculture for direct application on domestic animals 4. Chlorhexidine 
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and alcohols are often used together for skin disinfection due to the rapid effect of alcohols and the 
residual effect of chlorhexidine  4. 
The mode of action of chlorhexidine on bacteria has been well studied and a sequence of event for 
the lethal effect has been described. This include a rapid attraction of the cationic compound to the 
negatively charged bacterial cell, followed by uptake of the compound and subsequently attack on 
the cytoplasmic membrane resulting in inhibition of membrane-bound enzymes and leakage of 
intracellular components. At high concentrations, chlorhexidine also causes precipitation of the 
cytoplasm 27.  
1.4.3.3 Iodine and iodophors 
Iodine in water solutions (I2) have been widely used for antiseptic purposes for many years 
however, they have been replaced by the iodophors (iodine-releasing agents), because of the tissue 
irritant and excessive staining adverse effect of iodine. The most widely used iodophors are 
povidone-iodine and poloxamer-iodine that are used for antisepsis and disinfection. Iodine is 
bactericidal, fungicidal, virucidal, and sporicidal 1. 
The effect of iodine is rapid and is believed to interact with proteins and enzymes (in particular the 
thiol groups), nucleotides and fatty acids however, the exact mechanism of action is unknown 1.  
1.4.4 Metals 
Copper sulphate (CuSO4) is the most widely used copper compound and is used for disinfection of 
hoofs of domestic animals. The most important silver compounds are silver nitrate (AgNO3) and 
silver sulfadiazine (AgSD) that are used for prevention of infections in burns 14 (T2, T3). Cu2+ is 
believed to interact with the thiol group of enzymes and proteins and cause a general coagulation of 
cytoplasmic constituents 28. Ag+ can also interact with thiol groups in enzymes and proteins, and 
react with nucleic acids. The cytoplamsmic membrane, which includes many important enzymes, is 
thought to be an important target site for Ag+ 1.  
1.4.5 Peroxygen compounds 
The most important compounds belonging to the group of peroxygens are hydrogen peroxide (HP) 
and peracetic acid (PAA).  
HP is a strong oxidizing compound with a broad spectrum of activity against microorganisms 
including bacteria, viruses, yeast and bacterial spores. It is widely used for disinfection, antisepsis, 
and sterilization purposes 1. In Denmark, HP is the most consumed biocide for disinfection of food 
handling areas and equipment in the food-processing industry 4. HP is also used for veterinary 
hygiene purposes including disinfection of areas in which animals are housed (including entire 
stables), kept or transported to reduce the load of microorganisms and prevent accumulation and 
spread of disease 4.   
HP attacks cells by formation of free hydroxyl radicals (·OH) that are highly reactive molecules due 
to their strong oxidizing properties 1. They can react with and destroy important cellular 
constituents such as membrane lipids, DNA, ribosomes, enzymes, and proteins 1,2. It has been 
proposed that sulphydryl groups and double bonds are particular targets 29. 
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Peracetic acid is used for disinfection and sterilizing purposes and is regarded as a more potent 
antimicrobial agent than HP due to its lethal effect on microorganisms at lower concentrations 29. It 
is widely used at hospitals for surface disinfection and sterilization of medical equipment 1,4 and 
PAA is also one of the most applied compounds for disinfection of food handlings areas in 
Denmark 4. 
Peracetic acid like HP also attack cells by formation of hydroxyl radicals and are therefore likely to 
cause similar reactions and damages to microorganism as HP 29.    
1.4.6 Phenols and bis-phenols 
Phenolic-type compounds are broad-spectrum antimicrobials having antibacterial, antifungal, and 
antiviral properties. They have long been used for antiseptic, disinfectant, and preservative 
purposes. The most important bis-phenol compounds are triclosan and hexachlorophene that are 
widely used for antiseptic soaps and hand-rinses 1. Triclosan is also used in the industry and is 
incorporated in diverse product including toys, tooth paste, cosmetic and deodorants 30.  
The mode of action of these compounds is believed to be the cytoplasmic membrane causing a rapid 
release of intracellular constituents 1. However, a specific target has been identified for triclosan, 
the enoyl-ACP reductase in bacteria, encoded by the fabI gene, involved in fatty acid synthesis 30.   
1.4.7 Quaternary ammonium compounds (QACs) 
Some of the most important compounds within the group of QACs are benzalkonium chloride 
(BC) and cetrimide. Quaternary ammonium compounds work primarily as antimicrobials against 
bacteria but are also effective against enveloped viruses and fungus 1. They are used for disinfection 
of areas where animals are housed, kept, and transported e.g. floors, walls, and transportation 
vehicles. They are also used for disinfection of food handling areas including floors, walls and 
inventory 4 (T3).  
Quaternary ammonium compounds are membrane active compounds; their main target is the 
cytoplasmic membrane. The mode of action of these compounds are believed to follow a sequence 
of event; adsorption to and diffusion through the cell wall followed by interaction with and 
disruption of the cytoplasmic membrane causing release of cellular constituents and precipitation of 
cell content and death 31. 
1.4.8 Bases and acids 
1.4.8.1 Bases 
Caustic soda (NaOH), caustic potash (KOH), soda (Na2CO3) and hydrated lime (Ca(OH)2) have 
disinfecting properties against some bacteria and especially to some viruses. Caustic soda and 
caustic potash have been extensively used for cleaning of surfaces, and are specifically used for 
cleaning of stables 23,32.   
1.4.8.2 Acids 
Acids can be divided into mineral and organic acids. The most important mineral acids are 
hydrochloric acid (HCl) and sulphuric acid (H2SO4) that are extensively used in the food processing 
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industry for cleaning of surfaces and inventory such as pipes and milking machines 23. Organic 
acids are primarily used as preservatives (e.g. lactic, acetic and citric acids). Other applications 
include; acetic acids can be used for treatment of wounds, and lactic acid for cleaning of udder and 
teats of domestic animals 4,23. Acids can inhibit growth of bacteria, but only the strong acids (e.g. 
HCl) are bactericidal 23,30.    
Acids are believed to cause pH-mediated coagulation of proteins 30.  
1.4.9 Factors affecting biocide activity 
Several intrinsic and extrinsic factors can affect the efficacy of biocides; intrinsic factors depend on 
the biocidal compound and its application, whereas extrinsic factors are defined by the environment 
during application. Regarding the intrinsic factors, the concentration of the biocidal agent and 
contact time between the compound and microorganism are essential parameters 5,33. Generally, 
biocides are used at very high concentrations, way above the lethal dose of microorganisms. 
However, there are several factors that can affect the final concentration of the biocidal agent that 
come into contact with the microorganism. Commercial biocide products may have to be diluted 
before they are used for disinfection and incorrect dilution might occur. Also, insufficient cleaning 
before disinfection might lead to inactivation of the biocidal compound due to the presence of 
organic matter (e.g. blood, serum, pus, dirt or food debris), which can interact with the biocide. 
Furthermore, the presence of dust might hamper contact between cells and the biocidal agent 33,34. 
Important extrinsic factors that can affect the activity of biocides are the temperature and pH 5,33,34. 
Consequently, incorrect use of biocides can reduce the efficacy of biocides and cause bacterial 
exposure to non-lethal/sub-inhibitory concentrations of these compounds.   
1.4.10 Biocides vs. antimicrobials used for treatment 
Even though antimicrobials agents for human and animal therapy are able to inhibit or destroy 
bacteria, or other microorganisms, they are different from that of biocides. This is due to some very 
general differences in the application and mode of action between these two groups of compounds. 
An antimicrobial can be defined as “a drug that at low concentrations exerts an action against 
microbial pathogens and exhibits selective toxicity towards them” 35. Thus, antimicrobial agents 
typically have one specific target site within the microbial cell interfering with a vital physiological 
process that generally can be grouped into the following actions; inhibition of peptidoglycan 
synthesis (e.g. β-lactams, glycopeptides), protein synthesis (e.g. tetracyclines, chloramphenicol, 
macrolides), and nucleic acid synthesis by interrupting nucleotide metabolism (e.g. sulphonamides), 
inhibition of RNA polymerase (rifamycins), or inhibition of  topoisomerase IV / DNA gyrase 
(quinolones) 36. In contrast, biocides are generally broad-spectrum and believed to have multiple 
targets within the cell, interfering with multiple cellular components e.g. the cellular membrane, 
proteins, enzymes, DNA, and RNA through physiochemical interactions or chemical reactions 1. 
Furthermore, therapeutic antimicrobials are generally used for in vivo purposes and applied in 
concentrations close to the minimal inhibitory concentration (MIC) at the site of infection, where 
after the immune system of the host can eliminate the pathogen 37. Biocides, however, are 
commonly used at concentrations that greatly exceed the MIC and the minimum bactericidal 
concentration (MBC) and they are often used at inanimate objects or surfaces. Moreover, the action 
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of biocides is generally achieved within minutes or hours, whereas antimicrobial treatments last for 
days and up to weeks 1.  
The term resistance of bacteria within the two groups of compounds have often very different 
meanings. For antimicrobial agents standardized test methods exist for estimating the susceptibility 
of the bacterium to the antimicrobial agent, which is expressed by the MIC-value. In addition, well 
defined cut-off values for dividing bacteria into susceptible or resistance isolates are available: 
clinical breakpoints and epidemiological cut-off values 38. Resistance according to the clinical 
breakpoints is associated with a high likelihood of therapeutic failure with the given antimicrobial 
agent, whereas resistance defined by the epidemiological cut-off value refers to a non-wild type 
isolate for a species due to the presence of an acquired or mutational resistance mechanism to the 
antimicrobial agent in question 38. However, in the case of biocides no well defined susceptibility 
testing methods or cut-off values are available. The term biocide resistance in the literature is used 
indiscriminately and does primarily refer to reduced susceptibility/tolerance to the biocide in 
question and not to disinfection failure.  
Throughout this thesis, the term antimicrobial will cover compounds used for treatment of bacterial 
infections in humans and/or animals, whereas the term biocide refers to compounds used for 
disinfection, antisepsis and preservative purposes. Furthermore, resistance and resistance 
mechanisms used in the context of biocides refer to bacteria with reduced susceptibility to the 
biocide and cellular mechanisms leading to reduced susceptibility.  
2 Concerns about biocide usage and resistance development  
There is no doubt that the use of biocides plays a crucial role in providing society with a number of 
benefits and contributes to human health and welfare. Biocides have become invaluable compounds 
and it is of upmost importance that they remain effective in the control of unwanted 
microorganisms in various applications. However, the widespread use of biocides has led to 
concerns on the emergence of bacteria with reduced susceptibility to biocides and their potential 
role in development of antimicrobial resistance in bacteria 5. Within recent years, several opinions 
from Scientific Committees and the European Food Safety Authority (EFSA) have been composed 
to access the risk of resistance development to biocides and cross-resistance to therapeutic 
antimicrobials 5,35,39,40. The Scientific Committees provide the European Commission with scientific 
advice for preparation of policies and proposals that are related to consumer safety, public health 
and the environment. Furthermore, they draw the attention of the Commission to new and emerging 
problems that pose or might pose a threat. The European Commission also relies on the work of 
EFSA that constitute the risk assessment body in food safety 39. In 2009, SCENIHR (Scientific 
Committee on Emerging and Newly Identified Health Risks) published an opinion on Assesment of 
the Antibiotic Resistance Effect of Biocides with the purpose amongst other, to review current 
published data on certain active substances to estimate if they are likely to contribute to the 
development of antibiotic resistant bacteria 5. The Opinion concluded that there is convincing 
evidence for the existence of common mechanisms conferring reduced susceptibility to biocides and 
antimicrobials and that co- and cross-resistance to biocides and therapeutic antimicrobials exist 5. 
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However, knowledge on the emergence of natural isolates with reduced susceptibility to currently 
used biocides and the occurrence of co- and cross-resistance is needed. Furthermore, knowledge on 
the possible contribution of sub-inhibitory or residual concentrations of biocides on antimicrobial 
resistance in bacteria by promoting the horizontal transfer of resistance determinants or by inducing 
the mutation rate in bacteria is very limited.  
The serious concern for development of resistance to biocides and/or antimicrobial agents due to 
biocide usage has contributed to a regulation (Regulation (EU) No 528/2012) to the current 
Directive (98/8/EC) that was adopted the 22th of May 2012 and will replace the current directive as 
of 1st of September 2013 14. For authorisation of a new biocidal product in the EU, data proving 
that the product in question is effective and does not give rise to resistance development to biocides 
or antimicrobial agents, have to be submitted 14. This has led to the preparation of “Revision of the 
joint AFC/BIOHAZ guidance document on the submission of data for the valuation of the safety 
and efficacy of substances for the removal of microbial surface contamination of foods of animal 
origin intended for human consumption” from EFSA 41. The objective of the document is to provide 
guidance to applicants for submission of necessary data for evaluating the safety for consumers and 
the environment, including the effect of residual concentrations of biocides, in addition to the 
efficacy of substances for removal/reduction of microbial surface contamination of foods of animal 
origin 41. This includes the necessary information to evaluate the potential emergence of acquired 
reduced susceptibility to biocides and/or resistance to therapeutic antimicrobials 41. 
2.1 Mechanisms of reduced susceptibility to biocides 
Biocides have multiple target sites against the microbial cell. Therefore, the emergence of reduced 
susceptibility to biocides caused by target site modification or by-pass of a metabolic process is rare 
5, which is in contrast to common resistance mechanisms to therapeutic antimicrobials 36. 
Consequently, the general mechanism by which bacteria show reduced susceptibility to biocides is 
by decreasing the intracellular concentration of the biocidal compound to a level that is not harmful 
to the cell 5. Several mechanisms of reduced susceptibility to biocides have been described in 
bacteria and can either be intrinsic or acquired. Intrinsic resistance refers to a natural property of the 
cell, whereas acquired resistance is the result of acquisition of genetic elements (e.g. plasmid, 
transposon) or mutations 1. In Figure 3 the different mechanisms that can lead to reduced 
susceptibility of bacteria to biocides is illustrated.    
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2.1.1 Intrinsic resistance 
2.1.1.1 Reduced uptake 
2.1.1.1.1 Permeability barrier 
The most described intrinsic mechanism of reduced susceptibility to biocides is the permeability 
barrier, comprised by the cell envelope, which can limit the adsorption and penetration of the 
biocide thereby reducing its efficacy. The susceptibility to biocides varies greatly between different 
microorganisms and it is generally believed that the chemical structure and composition of the outer 
cellular layer is an important factor (Figure 4). Mycobacteria are the least sensitive of the vegetative 
bacteria, which are probably due to their lipid rich and waxy cell wall that can act as a barrier and 
limit the uptake of many biocidal agents 34. Gram-negative bacteria are generally less susceptible to 
biocides than Gram-positive bacteria. The outer membrane of Gram-negative bacteria is believed to 
be the major reason for this difference, since it can act as a permeability barrier and also reduce the 
uptake of biocides 34.  
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2.1.1.1.2 Multi-drug efflux pumps  
Multidrug efflux pump systems are widespread among bacteria and five main classes of efflux 
pump systems capable of accommodating antimicrobials have been described; the major facilitator 
(MF) superfamily, the ATP-binding cassette (ABC) family, the resistance-nodulation-division 
(RND) family, the small multidrug resistance (SMR) family (now part of the drug/metabolite 
transporter (DMT) superfamily), and the multidrug and toxic compound extrusion (MATE) family 
42. Several chromosomally encoded multidrug efflux pump systems, with specificity for biocides, 
have been described in Gram-negative bacteria. Examples of these are shown in Table 2. These 
systems generally accommodate QACs and/or triclosan, however the SdeXY efflux pump of 
Serratia marcescens has also been shown to transport the biguanide CHX 42. In comparison to the 
Gram-negative bacteria, chromosomal efflux determinants capable of accommodating biocides are 
rare in Gram-positive bacteria. However, a few chromosomal encoded efflux pumps that can 
accommodate certain biocides have been described in S. aureus (Table 2) 42; the NorA 43, NorB 44, 
MdeA 45 and MepA 46 efflux pumps can all accommodate several QACs and dyes (e.g. ethidium 
bromide (EtBr)), whereas MepA in addition can transport CHX 42. A multidrug efflux pump 
homolog to the NorA transporter protein of S. aureus has been identified in Enterococcus faecalis 
and has been found to accommodate the dye EtBr 47. The importance of these efflux pumps in 
relation to reduced susceptibility to biocides in bacteria and their clinical relevance is however 
uncertain, since they only give rise to a modest level of reduced susceptibility against the described 
biocides 48.  
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2.1.1.2 Physiological adaptation 
In addition to species differences, the physiological state of bacteria can also influence their 
sensitivity to biocides. Biofilms for instance comprise a serious problem both within the medical 
field and in the industry as bacterial cells residing within biofilms have shown to be less susceptible 
to both antibiotics and biocides 49. Several mechanisms can account for this reduction in 
susceptibility: penetration of the biocidal compound into the biofilm might be limited, chemical 
interaction between constituents of the biocidal molecules and the biofilm matrix (e.g. proteins, 
nucleic acids or carbohydrates) that reduce the efficacy of the biocide, and the formation of micro-
environments that are nutrient- and oxygen-limited. Physiological adaptation to these micro-
environments can render bacteria less susceptible e.g. by modification of the cell membrane 
reducing accessibility of the disinfectant to the interior of the cell 49. It has been shown that bacteria 
growing in biofilms can exhibit a 150 to 3000 times greater tolerance to hypochlorite compared to 
its corresponding planktonic cells 50.  
S. aureus have the ability to produce a surrounding layer of slime giving rise to mucoid strains and 
it has been shown that this layer to some extent can protect the cell from the action of different 
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chlorine and phenol compounds 51. The protection of this slime layer has been suggested to act as a 
physical barrier and also to reduce the efficacy of these compounds due to interaction with the 
components of the slime layer 51. Also, it has been shown for Escherichia coli that starvation of this 
bacterium can give rise to increased tolerance to chlorine 52,53.  
 
2.1.1.3 Enzymatic transformation 
Enzymatic transformation of biocidal compounds into non-toxic forms has been described in 
bacteria, particularly for heavy metals, where the metal ion is reduced to a less toxic oxidation state 
54. In addition, aerobic microorganisms have enzymatic systems to relief the bacteria from the toxic 
side-effects (e.g. production of hydrogen peroxide and superoxide) during oxidative respiration; the 
enzyme superoxide dismutase can eliminate superoxide in the cell, whereas catalase handles the 
disposal of hydrogen peroxide 55.  
2.1.2 Acquired resistance 
Resistance to antimicrobial agents is a common and increasing problem among many important 
human pathogens. The main mechanisms by which bacteria acquire resistance to therapeutic 
antimicrobials involve; i) target alteration, ii) impermeability, iii) enzymatic modification or 
destruction of the compound, and iv) active efflux 36. Since antimicrobial agents generally have a 
specific target site within the cell, acquisition of one of these mechanisms can render the bacteria 
resistant to the antimicrobial agents or to multiple compounds within the same class 36. Acquired 
reduced susceptibility to biocides is much less common and one likely reason is that biocides 
appear to have multiple target sites within the cell. However, reduced susceptibility to biocides does 
occur and in the next section, known acquired resistance mechanisms are introduced. 
2.1.2.1 Acquisition of resistance genes 
2.1.2.1.1 Efflux pump systems 
Efflux pumps are probably the most described resistance mechanism in terms of acquired resistance 
to biocides. The QAC efflux pump systems were named after one of their main substrates; the 
QACs. A range of various qac genes have so far been described and constitute the qacA 56, qacB 56, 
qacC 56,57, qacD 57, qacE 58, qacEΔ1 58 (attenuated version of qacE), qacF 59, qacG 60, qacH 61, qacI 
62, qacJ 63, and qacZ gene 64. The different genes and examples of substrate specificities are shown 
in Table 3.  
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The qacA and qacB genes share a high degree of homology 65 and are often referred to as the 
qacA/B gene. qacC and qacD encode the same polypeptide, however, their expression is under the 
control of different promoters and it has been suggested that qacC has evolved from qacD 57. They 
are often referred to as the qacC/D or smr gene. The qac genes have been identified in various 
bacterial species including environmental and clinical isolates, however the individual qac genes 
are in general found to be associated with specific bacterial species. Among the Gram positive 
bacteria, staphylococci by far represent the species in which qac genes most frequently have been 
described and include staphylococci of human (e.g. 57,66–68), animal (e.g. 63,69,70) and food-related 
(e.g. 60,61,71) origins. The qacA/B gene is often found in clinical strains of staphylococci, whereas 
smr is found to a lesser extent 72–74. The qacG, qacH, and qacJ genes are rare in human 
staphylococci isolates 74,75, and is primarily associated with isolates of animal or food origin 
60,61,63,70. Besides the presence of qac genes in staphylococci the qacA/B gene and the newly 
identified qacZ gene have been identified in the Gram positive bacteria E. faecalis 64,76. The qacEΔ1 
and qacE are associated with Gram-negative bacteria. Especially the qacEΔ1 gene has been 
detected in a wide variety of Gram-negative bacteria, and is likely to be due to their association with 
the 3’ conserved end of class I integrons that are widespread among Gram-negative bacteria 42,77,78. 
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The qacF and qacI genes have also been identified in Gram-negative bacteria, but to a much lesser 
extent 42. Acquisition of one of these qac genes however, only results in a modest reduction in the 
susceptibility to the biocidal compounds. In Table 4, some examples are giving on changes in the 
susceptibility of bacterial isolates with and without biocide resistance genes. 79 69 61 58 59 61 63 64 80 81 
82 83 
Recently, a new efflux pump, qrg, was identified in Streptococcus oralis that conferred reduced 
susceptibility to the QAC compound cetyltrimethylammonium bromide (CTAB) 80 (Table 4). 
 
 
 
 
Many metals are essential for different enzymatic processes in the cell, however too high 
concentrations are toxic to the cell and bacteria have evolved different systems to keep the 
concentration at non-toxic levels. Plasmid-mediated copper-resistance systems have been identified 
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in E. coli, Pseudomonas syringae and Xanthomonas campestris. These systems comprise four 
structural genes and are essentially identical. In E. coli the genes comprise pcoA, pcoB, pcoC, and 
pcoD, whereas the determinants are denoted copA, copB, copC, and copD in Pseudomonas. In 
addition, the tcrB gene has been found to confer transferable copper resistance in Enterococcus 
faecium and E. faecalis and is likely to be involved in copper efflux (Table 4) 81,84. Plasmid-
mediated resistance to silver has been identified in a number of bacterial species including the 
Enterobacteriaceae, Citrobacter spp., and Pseudomonas stutzeri, however the mechanism of 
resistance is yet unknown 85. Plasmids including resistance determinants to a wide range of other 
toxic heavy metal ions (e.g. Hg2+, Ni2+, Pb2+) have also been described 86. 
2.1.2.1.2 Additional target 
Recently, a novel mechanism for reduced susceptibility to triclosan was discovered in clinical 
isolates of S. aureus. An additional copy of the fabI gene, likely to originate from Staphylococcus 
haemolyticus was identified giving rise to heterologous target duplication 87. The authors further 
found, by database search, that the S. haemolyticus version of the fabI gene was present in different 
staphylococci, including S. aureus and Staphylococcus epidermidis in which the additional fabI 
gene was located on plasmids together with the qacA gene. This indicates that this novel mechanism 
for reduced susceptibility to triclosan is actively transferred among staphylococci 87. 
2.1.2.1.3 Enzymatic degradation 
Reduced susceptibility to formaldehyde has been identified amongst clinical isolates of 
Enterobacteriaceae and from contaminated disinfection solutions. The mechanism giving rise to 
reduced susceptibility has been identified as the transferable plasmid-born gene, adhC, encoding 
glutathione-dependent formaldehyde dehydrogenase that is capable of inactivating formaldehyde 
(Table 4) 82,88.  
2.1.2.1.4 Acquisition of mutations  
As previously mentioned, biocides are likely to have multiple unspecific target sites within the cell 
and mutation-mediated reduced susceptibility to biocides is rare. However, the enzyme enoyl-ACP 
reductase, encoded by the fabI gene, is a specific target site for triclosan 89. Mutation-mediated 
alterations of the target site reducing the inhibitory action of triclosan and over-expression of fabI 
have been described as mechanisms giving rise to reduced susceptibility to triclosan 48,90,91.  
2.1.2.2 Summary 
Bacteria have acquired mechanisms by which they can become less susceptible to the action of 
different biocides. However, these mechanisms often give rise to a modest reduction in the 
susceptibility to these compounds and not to in-use concentrations.  
In the next section, mechanisms of co- and cross-resistance to biocides and therapeutic 
antimicrobials are presented.  
2.1.3 Mechanisms of specific and unspecific selection of antimicrobial resistance by biocides  
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Biocides can select for therapeutic antimicrobial resistance in bacteria through specific or unspecific 
mechanism that are illustrated in Figure 5. The different direct and indirect resistance mechanisms 
are described in the next section.  
 
 
2.1.3.1 Biocide-antimicrobial co-resistance 
Separate genes encoding reduced susceptibility to biocides and antimicrobial agents can be linked 
on a mobile genetic element. Selection for one resistance gene will also select for the other 
resistance gene(s) and multiple resistances may be transferred in a single event 35. 
 
The various qac genes have been found to be associated with different mobile genetic elements 
including plasmids and integrons. qacA/B is predominantly located on the S. aureus pSK1 family of 
multi-resistance plasmids, encoding resistance to aminoglycosides and trimethoprim, and on β-
lactamase/heavy metal resistance plasmids (pSK57) 92. The smr genes are typically located on the 
small plasmid pSK89 and on large, conjugative multi-resistance plasmids, such as pSK41 and pJE1 
that also encode resistance to several antimicrobial agents within the class of aminoglycosides and 
trimethoprim in the case of pJE1 57,93. The smr gene has also been found on a plasmid (pLW1043) 
isolated from a high-level vancomycin-resistant clinical isolate of S. aureus 68. This plasmid 
included antimicrobial resistance determinants to vancomycin (located on transposon Tn156), β-
lactams, gentamicin and trimethoprim and had homologous regions to the pSK1 and pSK41 family 
of multi-resistance plasmids 68. 
Integrons are a group of mobile genetic elements that are widespread among Enterobacteriaceae and 
other Gram-negative bacteria. The most described type of integrons is the Class 1 integrons that 
comprise a 3’-conserved segment including the qacEΔ1 and sul1 (encoding sulphonamide 
resistance) genes. Integrons are able to incorporate single or multiple gene cassettes encoding 
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resistance to a wide range of antimicrobial agents and classes, including resistance to the β-lactams, 
aminoglycosides, trimethoprim, and chloramphenicol 94. Furthermore, the majority of gene cassettes 
lack a promoter upstream of the coding region and therefore depend on expression of the integron 
that relies on the promoter in the 5’-conserved segment 94. Expression of the antimicrobial 
resistance determinants and the qacEΔ1 gene can therefore be co-expressed. The qacF gene has also 
been found to reside on a Class 1 integron in addition to the qacEΔ1 59. qacI was identified on a 
Class 1 integron containing nine different genes encoding antimicrobial resistance to the class of β-
lactams, aminoglycosides, phenicol, rifampin, and sulphonamides in addition to the QAC resistance 
gene. The integron was located on a transposon residing in a plasmid and might therefore be easy 
disseminated among enterobacterial strains 62. 
The Class 1 integrons therefore constitute important mobile DNA elements in the dissemination of 
co-resistance to antimicrobial agents and QACs in a wide range of Gram-negative species. 
The qacZ gene has been identified in E. faecalis on plasmid pTEF1 64. This plasmid also includes 
genes encoding aminoglycoside and macrolide resistance that was identified by running the 
sequence of pTEF1 (accession no. AE016833) through ResFinder 95 where it was found to include 
the aac(6’)-aph(2’’) gene and erm(B) genes with 100 % identity.  
 
Co-localization of the qacG, qacH, and qacJ genes and antimicrobial agent resistance genes have so 
far not been described 60,61,63,70.  
 
A new gene, qrg, giving rise to QAC resistance was identified on transposon Tn6087, a member of 
the Tn916-like family of transposons and found to co-reside with the tet(M) gene encoding 
tetracycline resistance 80. The tcrB giving rise to copper resistance is genetically linked to 
macrolides (erm(B)) and glycopeptides (vanA) resistance, since they co-reside on the plasmid 
isolated from E. faecium 81.  
 
2.1.3.2 Biocide-antimicrobial cross-resistance - examples of some clinical relevant bacteria 
with multi-drug efflux pumps 
Chromosomally encoded efflux pumps in bacteria are major contributors to antimicrobial resistance 
predominantly in Gram-negatives. Some types of efflux pumps give rise to intrinsic resistance to 
certain antimicrobial agents by expression a basal level of efflux, whereas overexpression of some 
efflux proteins can give rise to acquired resistance in otherwise susceptible strains 96. Constitutive 
expression of efflux proteins can be acquired by mutations in the local repressor gene, in a global 
regulatory gene or in the promoter region. Overexpression of these efflux pumps typically has 
several un-structurally related molecules as substrate including antimicrobial agents and certain 
biocides 96. Over expression of NorA render S. aureus less susceptible to a number of antimicrobial 
agents including chloramphenicol and the fluoroquinolones, as well as biocides within the group of 
QACs and dyes. The only clinical relevant antimicrobials that are substrate for NorA is the 
fluoroquinolones and several clinical isolates of S. aureus over expressing NorA have been found to 
be fluoroquinolone resistant 42,96. Other efflux pumps of S. aureus capable of accommodating 
certain biocides also have antimicrobials as substrates; fluoroquinolones (NorB), lincosamides and 
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type A streptogramins (MdeA), and glycylcyclines (MepA). However, the clinical relevance of 
these efflux systems is unknown 96. Several efflux pumps in clinical relevant Gram-negative 
bacteria have been described. E. coli, Pseudomonas aeruginose and Salmonella enteric serovar 
Typhimurium (S. Typhimurium) and Salmonella enteric serovar Enteritidis (S. Enteritidis) are 
opportunistic pathogens. The AcrAB-TolC efflux pump system of E. coli and S. Typhimurium are 
similar and the substrate profile of these pumps includes several antimicrobial agents (e.g. 
chloramphenicol, fluoroquinolones, some β-betalactams, tetracycline, rifampicin) in addition to 
certain biocides (acriflavine, ethidium bromide, cetrimide, and triclosan). Overexpression of these 
efflux pump systems have been found in clinical isolates of E. coli and S. Thyphimurium 96. 
Reduced susceptibility to the antimicrobial agent ciprofloxacin can be of clinical relevance in 
treatment of infections with these two species. The Mex efflux systems of P. aeruginosa are able to 
accommodate several classes of antimicrobial agents including chloramphenicol, fluoroquinolones 
and tetracycline, as well as certain biocides (acriflavine, EtBr, bromide and triclosan) 42,96. 
Depending on the Mex efflux pump systems, clinically relevant substrates of the efflux pumps 
include ciprofloxacin, gentamicin, ceftazidime among other. Some of these pumps can be induced 
by some of their substrates 96.    
In vitro studies have demonstrated the emergence of less susceptible S. Thyphimurium and E. coli 
isolates to antimicrobial agents after exposure to sub-inhibitory concentrations of different biocides 
and in some cases this was shown to be associated with over expression of efflux pumps 97–99. 
Exposure of clinically S. aureus isolates to non-lethal concentrations of several biocides and dyes 
has been demonstrated to produce mutants overexpressing multi-drug efflux pumps, such as NorA, 
MepA and MdeA that have several antimicrobial agents as substrate 100. It was suggested that 
exposure to substrates of the multi-drug efflux pumps including clinically relevant antimicrobial 
agents as well as disinfectants used at hospitals could result in the emergence of S. aureus strains 
adapted to these compounds 100.   
Isolation of a plasmid-encoded multidrug efflux pump, OqxAB, has also been described in E. coli. 
This pump confers resistance to chloramphenicol and EtBr, however the substrate specificity was 
further studied by Hansen et al. (2007) and it was shown that the OqxAB pump also gave rise to 
reduced susceptibility to QACs (BC and to some extent cetrimide) as well as to trimethoprim and 
antimicrobial agents within the class of the quinolones and fluoroquinolones 83, which might be of 
clinically relevance for treatment of E. coli infections.  
 
2.1.3.3 Summary  
The above mentioned examples show the evidence of co- and cross-resistance mechanisms to 
biocides and antimicrobials agents. This is a potential serious problem since the use of biocides in 
addition to therapeutic antimicrobials at hospitals might select for strains with reduced susceptibility 
to antimicrobial agents. Moreover, the use of antimicrobials and biocides in veterinary practices and 
animal husbandries may contribute to the selection and maintenance of antimicrobial resistance 
determinants.  
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2.1.4 The SOS response 
Bacteria have evolved a number of stress response systems to adapt to and survive many forms of 
environmental stresses. One of these systems is the SOS response that is activated by formation of 
single-stranded DNA (ssDNA). The SOS response is governed by the activator RecA and the 
repressor LexA. RecA recognises and binds to ssDNA forming nucleoprotein complexes that 
stimulate the self-cleavage of the LexA repressor. This result in the de-repression of the SOS 
regulon that include genes encoding error-prone DNA polymerases, and proteins involved in DNA 
repair and recombination 101. In addition to the classical inducers of the SOS response; UV-light and 
mitomycin C, a variety of additional factors have been found to trigger the SOS response including 
exposure to a number of therapeutic antimicrobials, pH-extremes, high pressure, oxidative stress, 
and nutrient starvation 102.  
Genes that are repressed by LexA and thereby activated upon SOS induction have been identified in 
E. coli 103,104, Bacillus subtilis 105, P. aeruginosa 106, S. aureus 107, and Listeria monocytogenes 108. 
In all cases the SOS response is controlled by the expression of the positive and negative regulator, 
RecA and LexA respectively. Furthermore, the SOS responses also include at least one gene 
encoding an error-prone DNA polymerase. However, diversity among the SOS response network in 
the different bacterial species exists. The SOS response systems of E. coli 103,104 and B. subtilis 105 
constitute 31 and 33 genes respectively that are repressed by LexA however, only eight of these are 
homologues to each other. Activation of the SOS response in L. monocytogenes has been found to 
up-regulate 29 genes 108. This is in contrast to the number of genes repressed by LexA in P. 
aeruginosa 106 and S. aureus 107 that only constitute 15 and 16 genes, respectively. Therefore, 
regulation of the SOS response seems to be conserved between different bacterial species, however 
the genes and the number of genes constituting the SOS response differ. 
2.1.4.1 Stress-induced mutagenesis 
Activation of the SOS response includes activation of one or several error-prone DNA polymerases 
that can replicate pass DNA lesions and thus replicate damaged DNA opposed to the “normal” 
replicative polymerase 109. The error-prone property of the SOS-induced polymerases acts on both 
damaged and undamaged DNA and can introduce mutations into the chromosome and thereby 
increase the spontaneous mutation rate in cells 109. Acquired antimicrobial resistance in bacteria due 
to mutations in chromosomal genes have been described for several classes of antimicrobial agents, 
including the quinolones, rifamycins, and aminoglycosides 36. The SOS response might therefore 
play an important role in the development of resistance to important antimicrobials used for human 
and animal treatment. Also, any compound capable of activating the SOS response might contribute 
to the evolution of bacterial resistance in human and animal pathogens. For instance in S. aureus, 
induction of the SOS response by UV-light was shown to increase the mutation rate in the 
bacterium, giving rise to increased resistance to rifampicin and streptomycin 107.  
In recent years it has been demonstrated that sub-inhibitory concentrations of certain antimicrobial 
agents for therapy have the potential to trigger the SOS response and/or induce mutagenesis in 
bacteria. In S. aureus, exposure to ciprofloxacin and trimethoprim have been shown to induce the 
SOS response and a SOS-dependent increase in ciprofloxacin resistance has been demonstrated 
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107,110. In E. coli, exposure to several different antimicrobial agents (e.g. ciprofloxacin, rifampicin, 
ampicillin) at sub-inhibitory concentrations induced the mutation rate in a SOS-dependent matter 
and thereby resistance to these compounds 7,8. Moreover, the SOS response and/or mutagenesis in 
S. Thyphimurium, Mycobacterium fortuitum, Streptococcus pneumonia and Vibrio cholera have 
been induced in response to exposure to sub-inhibitory concentration of certain antimicrobial agents 
9,10,111,112, and the SOS response was found to be an important player in S. Thyphimurium 9 and V. 
cholera 10. 
Activation of the SOS response can therefore result in an increased mutagenesis that in turn can 
confer increased antimicrobial resistance in bacteria. Sub-inhibitory concentration of antimicrobial 
agents used for treatment can induce this response. The SOS response in bacteria might therefore 
play an important role in development of resistance during treatment in a selective manner or 
increase resistance to antimicrobials in a non-selective manner. Inhibition of the SOS response and 
thereby inhibition of mutations has been suggested to be a novel therapeutic strategy to fight 
evolution of antimicrobial resistance to drugs 7. However, bacterial stress caused by exposure to 
sub-inhibitory concentrations of biocides has also been suggested to induce the SOS response and 
induce antimicrobial resistance in bacteria 108. So far, knowledge about the potential effect of sub-
inhibitory concentrations of commonly used biocides on the SOS response and mutagenesis in 
different bacterial species is very limited. A few studies have investigated the transcriptional 
response to a couple of biocides in a few bacterial species.  
The transcriptional response to hydrogen peroxide has been investigated in S. aureus 113, E. coli 114, 
P. aeruginosa 115, and L. Monocytogenes 108. Increased expression of recA indicative of SOS 
response induction was observed in all four bacterial species. The transcriptome response to 
peracetic acid has also been investigated in S. aureus and P. aeruginosa and in both bacteria, the 
expression of genes involved in DNA damage was induced 113,116. Also, Ceragioli et al. (2010) 
investigated the genome-wide transcriptional and mutational response of Bacillus cereus to various 
biocides used in the food industry due to the frequent isolation of this bacterium in contaminated 
raw and processed foods. They found HP and PAA acid to induce the expression of SOS-related 
genes and to induce the mutation rate 117.  
The bacterial response to sub-inhibitory concentrations of biocides is therefore an important area of 
investigation to elucidate the potential of biocides to promote antimicrobial resistance through an 
increase in the mutation rate. 
2.1.4.2 Other stress-induced factors contributing to antimicrobial resistance 
Beside its role in stress-induced mutagenesis, the SOS response has also been shown to contribute 
to development of antimicrobial resistance by promoting transfer of resistance genes. Transfer of 
the integrating conjugative element SXT, encoding resistance to chloramphenicol, 
sulphamethoxazole, trimethoprim, and streptomycin, has been shown to be stimulated by induction 
of the SOS response in V. cholerae and E. coli and ciprofloxacin was found to promote this transfer 
6. Furthermore, activation of the SOS response in E. coli by β-lactams has been found to 
compromise the lethal effect of the agents due to a SOS-induced temporarily halt in cell division 
protecting it from the lethal effect due to that β-lactams only act on growing cells 118. In E. coli 
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expression of the qnrB gene, a plasmid-born quinolone-resistance gene, was detected and found to 
be induced by ciprofloxacin 119.   
2.1.4.3 Summary 
The SOS response can be an important player when it comes to evolution of antimicrobial 
resistance in bacteria and different classes of antimicrobials can induce this response. However, 
bacteria are constantly exposed to stressful environments and exposure to sub-inhibitory 
concentrations of biocides might not be an uncommon event in areas where they are widely used, 
such as in the food-industry and at hospitals. So far only limited knowledge is available on the 
possible effect of biocides on the SOS response and their possible effect on antimicrobial resistance 
development in bacteria. 
2.1.5 Non SOS-induced transfer of resistance genes 
Very few studies have investigated the contribution of biocides on dissemination of antimicrobial 
resistance determinants. So far, plasmid conjugation or transduction of resistance determinants in S. 
aureus has been found to be either not affected or reduced by sub-inhibitory concentrations of a 
number of biocides, including povidione-iodine, CHX, and different QACs 120,121. However one 
QAC, cetrimide was found to cause a pronounced increase in the transducing efficiency 121. Thus, 
there is a lack of results in this area in order to establish the risk of the contribution of biocides in 
transfer of antimicrobial resistance genes. 
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CHAPTER II 
3 Summary of own results from the three manuscripts included and 
discussion 
Biocides have become invaluable compounds in the industrialized world in many aspects providing 
society with a number of benefits. However, the large and increasing amount of biocide usage has 
led to concerns on development and emergence of bacteria with reduced susceptibility to biocides 
and the possible contribution of biocide usage on antimicrobial resistance development in bacteria.     
The overall objective of this PhD study is the development of bacterial resistance to biocides and 
antimicrobial agents as a consequence of biocide usage and has resulted in three manuscripts 
(Manuscript I-III). In Manuscript III the susceptibility of porcine S. aureus isolates to commonly 
used biocides in pig farming and the presence of co-resistance to antimicrobial agents are examined. 
In Manuscript II and I the possible role of sub-inhibitory concentration of biocides on antimicrobial 
resistance development by increasing the mutation rate in S. aureus (Manuscript II) or by inducing 
the horizontal transfer of the tet(M) gene (Manuscript I) are investigate.  
In this chapter, results obtained in Manuscript I-III are summarized and discussed in respect to the 
hypotheses presented in the introduction. In the first part results from Manuscript III are presented 
and discussed. This is followed by a presentation of results obtained from Manuscript II and 
Manuscript I, which will be discussed together. 
3.1 The susceptibility of porcine S. aureus isolates belonging to CC398 and CC30 
to biocides used for disinfection in pig farming 
Knowledge about the occurrence of reduced susceptibility to active biocidal substances in natural 
bacterial isolates is limited. In the study of manuscript III the susceptibility of S. aureus pig isolates 
to active biocidal substances present in commonly used biocides for disinfection in pig farming was 
investigated. The selection of biocides was based on a report by the National Food Institute, 
Technical University of Denmark that constituted a characterization of Danish finisher herds 12. 
From this report it was obvious that many different substances were used for disinfection of finisher 
herd stables and that the use of active biocidal substances belonging to the chemical groups of 
chlorine compounds, oxidizing compounds, QACs, aldehydes and strong alkaline compounds were 
frequent 12.  
No standardized methods exist for susceptibility testing of microorganisms to biocides and it was 
therefore decided to use pre-existing methods for susceptibility testing of bacteria to antimicrobial 
agents comprising the CLSI Approved standard for MIC determinations 122 and the NCCLS 
approved Guideline for determination of MBCs 123. In both cases the microdilution method was 
used with 2-fold increasing concentrations. MICs and MBCs were measured to explore if 
differences in susceptibility were present at the inhibitory or the bactericidal level.  
S. aureus isolates belonging to CC398 and CC30 are the most and second most frequently identified 
methicillin sensitive S. aureus (MSSA) isolates among Danish pigs. Pigs are increasingly 
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recognized as a potential reservoir of community-acquired MRSA CC398 that has been found to 
cause infections in human 11. Recently, S. aureus CC30 was for the first time described as MRSA in 
Danish pigs and the first cases of human nasal carriage of porcine associated MRSA CC30 has been 
detected 124. MRSA and MSSA pig isolates belonging to CC398 and CC30 was therefore included 
in the study to examine their susceptibility to the different active biocidal agents used in pig 
farming. Isolates included in the study originated from diagnostic as well as colonization samples 
from pigs from several farms and slaughter houses.  
3.1.1 No widespread selection for reduced susceptibility in porcine S. aureus isolates to 
disinfectants commonly used in pig farming  
The obtained MIC- and MBC-values each gave rise to continuous distributions that were within the 
MICs and MBCs of the control strain. No sub-populations with reduced susceptibility to the tested 
active biocidal substances, based on increases in the MIC- and MBC-values, were therefore 
detected. The inhibitory and bactericidal concentrations were all well below working 
concentrations. Consequently, if proper disinfectant procedures are followed eradication of pig S. 
aureus isolates belonging to CC398 and CC30 do not seem to be an issue. Since isolates were 
collected from pigs originating from various farms and the biocide selection was based on a general 
overview of disinfectant compounds used in finisher herds, this study cannot be used for 
dose/response information. However, it would be interesting to compare isolates collected from 
farms using different biocidal products or different levels of consumption of the same compounds.  
Even though the susceptibility testing of S. aureus pig isolates did not suggest that reduced 
susceptibility was present, the results do not give information about the possibility of a time-
dependent development of reduced susceptibility to the compounds. This would require bacterial 
isolates collected before the introduction of the different biocides. In a study by Skovgaard et al. 
(2013) they investigated the triclosan susceptibility of Danish human clinical Staphylococcus 
epidermidis blood isolates from before (old) and after the introduction (current) of triclosan in 
Denmark 91. They found that the collection of current isolates included significantly more triclosan 
(MIC≥0.25 µg/ml) tolerant isolates (12.5%) compared to the collection of old isolates (0%). The 
authors suggested that the wild-type S. epidermidis population structure had changed due to 
adaptation to the widespread use of triclosan resulting in a triclosan tolerant subpopulation present 
in Denmark 91.  
The susceptibility testing of S. aureus isolates to biocides did have some limitations. In terms of 
disinfection procedure the actual rate of killing may have been more correct and important assay to 
use instead of determining the concentration at which a 99.9% killing of the final inoculums is 
reached (MBC-value). However, this method is too laborious to handle as many isolates that was 
included in the study. Furthermore, alkaline calcium compounds/lime was the most widely used 
compounds for disinfection of pig finisher herds. However, lime is not suitable for susceptibility 
testing by the methods employed in this study, and the strong alkaline calcium compound calcium 
hydroxide has very low water solubility. Caustic soda however is widely used for cleaning purposes 
in stables and has disinfecting properties 32 and was therefore included instead of alkaline calcium 
compounds or lime. 
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3.1.1.1 Detection of the QAC resistance gene, qacG, in MRSA CC30 isolates 
Efflux-mediated resistance to QACs have been described in staphylococci of human 57,66–68, animal 
63,69,70, and food-related 61,71,125 origin. The presence of certain qac genes does not necessarily give 
rise to an increase in the MIC toward the QAC BC. All isolates were therefore investigated in an 
EtBr-based efflux pump activity assay for increased activity. Four MRSA CC30 isolates showed 
increased EtBr efflux activity and the presence of the QAC resistance gene, qacG, was identified in 
all of the isolates. The qacG gene has previously been identified in staphylococci isolated from food 
processing plant 125, from bovine (unpasteurized milk) 70, and in porcine MRSA (CC9). The food-
related staphylococci isolates were collected from different food processing plant and the qacG-
containing isolates from bovine comprised two different coagulase-negative species 
(Staphylococcus cohnii and Staphylococcus warneri) from two different herds. In our study qacG 
was identified in three isolates of S. aureus collected from pigs at the same slaughter house, which 
however originated from different farms and from a S. aureus isolate collected from an unrelated 
farm. This suggests that qacG might be widespread “from farm to fork”. In the study by Bjorland et 
al. (2005) they found a widespread distribution of QAC resistance genes among bovine and caprine 
origin. The fact that they identified qacG in two different staphylococci species with 100% identical 
gene sequences that was found to be located on highly similar plasmids suggested that interspecies 
dissemination of qacG occurs 70.     
Two of the S. aureus pig isolates containing the qacG gene was found to have the highest MIC (8 
µg/ml) to BC than the remaining isolates, whereas the other two qacG positive isolates had MICs of 
4 µg/ml that was identical to several of the qacG negative isolates. However, the MBC-values to 
BC for all four isolates (8 µg/ml) were similar to several of the qacG negative S. aureus isolates. 
Even though the susceptibility to BC for qacG positive and negative isolates generally were similar, 
incorrect use of disinfectants or the presence of residual concentrations may result in bacteria being 
exposed to low concentrations of disinfectants that might give strains harbouring QAC resistance 
genes a selective advantage. Furthermore, Heir et al. (1999) demonstrated that qacG positive 
isolates by exposure to sub-lethal levels of BC could be adapted to grow at higher BC 
concentrations 60. The presence of the QAC resistance gene, qacG, in MRSA isolates and exposure 
to sub-lethal concentration of QACs might make the task of eradication of MRSA more difficult. 
3.1.1.2 Co-selection to antimicrobial agents was not detected  
The various qac genes are widespread among Gram positive (mainly staphylococci) and Gram 
negative bacteria and can be associated with mobile genetic elements including resistance genes to 
antimicrobial agents 57,59,68,92–94. This may lead to co-selection and maintenance of these elements 
due to antimicrobial treatment or disinfection with QACs.  
Three of the qacG positive S. aureus pig isolates were whole genome sequenced. The qacG gene in 
these isolates was found likely to be located on the pST94 or a pST94-like plasmid on which qacG 
was detected for the first time. The presence of antimicrobial resistance genes on this plasmid has 
so far not been detected 60. The presence of qacG in these isolates is therefore not likely to give rise 
to co-selection of resistance to antimicrobial agents by QACs. The presence of a QAC resistance 
gene on a small plasmid without any additional resistance genes however indicate that a selective 
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pressure from the use of QACs is presents in the environment. It is possible that pST94 can acquire 
additional genes, such as antimicrobial resistance determinants, from other mobile genetic elements 
by homologous recombination. Furthermore, it is also plausible that the small plasmid can be taken 
up by larger conjugative plasmids encoding multiple antimicrobial resistance genes. The QAC 
resistance gene smr are associated with the pSK41 family of staphylococci multi-resistance 
plasmids. Several of the antimicrobial resistance determinants carried by the pSK41 plasmid family 
have been found to be located on smaller co-integrated plasmids 93. It has been suggested that the 
resistance genes have been collected by pre-existing conjugative plasmids via transposon insertion 
and insertion sequences (IS257)-mediated co-integrative capture of other plasmids 93.  
One of the qacG positive MRSA CC30 isolates was found to be phenotypically resistant to 
gentamicin. This antimicrobial agent can be used for treatment of S. aureus infections. Exposure to 
low concentrations of QACs may therefore select for MRSA strains that are resistant to clinically 
important antimicrobial agents.   
3.1.2 Porcine S. aures isolates are resistant to antimicrobial agent typically used in pig, 
however a high level of CIP resistance was observed 
The phenotypic resistance profile of S. aureus pig isolates to antimicrobial agents in generally 
correlated with the use of antimicrobial agents in the Danish pig production. However, one 
exception was the high occurrence of CIP resistance (20 %) in S. aureus CC398 MRSA and MSSA 
isolates, since only low amount of this compound is used in pigs. Other environmental conditions 
may therefore contribute to the development of ciprofloxacin resistance in these strains. 
Ciprofloxacin resistance can arise from mutations in the chromosome including the molecular 
targets DNA gyrase and topoisomerase IV or in genes resulting in overexpressing of naturally 
occurring multi-drug efflux pumps having ciprofloxacin as a substrate 36. The study of Manuscript 
II demonstrated that exposure to sub-inhibitory concentrations of HP and PAA could significantly 
increase the mutation rate in S. aureus isolates and may contribute to the development of CIP 
resistance. However, this is merely speculation and will require further experiments to elucidate. 
3.2 The potential of biocides to increase antimicrobial resistance in bacteria 
3.2.1 Certain biocides can induce the SOS response and increase mutagenesis in S. aureus 
Within recent years is has been suggested that the SOS response system in bacteria might be an 
important player in development and emergence of antimicrobial resistance. Activation of the SOS 
system can induce mutagenesis in bacteria giving rise to mutation-mediated resistance to certain 
therapeutic antimicrobials. Furthermore, induction of the SOS response has been found to induce 
the transfer of antimicrobial resistance genes 126. Several factors have been shown to induce the 
SOS response including some antimicrobial agents, pH-extremes, high pressure, and oxidative 
agents, however, knowledge about the stress response to various biocidal agents in bacteria are 
limited. 
BC, CHX, HP, PAA, and SH are biocides widely used in health care facilities, food production, 
and/or in animal husbandry. Their ability to induce the SOS response was tested in S. aureus using 
a recA-lacZ fusion strain. BC, CHX, and HP were shown to be inducers of the SOS response in S. 
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aureus, whereas SH was not. Sub-inhibitory concentrations of these biocides were investigated for 
their potential to increase the mutation rate in different S. aureus isolates and HP and PAA were 
found to significantly (p ≤ 0.05) increase mutagenesis and the development of resistance by 5-15-
fold and 3-8-fold, respectively.  
Stress-induced mutagenesis is important for evolution of drug resistance in pathogens; several 
studies have demonstrated a SOS-dependent induction of mutagenesis resulting in increased 
development of resistance to the exposed antimicrobial compound or other drugs 7–10. A study by 
Cirz et al. (2005) demonstrated by in vitro and in vivo (murine infection model) studies that E. coli 
was unable to develop resistance to either ciprofloxacin or rifampicin in cells by preventing 
induction of the SOS response 7. Introduction of mutations into the chromosome of bacteria is in 
general an important factor in driving bacterial evolution. Mutations can be deleterious or neutral to 
the cell hence, for well adapted strains a low constant mutation rate are probably beneficial in the 
long run. Conversely, in stressful environments an increase in mutagenesis induces genomic 
instability and might result in the development of mutations that are advantageous to the cell 127. 
Hence, use of and bacterial exposure to biocides that are capable of increasing mutagenesis in 
bacteria might potentially accelerate adaptive evolution in populations. This can subsequently result 
in development of bacterial persisters in their surrounding environment, such as the hospital 
environment, the food processing industry or in animal husbandry and potentially compromise 
patient and food safety. 
3.2.2 Ethanol can induce transfer of Tn916 
To investigate if bacterial exposure to sub-inhibitory concentrations of biocides can affect the 
spread of resistance genes the transfer of Tn916 in B. subtilis was used as a model system. The 
conjugative transposon Tn916 is the prototype of a large family of related elements (Tn916-like 
elements) that has an extremely broad host range; they have been found in at least 36 genera, 
including pathogenic and commensal bacteria 13. Nearly all the members of the Tn916 family of 
conjugative transposons have been found to encode TET resistance; however some members of this 
family also confer resistance to other antimicrobial agents such as macrolides and kanamycin. 
Furthermore, Tn916-like elements can be associated with non-conjugative transposons (e.g. Tn917), 
including additional antimicrobial resistance genes 13. Tn916 and Tn916-like elements therefore 
constitute important vectors in the dissemination of antimicrobial resistance. The conjugation 
experiment was carried out in B. subtilis because a gusA (encoding β-glucuronidase) reporter 
construct estimating transcription from the tet(M) promoter was available. Transcription of tet(M) 
in Tn916 is thought to give rise to transcription of genes involved in recombination and 
conjugation. The reporter construct was therefore used in a β-glucuronidase assay to estimate 
exposure times of each biocidal compound that gave rise to changes in transcription and possibly in 
Tn916 transfer. Based on the results from the β-glucuronidase assay the conjugation experiment 
was set-up by pre-exposing donors in sub-inhibitory concentrations of biocides for the determined 
times. 
Ethanol was found to significantly (p < 0.05) increase transfer of Tn916 by an average of 5-fold, 
whereas an average increase of 4-fold on Tn916 conjugation was observed (p = 0.12) when donors 
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were pre-exposed to hydrogen peroxide. In comparison, TET was found to increase transfer by 12-
fold (p < 0.05) in average. This is in contrast to CHX that caused a small reduction (0.7-fold) and 
SH that did not have an effect on Tn916 transfer. The results of the β-glucuronidase reporter assay 
and the conjugative transfer of Tn916 was in good correlation; compounds giving rise to an 
increase, a reduction or no response in the GusA activity was overall found to have the same effect 
on the transfer frequency. ETOH and CHX are both membrane active compounds; however their 
chemical structures differ why the overall effect on cells may be different. Also, HP and SH are 
both highly oxidizing compounds, nevertheless an increasing effect on the β-glucuronidase activity 
and an increase in the conjugative transfer of Tn916 could only be suggested for exposure to HP. 
Interestingly, HP has been shown to cause reversible dissociation of ribosomes which might 
therefore result in fewer active ribosomes and thereby slowing down protein synthesis in a similar 
manner as TET. Since the efficacy of a biocidal compound is very reliant on the concentration and 
contact time with the microorganism it cannot be rejected that CHX and SH under different test 
conditions can promote the transfer of Tn916. Based on these results it is therefore apparent that 
compounds with the same overall effect on bacteria do not necessarily induce the same response in 
the cell. 
As mentioned above transcription of tet(M) in Tn916 is hypothesised to give rise to transcription of 
genes involved in recombination and conjugation of the Tn916 element. Furthermore, transcription 
of tet(M) is believed to be regulated by a tetracycline dependent transcriptional attenuation 
mechanism; the upstream region of tet(M) is predicted to encode a leader-peptide (orf12) and 
transcriptional read-through of orf12 is believed to result in transcription of tet(M), which then 
initiate the regulatory cascade leading to increased expression of genes required for recombination 
and the conjugative transfer of Tn916 128,129. Exposure to TET inhibits most of the ribosomes in the 
cell, except for those that are protected by the basal level of Tet(M) production. This will 
subsequently slow down translation and result in the build-up of charged-tRNA molecules leading 
to increased expression of tet(M) and the recombination and transfer genes. A very interesting 
aspect of this regulation process is that any compound that increase the pool of charged-tRNA 
molecules in the cell is likely to increase transcription of tet(M) and possibly increase transfer of 
Tn916 13. Furthermore, the regulatory region of Tn916 is conserved in nearly all the Tn916-like 
elements. ETOH may not only induce the spread of Tn916, but also other members of the Tn916-
like family and their resistance genes. In theory any compound in addition to TET that leads to the 
build-up of charged tRNA-molecules might induce the spread of Tn916 and members of the Tn916-
like family 13.  
3.2.3 Indirect selection of resistance to antimicrobial agents by biocides 
Results from the studies of manuscript I and II demonstrate that exposure to sub-inhibitory 
concentrations of various biocides can induce development of antimicrobial resistance and 
emergence in bacteria by increasing the horizontal transfer of the TET resistance gene tet(M) and 
by increasing the mutation rate in S. aureus. This means that inappropriate consideration of the 
factors affecting the efficiency of biocides might contribute to the development of antimicrobial 
resistance in bacteria. Another factor to consider as a possible contributor of resistance development 
is the presence of residual concentrations of biocides after disinfection. It is well known that 
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prudent use of antimicrobial agents for treatment of humans and animals has driven the dramatically 
increase in antimicrobial resistance in human and animal pathogens. However, the above data 
indicate that not only the direct selection of resistance genes by use of antimicrobial agents occur, 
but also the indirect selection by biocides may contribute to resistance development.  
The overall risk assessment of these findings is however difficult to determine due to several 
factors. The effect of biocides is investigated for sub-inhibitory concentrations of biocides because 
bacterial exposure to low concentrations of these compounds in natural environments might occur 
due to previously mentioned factors. However, the occurrence of these microenvironments in real 
life needs to be elucidated. Furthermore, the relevance of in vitro findings in situ is unknown. The 
results of in vitro studies nevertheless point toward what may occur in natural environments.  
4 Concluding remarks and future perspective 
No widespread selection for reduced susceptibility to commonly used disinfectants in pig farming 
in porcine S. aureus isolates was detected. However, a biocide resistance gene, qacG, was identified 
in several of the MRSA isolates, which has also been found in other animal related staphylococci. 
Surveillance of the occurrence and emergence of reduced susceptibility to biocides in bacteria are 
however, still encouraged, since this will provide important data to determine if decreased 
susceptibility to biocides happen over time. The increasing use of whole genome sequencing 
encourage to development of simple and easy to handle bioinformatic tools that can be used for 
instance to determine if the bacterial isolate has acquired biocide resistance genes and the possible 
linkage to antimicrobial resistance genes. In our research group a data base has been constructed 
that are able to identify the presence of any known acquired antimicrobial resistance gene. A similar 
tool could be constructed for all known biocide resistance genes. This would be very useful 
especially because phenotypically detection of resistance to biocides are difficult since the presence 
of biocide resistance genes in general give rise to modest changes in susceptibility. Within this PhD 
study sequences of all known qac genes and their variants have been collected and a database for 
identification of qac genes is currently under construction. 
 
Importantly, the data from this thesis demonstrated a potential of certain biocides to contribute to 
antimicrobial resistance development and emergence in bacteria. Of the four biocides examined 
ethanol was found to induce transfer of the conjugative transposon, Tn916, that includes the 
tetracycline resistance gene tet(M). Furthermore, hydrogen peroxide and peracetic acid were shown 
to increase the mutation rate and antimicrobial resistance emergence in S. aureus isolates. On the 
short term these results emphasises that correct use of biocides are of outmost importance and 
should not be compromised. On the long term, more studies are needed to elucidate the actual risk 
of biocide use on generating antimicrobial resistant bacteria in practice. Moreover, the presence of 
residual concentrations after disinfection should be assessed, since these concentrations may give 
rise to bacterial exposure to low non-lethal concentrations. Furthermore, there is a need for data on 
quantities of biocide consumption making it possible to conduct dose / response studies. Knowledge 
about the consumption of the different biocidal substances in combination with data on their 
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potential of developing antimicrobial resistance are necessary to determine which biocides create 
the highest risk of contributing to antimicrobial resistance in bacteria.  
 
Many biocidal compounds exist and the activity of biocides are very dependent on the 
concentration, therefore, simple and fast screening methods to investigate the effect on bacteria of a 
variety of biocides at multiple concentrations at one time would be very useful. For future studies 
there is a need for standardized methods to determine the susceptibility of bacteria to biocides and 
to estimate the potential contribution to antimicrobial resistance development. This will make 
scientific data obtained from different studies more comparable and valuable in overall risk 
assessment. Surveillance programmes using these standardized methods will then be able to 
monitor the level of biocide resistance and co- and cross-resistance to antimicrobial agents in all 
areas where biocides are used. 
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Abstract 
OBJECTIVES; large amounts of biocides are used to reduce and control bacterial growth in 
the health care sector, food production and agriculture. It has been suggested that bacterial 
exposure to sub-inhibitory concentrations of biocides may induce DNA transfer between 
bacteria. Here we investigated the effect of sub-inhibitory concentrations of the four 
commonly used biocides; ethanol, hydrogen peroxide, chlorhexidine digluconate and sodium 
hypochlorite on the conjugative transposition of the mobile genetic element Tn916.  
METHODS; conjugation assays were carried out between B. subtilis strains where the donor 
containing Tn916 was pre-exposed to sub-inhibitory concentrations of each biocide for a 
defined length of time.   
RESULTS; ethanol was found to significantly (p < 0.05) increase transfer of Tn916 by 5-
fold, whereas an increase of 4-fold on Tn916 conjugation frequency was observed (p = 0.12) 
when donors were exposed to hydrogen peroxide. Chlorhexidine digluconate and sodium 
hypochlorite did not induce an increase in transfer frequency.  
CONCLUSIONS; these results suggest that exposure to sub-inhibitory concentrations of 
ethanol and hydrogen peroxide may induce the spread of Tn916-like elements and their 
resistance genes, which is clinically important since these biocides are frequently used in 
hospitals. 
 
Introduction 
Biocides are chemical compounds capable of inactivating microorganisms 1. These are used 
for disinfection, antisepsis and preservation to inhibit or reduce bacterial loads in various 
settings such as the health care sector, agriculture and the food industry 1,2. In Denmark, the 
yearly consumption of biocides has been estimated to comprise up to 5,000 tonnes 2, 
compared to less than 160 tonnes of antimicrobial agents for therapy 3. Despite the 
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widespread use of these compounds, our knowledge about their mode of action, especially at 
sub-inhibitory concentrations, and the microbial response to exposure is relatively limited 4,5. 
The working concentrations of disinfectants and antiseptics are generally much higher than 
the lethal dose, however the efficacy of a biocide can be significantly reduced due to the 
presence of organic matter (e.g. blood, serum, pus, and food debris), over-dilution or 
insufficient contact time with microorganisms. Also, the presence of residual concentrations 
might result in bacterial exposure to sub-inhibitory concentrations 6.   
During recent years, it has been suggested that the use of biocides might lead to increased 
resistance to antimicrobial agents used for treatment of humans and animals, through 
increasing mutation rates in bacteria or increasing horizontal gene transfer 7,8, however 
evidence for such an increase is currently lacking 9. Previously studies have shown that stress 
in bacteria caused by sub-inhibitory concentrations of antibiotics can promote transfer of 
antibiotic resistance and virulence genes 10–13. However, the effect of different biocides has 
been much less studied.  Plasmid conjugation or transduction in Staphylococcus aureus of 
resistance determinants has been found to be either not affected or reduced by sub-inhibitory 
concentrations of a number of biocides, including povidone-iodine, chlorhexidine, and 
different quaternary ammonium compounds 14,15. However one compound cetrimide was 
found to cause a pronounced increase in the transduction efficiency 14. Effects of biocides on 
transfer of other resistance determinants and in other species have however, not been studied. 
Mobile genetic elements such as conjugative transposons are important vectors in the 
dissemination of antibiotic resistance determinants. Tn916 is a conjugative transposon and 
the prototype of a large family of related elements. They have an extremely broad host range, 
including more than 30 bacterial genera, and have been found in both pathogenic and 
commensal bacteria 16. Most of these elements contain the tetracycline resistance gene tet(M), 
but some members of this family also confer resistance to other antimicrobial agents; 
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macrolides, kanamycin, mercury and cetrimonium bromide (CTAB). Furthermore, Tn916-
like elements have also been found to be associated with non-conjugative transposons (e.g. 
Tn917), which contain additional antibiotic resistance genes 16,17.  It has been hypothesised 
that transcription of tet(M) in Tn916 leads to transcription of downstream genes involved in 
recombination and conjugation of the element and that transcription of tet(M) is regulated by 
a tetracycline dependant transcriptional attenuation mechanism reliant on the levels of 
charged-tRNA molecules within the cell 18,19.  It has subsequently been suggested that any 
stress that the cell encounters (other than exposure to tetracycline) that results in the build-up 
of charged-tRNAs is also likely to cause an increase in transcription of tet(M) and 
downstream genes and possibly an increase in transfer 16. 
The aim of this study was to investigate the effect of sub-inhibitory concentrations of four 
commonly used biocides; ethanol, hydrogen peroxide, chlorhexidine digluconate and sodium 
hypochlorite on the conjugative transposition of Tn916.  
  
Material and methods 
Chloramphenicol (CHL), fusidic acid sodium salt (FUS), rifampicin (RIF), streptomycin 
sulphate salt (STR) and tetracycline hydrochloride (TET) were purchased from Sigma. 
Tetracycline discs (30 µg) were from Oxoid. BHI agar and broth were obtained from either 
Oxoid or Difco. BBLTM Mueller-Hinton II broth (MH II) was from Becton, Dickinson and 
Company, and premade tryptone soya agar plates with 5 % sheep blood (blood agar plates) 
were purchased from Oxoid. Biocides included in this study were: Chlorhexidine digluconate 
(CHX), 20 % (w/v) from Alfa Aesar; hydrogen peroxide (HP), 30 % solution from Fluka; 
sodium hypochlorite (SH), 10-15 % available chlorine from Sigma and absolute ethanol 
Chemicals and reagents 
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(ETOH) from either BDH Prolabo or Kemetyl AB. 4-Nitrophenyl β-D-glucuronide was 
obtained from Sigma. 
 
All bacterial isolates and plasmids included in this study are listed in Table 1. 
Bacterial isolates 
 
In order to determine the optimal time of exposure to sub-inhibitory concentrations of the 
antimicrobials prior to filter-mating a reporter construct was generated in B. subtilis as 
follows. A 450 bp fragment of Tn916, which includes the tet(M) promoter, orf12 and the 
terminator sequences was amplified by PCR using the primers Ptet(M) For (5’-
GGCGGCG
Construction of Bacillus subtilis gusA reporter strain  
GGTACCCAAAGCAACGCAGGTATCTC-3’) and Ptet(M) Rev (5’-
GGCGGCGGAATTC
 
GTGATTTTCCTCCAT-3’). The restriction sites KpnI and EcoRI 
were included in the primers (underlined). Next the cwp2 promoter fragment was removed 
from the pUC19 based pCBR026  22 and replaced with the KpnI-EcoRI digested tet(M) 
promoter amplicon resulting in pUC19-Ptet(M)-gusA. The fused Ptet(M)-gusA was excised 
from pUC19-Ptet(M)-gusA on a  KpnI-BamHI fragment and directionally cloned into the 
corresponding sites of  pHCMCO5, resulting in the B. subtilis reporter construct, pHCMCO5-
Ptet(M)-gusA. The construct was then transformed into B. subtilis BS34A 21 using a 
previously described protocol 23. BS34A contains a wildtype copy of Tn916 therefore 
providing resistance to tetracycline. BS34A is the donor strain used in all of the transfer 
studies which is why we also used it as the reporter strain. 
Minimal inhibitory concentration (MIC)-determination of biocides by the broth microdilution 
method 
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The MIC of ETOH, HP, CHX and SH was determined as recommended by CLSI guidelines 
24. Isolates were grown over night (ON) on blood agar or BHI agar plates at 37˚C. Colonies 
were re-suspended in 0.9 % NaCl to a McFarland standard of 0.5 or an OD600 between 0.08 
and 0.13, and then 100-fold diluted in MH II. Biocide working solutions were prepared in 
MH II just before two-fold dilution series were made in 96-round bottom well microtiter 
plates (Nunc) (50 µl per well). Then, 50 µl of cell suspension was transferred to the microtiter 
plate and incubated 16-20 hours at 37˚C under aerobic conditions. Escherichia coli ATCC 
25922 or S. aureus ATCC29213 were included as control strains for reproducibility of the 
susceptibility testing procedure. The MIC-value was defined as the lowest concentration of 
the compounds giving rise to no visible growth. MIC-determinations were done in duplicates 
and as a minimum repeated twice. 
 
Culture preparation for β-glucuronidase enzyme assay 
Effect of biocides on β-glucuronidase enzyme activity 
B. subtilis BS34A:: pHCMCO5-Ptet(M)-gusA was grown ON at 37˚C on BHI agar plates 
supplemented with 10 µg/ml CHL to select for the reporter plasmid construct. Cells were 
inoculated in 20 ml BHI (without CHL) and grown ON at 37˚C with rotary shaking (200 
rpm). ON cultures were diluted to an OD600 of approx 0.1 in 500 ml Erlenmeyer flasks 
containing a final volume of 100 ml BHI broth and incubated at 37˚ C with shaking. After two 
hours of growth TET (10 µg/ml) and sub-inhibitory concentrations of biocides (MIC/4) were 
added to the cultures. OD600 was measured and 5 ml samples were collected before (1.5 h and 
2.0 hours of growth) and after addition of the compounds (0.5 h, 1.0 h, 1.5 h and 2.0 h of 
exposure). Cells were harvested by centrifugation (3000 × g, 4 ˚C, 10 min) and pellets were 
stored at -80˚C. Cells from each of the 2.0 h samples were plated on BHI and BHI 
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supplemented with 10 µg/ml CHL agar to determine the stability of pHCMCO5-Ptet(M)-
gusA.   
 
Measurement of β-glucuronidase enzyme activity 
The β-glucuronidase activity was measured as previously described with some modifications 
25: Cell pellets were thawed at room temperature (RT) and re-suspended in 800 µl of Z-buffer 
(60 mM Na2HPO4∙7H2O; 40 mM NaH2PO4 H2O; 10 mM KCl; 1 mM MgSO4 ∙ 7H2O; 50 mM 
2-mercaptoethanol) adjusted to pH 7.0. Eight µl of toluene was added and the mixture was 
transferred to a new tube with approximately 250 µl of unwashed glass beads (150-212 µm in 
diameter) (Sigma) and treated in a RiboLyser (Hybaid) at a speed of 6.5 for 2 x 25 sec, with a 
1 min pause in-between the two runs. Lysates were cooled on ice for 2 min and glass beads 
were removed by centrifugation (3000 × g, 4˚C , 3 min). 400µl of the supernatant was 
transferred to a fresh tube and 400 µl of Z-buffer was added. Samples were incubated at 37˚C 
for 5 min and the enzyme reactions were started by adding 160 µl of 6 mM 4-Nitrophenyl β-
D-glucuronide. The enzymatic reaction was stopped after incubation at 37˚C for 5 min  with 
400 µl of a 1 M disodium carbonate solution and cell debris was removed by centrifugation 
(3000 x g, 25˚C, 10 min). Finally, OD405 of the supernatants were measured and the specific 
enzyme activities were calculated using the following equation: (A405 × 1000) / [OD600 × t 
(min) × 1.25 × vol. (ml)] 25. Experiments were performed on three separate occasions, except 
for exposure to TET, which was repeated six times.  
 
A derivative of B. subtilis BS34A, selected for resistance to STR (BS34ASTR) was used as 
the donor strain and a derivative of B. subtilis CU2189 selected for resistance to RIF and FUS 
(BSCU2189RF) was used as a recipient strain. Conjugation by filter mating was performed as 
Measurement of the effect of biocides on the conjugative transposition of Tn916  
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previously described 26 with some modifications. B. subtilis BS34ASTR and BSCU2189RF 
were grown ON at 37˚C on blood agar plates including a TET disc on the donor plate for 
selection of Tn916. Colonies from ON plates were inoculated in 10 ml BHI broth and 
incubated ON (without antibiotics) at 37˚C with shaking (150 rpm). ON cultures were diluted 
in pre-warmed BHI broth to an OD600 of approx 0.1 in 500 ml Erlenmeyer flasks to a final 
volume of 100 ml. Cultures were grown shaking (200 rpm) until donor cultures reached an 
OD600 between 0.5 and 0.6. Then, sub-inhibitory concentrations (MIC/4) of ETOH, HP, CHX 
and SH and 10 µg/ml of TET were added to separate donor cultures and further grown for 
2.0, 1.5, 0.5, 1.5 and 1.0 hour, respectively. The length of exposure time of each compound 
was equal to the length of that expected to have the greatest effect on transcription from the 
promoter upstream of tet(M) based on the β-glucuronidase enzyme assay. Within each 
repetition, one culture where no compound was added served as the control donor. Then, 
donor and recipient cells were harvested (6000 × g, 5 min, 4˚C) and re-suspended in BHI 
broth to an OD600 of approx 0.5 and 5.0, respectively and mixed in a 1:1 volume resulting in 
an output recipient-donor ratio of approx. 1:1. 500 µl of each mixture was transferred to a 
sterile filter (0.45 µm, white gridded, 47 mm; Millipore) placed on a BHI agar plate. The cell 
mixtures were left to absorb into the filter for 0.5 hour and then incubated at 37˚C for 17.5 
hours. After incubation mating filters were transferred to 10 ml 0.9% NaCl and re-suspended 
by vortex mixing. The numbers of donors and recipients were determined by counting on 
BHI agar supplemented with 10 µg/ml TET or 12.5 µg/ml RIF and 5 µg/ml FUS, respectively 
after 24 hours of incubation at 37˚C. Transconjugants were selected on BHI agar plates 
containing 10 µg/ml TET, 12.5 µg/ml RIF and 5 µg/ml FUS and counted after 48 h of 
incubation at 37˚ C. At least ten transconjugants from each transfer experiment were verified 
by sub-culturing on transconjugant plates twice and once on BHI agar plates supplemented 
with 100 µg/ml STR on which only donor cells can grow. Transconjugants were also 
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screened for the presence of tet(M) by PCR using primer tet(M)-1 (5’-
GTTAAATAGTGTTCTTGGAG-3’) and tet(M)-2 (5’-CTAAGATATGGCTCTAACAA-3’) 
27. Conjugation experiments were repeated five times.  
The input recipient-donor ratio and the stability of Tn916 in the control and exposed cultures 
were estimated in two of the conjugation experiments (expt 4 and 5) by plating donor pre-
mating cultures on BHI agar plates with and without the addition of 10 µg/ml TET and 
recipient pre-mating cultures on antibiotic free BHI agar plates. 
 
β-glucuronidase enzyme activity 
Data analysis   
Measures of the specific β-glucuronidase enzyme activities in exposed cultures (prior to and 
after addition of biocides) were standardized to the corresponding control sample as the 
percentage difference in β-glucuronidase enzyme activity. The transcriptional effect of 
biocides on enzyme activity was estimated as the difference in the standardized enzyme 
activity after addition of the compound (0.5 h, 1.0 h, 1.5 h and 2.0 h samples) relative to the 
enzyme activity before addition (0 h sample). The enzyme activity before addition was 
estimated as the average of the two samples collected before addition of the biocides.     
 
Conjugative transposition of Tn916 
The transfer frequencies of Tn916 were calculated as the number of transconjugants per 
output donor. The significance of changes in transfer frequencies between control and treated 
conjugations were statistically tested using the paired, two-sided, Student’s t-test, where a 
pair represents the transfer frequency of the control and the treated conjugations within an 
experimental repetition. The normality of the differences in transfer frequencies between the 
control and exposed conjugations were visually assessed using QQ-plots. 
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Results 
MIC-values of B. subtilis strain BS34A::pHCMCO5-Ptet(M)-gusA to ETOH, HP, CHX and 
SH are shown in Table 2 together with the corresponding sub-inhibitory concentrations 
(MIC/4) used in the leader peptide transcription assay and the Tn916 conjugation experiment. 
     
Transcription from the promoter upstream of tet(M) was estimated using a β-glucuronidase 
(gusA) reporter construct in B. subtilis. The effect of ETOH, HP, CHX, SH and TET on the 
β-glucuronidase enzyme activity is shown in Figure 1. The times where the greatest deviation 
in GusA activity from the normalised value were chosen as the times for pre-exposure to the 
biocides prior to filter-mating. The stability of the reporter construct pHCMC05-Ptet(M)-
gusA during all the experiments was found to be similar (an average of 74 – 85 %) at the end 
of the experiment apart from the experiment where cells were challenged with TET. In this 
experiment the average stability was 64% (supplementary Figure S1).  
Determination of the optimum time of exposure to antimicrobials prior to filter-mating 
experiments 
 
The conjugative transfer of Tn916 was studied in B. subtilis where donors were pre-grown in 
ETOH, HP, CHX, SH and TET for 2.0, 1.5, 0.5, 1,5 and 1.0 hours, respectively prior to filter 
mating. Results for the effect of biocides and TET on the conjugative transposition of Tn916 
are presented in Table 3. TET and ETOH significantly (p ≤ 0.05) enhanced transfer of Tn916 
corresponding to an average increase of 12- and 5-fold, respectively. Exposure to HP resulted 
in average in a 4-fold increase (p = 0.12) and exposure to CHX in a small (0.7-fold) decrease 
The effect of biocides on the conjugative transposition of Tn916 
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(p = 0.10) in the transfer frequency. Pre-growing donor cells in SH did not affect the transfer 
of Tn916 (p = 0.33). 
Stability of Tn916 in donor cells was assessed in pre-mating cultures and was not found to be 
significantly different between the exposed and the control cultures (supplementary Table 
S1). Some variation in the output recipient-donor ratio occurred between matings with pre-
growth of donors in TET and ETOH and the corresponding controls. When the output 
recipient-donor ratios were compared to the transfer frequencies it did not suggest that 
differences in transfer was due to variations in this ratio. Furthermore, the input recipient-
donor ratio was determined for two experiments (expt 4 and 5, data not shown). In the case of 
ETOH and TET these two experiments represented one of the larger and smaller differences 
in transfer. In both cases differences in transfer frequencies were not found to correlate with 
variations in the input recipient-donor ratio, since this ratio for the treated matings were 
within the range of the controls (supplementary Figure S2).  
 
Discussion 
The effect of sub-inhibitory concentrations of ETOH, HP, CHX, SH and TET on the conjugal 
transfer of Tn916 between B. subtilis strains was analysed. The MIC-values of B. subtilis 
BS34A to the four biocides were comparable to MIC-values found for other Gram positive 
bacteria 28–33. The sub-inhibitory concentration of each biocide used in this study was set to 
one quarter of the MIC. 
In order to determine the optimal time of pre-exposure to the various biocides prior to filter-
mating we determined the GusA activity of a plasmid based gusA under the expression of the 
Tn916 promoter upstream of tet(M). BS34A:: pHCMCO5-Ptet(M)-gusA was exposed to the 
four biocides for 2 h and the GusA activity recorded every 30 minutes. The greatest 
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difference in GusA activity occurred at 2h after exposure for ETOH, 1.5 h for HP, 0.5 h for 
CHX and 1.5 h for SH. Although a relatively crude assessment of the transcriptional activity 
of the tet(M) promoter in response to biocide exposure it provided valuable data on which to 
design the conjugation experiments. As a control the experiment was carried out with 
inhibitory concentrations of TET and the maximum response was observed at 1 h following 
exposure which agrees with the proposed mechanism for the transcriptional regulation of 
Tn916 and previous transcriptional analysis 18. 
Pre-exposing donors to TET resulted in a 12-fold increase in the transfer frequency of Tn916, 
which is in good agreement with the TET induced Tn916 transfer study reported by Showsh 
and Andrews (1992) between Bacillus subtilis and Bacillus thuringiensis subsp. israelensis 
(19-fold increase calculated as transconjugants per output recipients) 13. In our study 
exposure of donors to ETOH also significantly increased the transfer of Tn916, which 
corresponded to an average increase of 5-fold. 
An increasing and a small decreasing effect on the conjugative transposition of Tn916 could 
be seen for HP and CHX, respectively. In a previous study by Pearce et al. (1999) 14, CHX at 
the same concentration as in this study was also found not to significantly reduce (p > 0.05)  
plasmid transfer by conjugation in one mating system of S. aureus in the same range as in our 
study. Sodium hypochlorite was not found to affect the transfer frequency of Tn916 under 
our test conditions. 
In contrary to the specific action of tetracycline and antibiotics in general, biocides are 
generally believed to have multiple target sites within the cell, but knowledge about the exact 
mechanism of action is limited, especially at sub-inhibitory concentrations where only few 
target sites might be involved 4,5. Therefore the specific mechanisms of action of sub-
inhibitory concentrations of ETOH, HP, CHX and SH on cells are difficult to elucidate. 
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However one hypothesis which is currently being tested is that the multiple, unspecific 
actions of the biocides slow down protein synthesis and lead to an increase in the pool of 
charged-tRNAs within the cell; the rate determining step in the de-repression of 
transcriptional attenuation proposed for Tn916 18. Since the regulatory region of Tn916 is 
conserved in nearly all of the Tn916-like elements 16 ETOH and HP might therefore not only 
induce the spread of Tn916, but also other members of the Tn916-like family and their 
resistance genes.  
An increase in horizontal transfer of Tn916 is worrying from a clinical perspective. Ethanol is 
primarily used for hard surface disinfection and skin antisepsis in hospitals, but is also widely 
used for disinfection in the food industry, day care institutions and for preservation purposes 
1,2,34. Hydrogen peroxide is widely used for disinfection, antisepsis and sterilization purposes 
and is commonly used in the food industry, in hospitals and in agriculture 1,2. Incorrect use of, 
or the presence of residual concentrations of these biocides may therefore promote the spread 
of Tn916 and possibly other elements belonging to the Tn916-like family.  
In summary, these results show that sub-inhibitory concentrations of ETOH and to a lesser 
degree HP increase the transfer frequency of Tn916. Current investigations are focused on 
determining the exact molecular mechanisms for this increase in transfer frequency with the 
obvious focus being on the effect on transcriptional attenuation upstream of tet(M). The 
results of this study emphasise the importance of correct use of biocides and demonstrate that 
transfer of Tn916 encoded antibiotic resistance may be promoted by sub-inhibitory 
concentrations. 
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FIG. 1. The average effect of ethanol (ETOH), hydrogen peroxide (HP), chlorhexidine 
digluconate (CHX), sodium hypochlorite (SH), and tetracycline (TET) on β-glucuronidase 
enzyme activity. Data illustrate changes in enzyme activity after addition of compounds (0.5 
h to 2.0 h) relatively to before addition (0.0 h). Experiments investigating the effect of TET 
were repeated six times, whereas the effect of biocides was repeated three times. Error bars 
represent ± standard deviation. 
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TABLE 1. Bacterial isolates and plasmids included in this study. Abbreviations: RIF, rifampicin; 
FUS, fusidic acid; TET, tetracycline; STR, streptomycin; CAMR, chloramphenicol resistant.  
 Relevant properties Reference or source 
B. subtilis   
CU2189 Recipient strain 20 
BSCU2189RF RIF and FUS resistant derivative of CU2189  This study 
BS34A B. subtilis::Tn916 (CU2189 x FM12A). TETR, contains a single 
copy of Tn916 
21 
BS34ASTR STR resistant derivative of BS34A This study 
BS34A:: 
pHCMCO5-
Ptet(M)-gusA 
BS34A including plasmid pHCMC05 containing a Ptet(M)-gusA 
construct, and CAMR marker 
This study 
 
Plasmids 
  
pCBR026 pUC19 containing the gusA reporter gene under the control of the 
cwp2 promoter from Clostridium difficile 
22 
pUC19-
Ptet(M)-gusA 
pCBR026 with the cwp2 promoter replaced by the tet(M) promoter 
upstream of gusA 
This study 
pHCMCO5 Escherichia coli / B. subtilis shuttle vector Bacillus Genetic Stock 
Centre, USA 
pHCMCO5-
Ptet(M)-gusA 
pHCMC05 containing the tet(M) promoter upstream of gusA This study 
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TABLE 2. Minimal inhibitory concentrations (MICs) and sub-inhibitory concentrations 
(MIC/4) to ethanol (ETOH), hydrogen peroxide (HP), chlorhexidine digluconate (CHX) and 
sodium hypochlorite (SH) determined for B. subtilis containing the gusA reporter construct 
(BS34A::  
pHCMCO5-Ptet(M)-gusA) and B. subtilis used as donor in the Tn916 transfer experiment 
(BS34ASTR).  
 
 BS34A::  
pHCMCO5- 
Ptet(M)-gusA BS34ASTR 
Biocide MIC MIC/4 MIC MIC/4 
ETOH (%) 16 4 8  2 
HP (%) 0.008 0.002 0.004 0.001 
CHX (%) 0.0002 0.00005 0.0002  0.00005 
SHa (%) 0.5 0.125 0.5 0.125 
aSH solution containing 14 % available chlorine. 
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TABLE 3. The effect of ethanol (ETOH), hydrogen peroxide (HP), chlorhexidine digluconate 
(CHX) sodium hypochlorite (SH) and tetracycline (TET) on the conjugative transfer of 
Tn916. Transfer frequencies were calculated as transconjugants per output donor cells. The p-
value was determined using the paired Student’s t-test. Abbreviations: R; recipient, D; donor, 
TF; transfer frequency.  
 
 Output cells (CFU/ml)  
 Control Exposure to ETOH (2 %) TF ratio 
(ETOH / control) Expt. R D R / D TF R D R / D TF  
1 2.8E+09 2.1E+09 1.4 4.8E-10 2.7E+09 1.0E+09 2.7 1.6E-09 3.2  
2 4.4E+09 2.3E+09 1.9 1.1E-09 4.5E+09 1.5E+09 3.0 1.9E-09 1.7  
3 2.4E+09 2.6E+09 0.9 3.5E-10 6.9E+09 1.4E+09 5.0 2.0E-09 5.9  
4 3.3E+09 5.1E+09 0.7 3.3E-10 5.2E+09 1.8E+09 2.9 3.3E-09 9.9  
5 2.1E+09 1.7E+09 1.2 1.0E-09 4.3E+09 1.8E+09 2.4 2.9E-09 2.9  
Avg. 3.0E+09 2.8E+09 1.2 6.6E-10 4.7E+09 1.5E+09 3.2 2.3E-09 4.7 p-value  
0.01 SD 9.0E+08 1.4E+09 0.5 3.8E-10 1.5E+09 3.4E+08 1.0 7.4E-10 3.3 
 
 Output cells (CFU / ml)  
 Control Exposure to HP (0.001 %) TF ratio 
(HP / control) Expt. R D R / D TF R D R / D TF  
1 2.5E+09 2.3E+09 1.1 4.4E-10 4.4E+09 9.6E+08 4.6 4.6E-09 10.3  
2 5.2E+09 3.6E+09 1.4 1.3E-09 4.9E+09 3.5E+09 1.4 1.6E-09 1.3  
3 3.1E+09 2.6E+09 1.2 4.6E-10 3.6E+09 2.7E+09 1.3 7.7E-10 1.7  
4 3.2E+09 2.2E+09 1.4 1.8E-09 2.6E+09 2.6E+09 1.0 2.4E-09 1.3  
5 2.5E+09 2.4E+09 1.0 5.1E-10 3.1E+09 1.8E+09 1.7 2.7E-09 5.2  
Avg. 3.3E+09 2.6E+09 1.2 9.1E-10 3.7E+09 2.3E+09 2.0 2.4E-09 4.0 p-value  
0.12 SD 1.1E+09 5.6E+08 0.2 6.3E-10 9.5E+08 9.6E+08 1.5 1.4E-09 3.9 
 
 Output cells (CFU / ml)   
 Control Exposure to CHX (0.00005 %) TF ratio  
(CHX / control) 
 
Expt. R D R / D TF R D R / D TF  
1 3.9E+09 1.9E+09 2.1 4.6E-10 5.2E+09 1.5E+09 3.6 4.8E-10 1.0  
2 5.2E+09 2.7E+09 1.9 1.3E-09 4.8E+09 2.5E+09 1.9 6.8E-10 0.5  
3 4.5E+09 2.5E+09 1.8 3.1E-10 3.1E+09 2.8E+09 1.1 2.3E-10 0.7  
4 2.4E+09 2.6E+09 0.9 6.4E-10 4.8E+09 3.3E+09 1.5 3.0E-10 0.5  
5 1.9E+09 1.0E+09 1.8 2.0E-09 3.3E+09 1.9E+09 1.7 1.8E-09 0.9  
Avg. 3.6E+09 2.1E+09 1.7 9.3E-10 4.2E+09 2.4E+09 2.0 6.9E-10 0.7 p-value 
0.10 SD 1.4E+09 7.0E+08 0.5 6.8E-10 9.7E+08 7.3E+08 1.0 6.3E-10 0.3 
 
 Output cells (CFU/ml)  
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 Control Exposure to SHa (0.125 %) TF ratio 
(SH / control) Expt. R D R / D TF R D R / D TF  
1 2.5E+09 2.3E+09 1.1 4.4E-10 2.5E+09 2.5E+09 1.0 3.8E-09 8.6  
2 5.2E+09 3.6E+09 1.4 1.3E-09 3.7E+09 4.7E+09 0.8 1.6E-09 1.2  
3 3.1E+09 2.6E+09 1.2 4.6E-10 4.3E+09 3.0E+09 1.4 1.2E-09 2.5  
4 3.2E+09 2.2E+09 1.4 1.8E-09 3.3E+09 4.0E+09 0.8 9.3E-10 0.5  
5 2.5E+09 2.4E+09 1.0 5.1E-10 2.5E+09 1.9E+09 1.3 9.5E-10 1.9  
Avg. 3.3E+09 2.6E+09 1.2 9.1E-10 3.3E+09 3.2E+09 1.1 1.7E-09 2.9 p-value  
0.33 SD. 1.1E+09 5.6E+08 0.2 6.3E-10 8.0E+08 1.1E+09 0.3 1.2E-09 3.2 
aSH solution containing 14 % available chlorine. 
 
 
 
 Output cells (CFU / ml)   
 Control Exposure to TET (10 µg/ml) TF ratio 
(TET / control) 
 
Expt. R D R / D TF R D R / D TF  
1 3.8E+09 2.1E+09 1.8 1.8E-09 2.4E+09 2.4E+08 9.7 1.0E-08 5.8  
2 5.3E+09 2.9E+09 1.8 3.0E-09 8.0E+09 3.2E+08 25.0 2.1E-08 7.0  
3 2.8E+09 3.2E+09 0.9 6.1E-10 6.8E+09 8.1E+08 8.4 1.1E-08 18.6  
4 3.5E+09 3.7E+09 1.0 2.6E-10 7.8E+09 6.4E+08 12.2 5.3E-09 20.8  
5 2.2E+09 2.6E+09 0.9 1.1E-09 2.5E+09 9.0E+08 2.8 8.9E-09 8.2  
Avg. 3.5E+09 2.9E+09 1.3 1.3E-09 5.5E+09 5.8E+08 11.6 1.1E-08 12.1 p-value  
0.01 SD 1.2E+09 6.0E+08 0.5 1.1E-09 2.8E+09 2.9E+08 8.2 5.9E-09 7.1 
 
 
 
  
 
 
FIG S1. Stability of the reporter plasmid construct pHCMCO5-Ptet(M)-gusA in B. subtilis in 
the β-glucuronidase enzyme assay was determined by plating the 2.0 h sample onto BHI agar 
with (+) and without (-) addition of 10 µg/ml chloramphenicol. Error bars correspond to ± 1 × 
standard deviation. 
 
Table S1. Tn916 stability in B. subtilis control and exposed pre-mating donor cultures. Donor 
cells were plated on BHI agar with and without 10 µg/ml tetracycline to estimate the stability.  
 
  
Tn916 stability in pre- mating cultures 
  
(control / donor) 
E
x
p
er
im
en
t 
4
 ETOH 1.9 
HP 1.0 
CHX 1.0 
SH 0.3 
TET 0.3 
E
x
p
er
im
en
t 
5
 ETOH 0.8 
HP 4 
CHX 0.7 
SH 1.3 
TET 0.3 
 
 
  
 
Figure S2: Transfer frequency (transconjugants per output donor) relative to input recipient–
donor ratio in experiment 4 and 5. Abbreviations: TF; transfer frequency, R; recipient, D; 
donor, TET; tetracycline and ETOH; ethanol.  
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Abstract 
Biocides are disinfectants widely used to reduce bacterial growth. However, residues or incorrect 
use may lead to the presence of sub-inhibitory concentrations. The bacterial response to sub-
inhibitory concentrations of biocides is unclear. It has been suggested that the SOS response 
contribute to antimicrobial resistance development by inducing mutagenesis. Therefore, the effect 
of sub-inhibitory concentrations of five common biocides; benzalkonium chloride (BC), 
chlorhexidine digluconate (CHX), hydrogen peroxide (HP), peracetic acid (PAA), and sodium 
hypochlorite (SH) on recA expression and mutagenesis in Staphylococcus aureus was studied. An 
assay based on a S. aureus recA-lacZ fusion strain and blue-coloring on TSA-X-gal was used to 
estimate recA expression. Mutagenesis was assessed by counting colonies on TSA with rifampicin 
(100 mg/L). Benzalkonium chloride, CHX, and HP were found to increase recA expression, 
whereas PAA had little effect and SH decreased expression. In addition, HP and PAA were found to 
significantly (p ≤ 0.05) increase the mutation rate 5-15 and 3-8 fold, respectively. These results 
suggest that exposure to sub-inhibitory concentrations of HP and PAA may contribute to emergence 
of antimicrobial resistance in S. aureus. This may be of potential risk for human health, since these 
disinfectants are widely used at hospitals and in the food industry.  
 
Introduction 
Biocides are chemical compounds with antimicrobial properties. They are widely used for 
disinfection, antisepsis and preservation purposes in various settings to inhibit or reduce the 
bacterial load of microorganisms (McDonnell & A D Russell 1999). At hospitals, biocides are 
extensively used for disinfection of equipment and inventory to eliminate the presence of pathogens 
on surfaces or object that patients or personal come into contact with (Department of Antibiotic 
Resistance and Hospital Hygiene 2004). They are also widely applied for hand disinfection to 
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prevent transmissions of pathogens and thereby the spread of disease among patients via the hands 
of the personnel (Department of Antibiotic Resistance and Hospital Hygiene 2004). In animal 
husbandries biocides are used for disinfection of stable, areas transport vehicles and for direct 
application on animals to prevent emergence and dissemination of animal diseases (Lassen et al. 
2001). In the food industry biocides are widely used for disinfection of machinery and inventory to 
prevent food contamination and as a preservative in foods to inhibit spoilage (Lassen et al. 2001). 
There is no doubt that biocides play a very important and beneficial role in human health and 
welfare. However, the widespread use of biocides has in recent years lead to concerns about their 
potential role in the development of antimicrobial resistance in bacteria through increased mutation 
rate (MR) or the horizontal transfer of resistance determinants (SCENIHR 2009; EFSA 2008; van 
der Veen & Abee 2011).  
The SOS response constitutes one of the stress response systems in bacteria. It is activated upon 
direct or indirect DNA damage and helps bacteria to survive and adapt to environmental stress 
conditions (Foster 2007).  The SOS response is governed by the activator RecA and the repressor 
LexA. DNA damage giving rise to single stranded DNA (ssDNA) is recognized by RecA that binds 
to ssDNA forming nucleoprotein complexes, which in turn stimulate the dissociation of the 
repressor LexA. Destruction of LexA causes the de-repression of SOS-related genes (Foster 2007). 
Genes constituting the SOS response have been identified in a number of bacteria including 
Staphylococcus aureus (Cirz et al. 2007), Bacillus subtilis (Au et al. 2005), Listeria monocytogenes 
(Van der Veen et al. 2010), Escherichia coli (Fernández De Henestrosa et al. 2000; Wade et al. 
2005), and Pseudomonas aeruginosa (Cirz et al. 2006). The SOS response systems of the various 
bacterial species have in common that they are controlled by the positive and negative regulator, 
RecA and LexA, respectively. However, the genes and number of genes constituting the SOS 
response in the different bacterial species differ. In S. aureus and P. aeruginose 16 and 15 genes 
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have been found to be repressed by LexA, whereas the SOS responses of E. coli and B. subtilis 
include 31 and 33 genes, respectively, yet, only eight of these genes are homologous to each other 
(Cirz et al. 2007; Au et al. 2005; van der Veen et al. 2010; Fernández De Henestrosa et al. 2000; 
Wade et al. 2005; Cirz et al. 2006). Activation of the SOS response has been shown to induce 
mutagenesis in bacteria and promote the transfer of resistance and virulence determinants (Peng 
Wang et al. 2010; Mamber & Kolek 1993; Cirz et al. 2007; Ubeda et al. 2005; Thi et al. 2011; 
Maiques et al. 2006; Cirz et al. 2005). Acquired antimicrobial resistance in bacteria due to 
mutations in chromosomal genes have been described for several classes of antimicrobial agents 
including the quinolones and rifamycins (Van Hoek et al. 2011). The SOS response might therefore 
be an important player in the development of antimicrobial resistance in bacteria, and any 
compound inducing this response might contribute to the evolution of bacterial resistance in human 
and animal pathogens. Despite the widespread use, knowledge on the bacterial response to sub-
inhibitory concentration of biocides is relatively limited. Previous studies in bacteria have shown 
that exposure to sub-inhibitory concentrations of hydrogen peroxide can induce expression of recA 
(Chang, Small, et al. 2006; Palma et al. 2004; Zheng et al. 2001). Exposure of S. aureus to PAA has 
also been shown to induce the expression of SOS-related genes. A study investigating the response 
of Bacillus cereus exposure to sub-inhibitory concentrations of several disinfectants showed that HP 
and PAA induced expression of genes involved in the SOS response as well as increased the MR in 
this bacterium (Ceragioli et al. 2010). Even though the applied concentration of biocides generally 
is much higher than the bactericidal dose, the efficacy of biocides are greatly affected by e.g. the 
presence of organic matters, over-dilution, inadequate contact time between compound and bacteria, 
and temperature (A. D. Russell 2003). Therefore, incorrect use of biocides or the presence of 
residual concentrations can lead to bacterial exposure to sub-inhibitory concentrations of biocides. 
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The bacterial response to such exposure is therefore an important area of investigation to elucidate 
the potential effect of these compounds on the development of antimicrobial resistance in bacteria. 
In this study we investigated the effect of sub-inhibitory concentrations of five biocidal compounds 
on recA expression, as an indicator of SOS response induction, as well as their mutagenic effect on 
S. aureus of both human and porcine origin. The biocides constitute benzalkonium chloride, 
chlorhexidine digluconate, hydrogen peroxide, peracetic acid, and sodium hypochlorite that are 
commonly used in the health care setting and/or in the food industry.  
 
Materials and methods 
Chemicals and reagents 
Tryptic soya broth (TSB), tryptic soya agar (TSA), and TSA with 5 % sheep blood (blood agar 
plates) were from Oxoid. Spectinomycin (SPE), rifampicin (RIF), sodium hypochlorite (SH); 10-15 
% available chlorine, chlorhexidine digluconate (CHX); 20 % (w/v), 5-bromo-4-chloro-3-indolyl-β-
D-galactopyranoside (X-gal), and dimethyl sulfoxide (DMSO); ≥ 99 % were provided from Sigma -
Aldrich. Ciprofloxacin (CIP) and hydrogen peroxide (HP); 30 % solution were from Fluka, Sigma-
Aldrich. Benzalkonium chloride (BC); 50 % (w/w) aqueous solution was obtained from Alfa Aesar 
and peracetic acid (PAA); 38 to 40 % was from Merck. Solvent used for stock solutions of CIP (25 
mg/ml) was 0.1 M hydrochloric acid (HCl), whereas DMSO was used as solvent for RIF (25 
mg/ml) and X-gal (20 mg/ml).   
 
Bacterial isolates 
An overview of the S. aureus isolates included in this study is shown in Table 1.  
 
Effect of biocides on β-galactosidase expression 
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The effect of biocides on recA gene expression in S. aureus was carried out using a previously 
described β-galactosidase plate assay (Anita Nielsen et al. 2010) using the  S. aureus recA-lacZ 
fusion strain HI2682 (Gottschalk et al. submitted). Shortly, S. aureus HI2682 was grown overnight 
(ON) in TSB supplemented with 100 µg/ml SPE at 37 ˚ C shaking (140 rpm). One ml of the ON 
culture was diluted to an OD600 of 0.05 in TSB and was subsequently poured into petri dishes with 
25 ml TSA (42 ˚C), 100 µg/ml SPE, and 150 µg/ml X-gal. All plates were dried and 6 × 5 mm wide 
wells were formed in plates with sterile straws. Five-fold dilutions of CIP (0.16 to 500 µg/ml), BC 
(0.32 to 1000 µg/ml), CHX (6.4 to 20,000 µg/ml), HP (0.001 to 4 %), PAA solution (0.006 to 20 
%), and SH solution (0.032 to 100 %) were prepared and 40 µl of each dilution were transferred to 
five of the wells in the agar plates. Forty µl of MiliQ water was added to the sixth well as a control 
compound. Agar plates containing SPE and X-gal, and dilutions of biocides and CIP, but without 
incorporation of bacterial cells served as a sterility control of compounds and to test for unintended 
dissociation of X-gal caused by the compounds. Hydrochloric acid was used as a solvent for CIP 
and was therefore included in the assay to ensure that HCl did not affect the activity of β-
galactosidase. Plates containing TSA and bacterial cells served as growth controls and plates solely 
containing TSA served as sterility control of the medium. All plates were incubated 18 to 20 hours 
at 37 ˚C in an aerobic atmosphere. Next, plates were examined for β-galactosidase activity indicated 
by formed blue colour in the agar due to hydrolysis of X-gal by β-galactosidase. Furthermore, the 
sizes of inhibition zones (concentrations greater than the minimal inhibitory concentration (MIC)) 
were noted. The β-galactosidase plate assay was performed in three independent experiments.  
  
Determination of MIC to biocides 
The MIC of S. aureus isolate 1, 2, 3, 4, and 5 were determined to BC (0.078 to 40 µg/ml), CHX 
(0.031 to 16 µg/ml), HP (0.0005 to 0.256 %), PAA solution (0.001 to 0.4 %), SH solution (0.004 to 
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2 %), and CIP (0.016 to 8 µg/ml) in TSB following the procedure described in the CLSI guideline 
(CLSI 2009). Briefly, isolates were grown ON on blood agar plates at 37 ˚C. Colonies were re -
suspended in 0.9 % NaCl to a McFarland standard of 0.5 (~ 108 cfu/ml) and further diluted 100-fold 
in TSB (~106 cfu/ml). Working concentrations of biocides were prepared in TSB just prior 
transferring the compounds to round-bottom 96 well micro-titre plates (Nunc). Two-fold dilutions 
of compounds were made in the plates (50 µl per well) followed by the addition of 50 µl diluted cell 
suspension (~ 5 × 105 cfu per well). One column contained a two-fold lower concentration than the 
lowest concentration of the test interval and served as a sterility control. One column only including 
TSB and bacteria served as growth control. Plates were incubated 16 to 20 h in an aerobic 
atmosphere at 37 ˚ C and afterwards visually inspected. The MIC -value corresponded to the lowest 
concentration of compounds giving rise to no visible growth. Minimal inhibitory concentrations 
were determined in duplicates and as a minimum repeated twice. Only two-fold variations within 
duplicate determinations were accepted and the most frequent MIC-value was considered as the 
final MIC. S. aureus ATCC 29213 was included as control strain for reproducibility of the 
susceptibility testing procedure.      
 
The effect of biocides on the mutation rate (MR) in S. aureus  
Isolate 1, 2, 3, 4 and 5 were incubated ON on blood agar plates at 37 ˚C, where after cultures of 
each isolate were prepared in TSB and grown ON shaking (150 rpm) at 37 ˚C. Then, ON cultures 
were diluted in TSB to an OD600 of ~0.1 in a final volume of 100 ml in 500 ml Erlenmeyer flasks. 
Cells were grown shaking at 37 ˚C until an OD 600 of 0.5 to 0.7 was reached. Ten ml of bacterial 
culture was subsequently transferred to six 50 ml Falcon tubes giving a final concentration of ½ × 
MIC (BC, CHX, HP, and CIP) or ¼ × MIC (SH and PAA) and further incubated for 1 h. A vial 
with 10 ml cell culture served as the control. Control and exposed cultures originated from the same 
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culture flask. Then, 100 µl from each culture were serial diluted (10-1 to 10-7) in 0.9 % NaCl and 3 × 
10 µl were spotted onto TSA plates and incubated ON at 37 ˚ C  to estimate the number of viable 
cells. Two to 10 ml of each exposed culture were harvested by centrifugation (6000 × g, 4 ˚C, 10 
min) and re-suspended in 100 µl 0.9 % NaCl. Re-suspensions were plated on big TSA plates 
containing 100 µg/ml of RIF. The number of mutants was counted after 48 h of incubation at 37 ˚ C 
in an aerobic atmosphere. At least three independent experiments were carried out per compound. 
Mutation rates were calculated as RIFR mutants per total viable cells. The effect (E) of biocides and 
CIP on the mutation rate was calculated by dividing the MR of the exposed culture with the MR of 
the control culture. E was assumed to follow a normal distribution and outliers in the data set were 
identified by determining the upper and lower fence of the data (Johnson 2005). Data point beyond 
the upper and lower fence values were excluded from the dataset (Johnson 2005). The significance 
of E was statistically tested using the paired, two-sided, Student’s t-test. A pair represents the MR 
of the control and the treated cultures within an experimental repetition. 
 
Results and discussion 
Effect of biocides on β-galactosidase activity 
The effect of BC, CHX, HP, PAA, SH, and CIP on recA gene expression in S. aureus was 
estimated using a β-galactosidase (lacZ) reporter construct in S. aureus. The reporter assay 
indirectly measures transcription of recA through expression of β-galactosidase that can be 
visualized by formation of a blue colour in the agar due to hydrolysis of X-gal by β-galactosidase in 
the medium. RecA constitute the positive regulator of the SOS response and the activity of β-
galactosidase is therefore an indirect measurement of the activity of the SOS response. The β-
galactosidase plate assay showed to be a simple assay to screen for the effect of several biocides on 
the SOS response. Since the bacterial response to compounds is dose-dependent it was an easy 
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method to include a large spectrum of concentrations due to diffusion of compounds into the agar. 
The results were generally easy to read with the exception of one compound PAA. The assay was 
repeated on three independent occasions and gave rise to consistent results for all compounds.   
The effect of biocides and CIP on β-galactosidase activity is shown in Figure 1. To ensure that the 
tested concentrations affected cells only wells giving rise to an inhibition zone were included as a 
valid result, since the formation of blue colour on the inner site of wells containing MQ water was 
detected. Ciprofloxacin is known to induce the SOS response (Lili Rosana Mesak et al. 2008; Peng 
Wang et al. 2010; Cirz et al. 2007, 2005; Kelley 2006) and was included as a positive control in the 
assay. Ciprofloxacin was found to induce expression of β-galactosidase in all experimental 
repetitions. Benzalkonium chloride, CHX, and HP induced expression of β-galactosidase, whereas 
PAA had little effect and SH was found to inhibit enzyme activity. Benzalkonium chloride and 
CHX are both membrane acting compounds. The mode of action is believed to follow a sequence of 
events including adsorption to the bacterial cell surface, diffusion through the cell wall, binding to 
and disruption of the cytoplasmic membrane causing release of intracellular constituents (Denton 
1991; Merianos 2001). Interaction and disruption of the cell membrane are likely to affect the 
physiological state of the cell and might interfere with DNA metabolism leading to activation of the 
SOS response e.g. by stalled replication forks. In a study by Ceragioli et al. (2010) the 
transcriptomic response to BC, HP, PAA, and SH in B. cereus was investigated  at mild, growth-
arresting, and lethal concentrations and induction of recA by BC was not detected in this organism 
(Ceragioli et al. 2010). Locher et al. (2010) studied the effect of CHX on the SOS response in a 
sulA fusion Escherichia coli strain and the SOS response was not found to be induced by CHX in 
E. coli  (Locher et al. 2010). Genes involved in the SOS response are expressed at different stages 
of the SOS induction and sulA represents one of the latest expressed genes, whereas recA is 
expressed at an earlier stage of the induction (Kuzminov 1999). Furthermore, a few studies have 
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investigated the genotoxic potential of CHX in mammalian cells due to its application as an 
endodontic compound. However, these results have shown to be very ambiguous; some studies 
demonstrated a genotoxic effect of CHX and others did not (Ribeiro 2008). The effect of biocides 
are very dependent on the concentration and exposure time and can also vary between bacterial 
species (a D Russell & McDonnell 2000; McDonnell & A D Russell 1999; Chang, Toghrol, et al. 
2006). The different responses to BC and CHX may therefore be due to variations between species 
or the experimental set-up. Hydrogen peroxide is a strong oxidizing compound that reacts by 
producing highly reactive hydroxyl radicals, which causes DNA damage (Block 2001). Hydrogen 
peroxide has been shown to evoke induction of the SOS response in bacteria, including S. aureus, 
which therefore is in accordance with our findings (Ceragioli et al. 2010; Bol & Yasbin 1990; 
Goerlich et al. 1989; Chang, Small, et al. 2006). The effect of PAA in the β-galactosidase assay was 
unclear; the response to PAA exposure differed between wells containing the highest and second 
highest concentration. The inhibition zone at the highest concentration (X0) was preceded by a 
colour close to the background, which again was followed by a small increase in the blue colour. 
However, the well including the second highest concentration (X1) of PAA lead to formation of a 
stronger blue colour just preceding the inhibition zone. Peracetic acid belongs to the chemical group 
of peroxygens like HP and also reacts with the bacterial cells by formation of the highly oxidative 
hydroxyl radical (Block 2001). It could therefore be expected that HP and PAA exposure in S. 
aureus would induce a similar response in recA expression. Also, HP and PAA exposure to B. 
cereus demonstrated a large overlap in the transcriptional response to HP and PAA exposure, 
including up-regulation of the recA gene (Ceragioli et al. 2010). Furthermore, Chang et al. (2006) 
studied the transcriptome response to PAA in S. aureus and showed that exposure to PAA up-
regulated transcription of DNA repair-related genes indicating DNA damage upon PAA exposure 
(Chang, Toghrol, et al. 2006). It is therefore likely that PAA can induce the SOS response in S. 
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aureus even though our result was unclear. Exposure to SH gave rise to a large white zone 
surrounding the inhibition zone indicative of reduced activity of β-galactosidase. In water SH 
dissociates into Na+ and the hypochlorite ion (OCl-) and establishes equilibrium with hypochlorous 
acid (HOCl). Hypochlorous acid is believed to be the active moiety of SH, but the exact mechanism 
of action is not entirely understood (Dychdala 2001). Although, it has been suggested that SH 
produce the same reactive oxidative species as HP in the cell, the two compounds were not found to 
have a similar effect on β-galactosidase activity. Also, HP and SH induced different transcriptional 
responses in B. cereus; HP was found to specifically induce expression of recA whereas SH was not 
(Ceragioli et al. 2010).  
 
Effect of sub-inhibitory concentrations of biocides on the MR in S. aureus 
In the β-galactosidase assay induction of enzyme activity was observed on the border of and near 
the inhibition zone. Bacterial exposure to sub-inhibitory concentrations of biocides corresponding to 
½ × MIC was therefore included in the mutation rate experiments. However, this concentration 
resulted in a 5 to 6 log10 reduction in the viable cell counts when exposed to SH and PAA, why a 
concentration corresponding to ¼ × MIC of these compounds was used instead. Five different 
isolates of S. aureus, including isolates of human and pig origin, were included in the mutation rate 
experiment. The sub-inhibitory concentrations of BC, CHX, HP, PAA, SH, and CIP that was used 
in the MR experiment are shown in Table 2 and their effect on the mutation rate in the five S. 
aureus isolates are illustrated in Figure 2. 
Hydrogen peroxide and PAA were found to significantly induce the MR in S. aureus by 5- to 15-
fold and 3- to 8-fold, respectively. The effect on the MR in response to HP and PAA exposure was 
found to be isolate dependent. Both compounds induced the MR in two out of the five isolates, and 
in one of these isolates a response to both compounds was observed (isolate 3). No response in the 
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MR was detected upon exposure to the remaining compounds. In the study by Ceragioli et al. 
(2010) HP and PAA was found to significantly induce the MR in B. cereus (Ceragioli et al. 2010). 
They tested the effect of both mild (sub-inhibitory) and lethal concentrations of HP and PAA and 
only found lethal concentrations to induce the MR. This is in contrast to our study, where an 
increase in the MR was observed after exposure to sub-inhibitory concentrations. Ciprofloxacin is a 
well known inducer of the SOS response and has been demonstrated to have mutagenic properties 
in several different bacterial species (Couce & Blázquez 2009; Peng Wang et al. 2010; Drlica & 
Zhao 1997; Mamber & Kolek 1993; Henderson-Begg et al. 2006; Lili R Mesak & Davies 2009; 
Gillespie et al. 2005) and was also found to induce recA expression in the β-galactosidase plate 
assay in our study. However, the compound at a concentration corresponding to ½ × MIC did not 
induce the MR in S. aureus. Mesak and Davies (2009) investigated the effect of three different CIP 
concentrations (0.1, 0.2, and 0.5 µg/ml) on three strains of S. aureus and only found the highest 
concentration to induce the MR in all strains (Lili R Mesak & Davies 2009). Therefore, the 
concentration included in our study (0.25 µg/ml) might have been too low to induce mutagenesis in 
S. aureus. Benzalkonium chloride and CHX was also not found to increase the MR in S. aureus 
even though they induced β-galactosidase expression. However, the effect on the MR seems to be 
highly concentration-dependent and it cannot be rejected that BC and CHX have mutagenic effects 
on S. aureus at higher concentrations. In addition, mutagenesis induced by the SOS response is 
likely to occur due to expression of error-prone DNA polymerases (Foster 2007). Exposure to BC 
and CHX might have an overall effect on DNA metabolism and interfere with DNA replication 
including the error-prone DNA polymerase inhibiting the introduction of mutations in the 
chromosome. Different biocides may also affect expression of genes in a compound dependent 
manner however, this is merely speculations and will need further investigation. Sodium 
hypochlorite did not induce the MR in S. aureus.  
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Recent studies have demonstrated that antibiotic-induced SOS responses can increase drug 
resistance in bacteria either by promoting transfer of resistance determinants or introduction of 
chromosomal mutation-mediated resistance (Beaber et al. 2004; Cirz et al. 2005; Nagel et al. 2011). 
Furthermore, antibiotic-induced SOS responses in S. aureus can affect virulence by promoting the 
transfer of virulence encoding factors (Ubeda et al. 2005; Maiques et al. 2006). S. aureus infections 
are an increasing public health issue worldwide causing considerable morbidity and mortality. We 
therefore found the effect of sub-inhibitory concentrations of biocides on the SOS response and 
mutagenesis in S. aureus to be a highly important area of investigation. Benzalkonium chloride, 
CHX, HP and likely PAA were found to induce the SOS response and sub-inhibitory concentrations 
of HP and PAA showed to have a mutagenic effect on S. aureus. Hydrogen peroxide- and PAA-
induced mutagenesis in S. aureus is to our knowledge for the first time described in this study. 
Hydrogen peroxide is widely used for disinfection, antisepsis and sterilization purposes and is 
commonly used in the food industry, at hospitals and in animal husbandries (Lassen et al. 2001; 
McDonnell & A D Russell 1999). Peracetic acid is widely applied for disinfection of hospital 
equipment and inventory and CHX is a commonly used antiseptic especially in the healthcare 
setting, but also for live-stock animals (Lassen et al. 2001; McDonnell & A D Russell 1999). 
Quaternary ammonium compounds, such as BC, are also commonly used as an antiseptics or 
disinfectants in animal husbandry (Lassen et al. 2001; McDonnell & A D Russell 1999). These 
findings is thus of potentially major clinical relevance because exposure of S. aureus to sub-
inhibitory concentrations of these compounds due to e.g. improper use or the presence of residual 
concentrations, might increase the pathogenesis of these isolates through promoting transfer of drug 
resistance or virulence determinants or by introducing mutations that give rise to antimicrobial 
resistance. Also, S. aureus is a frequent colonizer of live-stock animals, especially pigs, and S. 
aureus (CC398) has been shown to colonize and cause infections in humans (EFSA 2008). 
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Exposure of pig S. aureus isolates to sub-inhibitory concentrations of these biocides may contribute 
to the development of more pathogenic strains that might spread to humans and may compromise a 
potential threat to public health.  
The relevance of laboratory findings to what may occur in real life is difficult to ascertain, however 
the likely effect of these biocides on the SOS response and mutagenesis in S. aureus demonstrated 
in the laboratory points toward the potential of what might occur in natural environments. However, 
further experiments including field studies are needed to evaluate the potential risks of biocides 
under different real-life conditions.  
 
Conclusion 
Our results showed that BC, CHX, and HP are likely to induce the SOS response and that HP and 
PAA are able to induce mutagenesis in S. aureus inducing antimicrobial resistance development. 
This is highly clinical relevant since CHX, HP, and PAA are frequently used in the health care 
settings. Also, these compounds, including BC, are commonly used in animal husbandries and S. 
aureus among live-stock animals has the potential to spread to humans. Our findings also 
emphasizes that incorrect use of biocides might have unintended consequences and therefore 
highlights the importance of correct use of these compounds and that the presence of residual 
concentrations might be an important issue to consider. The effect of biocides on the evolution of 
antimicrobial resistance in bacteria is therefore an important area of investigation and further 
studies, taking real-life condition into consideration are needed to evaluate the potential risk of 
biocides used in different settings.  
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Tables and figures 
Table 1. Staphylococcus aureus isolates included in this study. SPER; spectinomycin resistant. 
 
 
Table 2. Minimal inhibitory concentrations (MICs) of S. aureus isolates to benzalkonium chloride (BC), chlorhexidine 
digluconate (CHX), hydrogen peroxide (HP), peracetic acid (PAA), sodium hypochlorite (SH), and ciprofloxacin (CIP) 
and concentrations used in the mutation rate experiment corresponding to ½ × MIC or ¼ × MIC. 
 BC (µg/ml) CHX (µg/ml) HP (%) PAA sol.1) (%) SH sol.2) (%) CIP (µg/ml) 
Isolate 
no. MIC 
½ × 
MIC MIC 
½ × 
MIC MIC 
½ × 
MIC MIC 
¼ × 
MIC MIC 
¼ × 
MIC MIC 
½ × 
MIC 
1 2.5 1.25 4 2 0.032 0.016 0.2 0.05 1 0.25 0,5 0,25 
2 2.5 1.25 4 2 0.032 0.016 0.2 0.05 1 0.25 0,5 0,25 
3 10 5 4 2 0.032 0.016 0.2 0.05 1 0.25 0,5 0,25 
4 2.5 1.25 4 2 0.032 0.016 0.2 0.05 1 0.25 0,5 0,25 
5 2.5 1.25 4 2 0.032 0.016 0.2 0.05 1 0.25 0,5 0,25 
1) PAA solution containing 38 to 40 % PAA; 2) SH solution containing 10-15 % available chlorine 
 
Isolate 
no. 
Name Clonal 
complex 
Relevant information Ref. 
- HI2682 CC8 8325-4 WT with pMTC100 including a recA-lacZ construct and 
SPER marker, incorporated into the host chromosome 
(Gottschalk et al. in 
preperation) 
1 8325-4 WT CC8 Derivative of NCTC 8325 devoid of bacteriophages and plasmids (Richard Novick 
1967) 
2 8797 CC45 Human origin (De Vries et al. 2009) 
3 34801 CC5 Human origin (De Vries et al. 2009) 
4 2007-70-52-4 CC398 Pig origin (Hasman et al. 2010) 
5 72-12400-1 CC30 Pig origin (Hasman et al. 2010) 
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Figure 1: The effect of biocides and ciprofloxacin on β-galactosidase expression in S. aureus. A 5-fold dilution series of 
each compound was prepared and 40 µl of each dilution was transferred to wells in agar plates incorporated with the S. 
aureus HI2682 recA-lacZ fusion strain.  MQ water was included as control compound. Plates were incubated 18 to 20 h 
at 37 ˚C in an aerobic atmosphere. A; exposure to benzalkonium chloride  (BC), B; exposure to chlorhexidine 
digluconate (CHX), C; exposure to hydrogen peroxide (HP), D; exposure to peracetic acid (PAA), E; exposure to 
sodium hypochlorite (SH), and F; exposure to ciprofloxacin (CIP). X0...X5; highest to lowest concentration.  
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Figure 2. The average effect of benzalkonium chloride (BC), chlorhexidine digluconate (CHX), hydrogen peroxide 
(HP), peracetic acid (PAA), sodium hypochlorite (SH), and ciprofloxacin (CIP) on the mutation rate (MR) in S. aureus. 
Mutation rates were determined by dividing the number of rifampicin mutants with the total cell count. The effect was 
calculated by dividing the MR of the treated culture with the MR of the control. Experiments were repeated at least 
three times at different occasions. Significance of the effect of biocides and CIP on the MR was determined using the 
paired, two-sided, Student’s t-test. A pair represents the MR of the control and the treated cultures within an 
experimental repetition. Asterisks (**) denote statistical significance at a 1 % level (P ≤ 0.01) and asterisk (*) denote 
significance at a 5 % level (P ≤ 0.05). Error bars represent the standard error of mean. 
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Abstract 
Objectives: Methicillin-resistant Staphylococcus aureus (MRSA), in particular clonal complex 
(CC) 398, are increasingly identified in livestock animals. Recently, MRSA within CC30 was 
identified in Danish pigs. Here we determined the susceptibility of porcine S. aureus isolates of 
CC398 and CC30 to disinfectants used in pig farming; benzalkonium chloride, hydrogen peroxide, 
formaldehyde, sodium hypochlorite, and caustic soda. Furthermore, the antimicrobial resistance 
profiles, hemolysis properties, and the presence of TSST-1 and PVL encoding virulence factors 
were investigated. 
Methods: In total, 79 porcine S. aureus isolates were included in the study. The susceptibility to 
biocides and antimicrobial agents were determined by the micro-dilution method. The presence of 
quaternary ammonium compound (QAC) efflux pumps causing resistance was analysed using an 
ethidium bromide efflux pump assay. Isolates were screened for lukPV and tst genes with PCR and 
haemolytic activities were determined using a simple agar plate assay. 
Results: S. aureus isolates did in general not show reduced susceptibility to the biocides tested. 
However, a QAC resistance gene, qacG, was detected in MRSA CC30 isolates. Resistance to 
antimicrobial agents was generally found against compounds typically used in pigs. Isolates 
generally had low haemolytic activity and none of the isolates included the PVL or TSST-1 
encoding genes. 
Conclusion: The presence of qacG in MRSA CC30 is worrying, since usage of QACs may 
contribute to the selection and spread of these isolates. MRSA CC30 is often associated with 
MRSA types giving rise to clinical infections in Denmark and porcine MRSA CC30 may be prone 
to adapt to humans.  
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Introduction 
During the last decade, livestock-associated methicillin-resistant Staphylococcus aureus (LA-
MRSA) has been emerging throughout Europe and North America, and food production animals are 
increasingly recognised as a potential reservoir of MRSA 1. The predominant clonal lineage of LA-
MRSA belongs to clonal complex (CC) CC398 and pigs are particular regarded as a reservoir of 
this clone 1,2. Even though, MRSA CC398 rarely causes infections in animals, this clonal lineage 
has attracted much attention due to its potential to colonize and cause infections in humans, making 
colonized/contaminated animals a potential source of community-acquired MRSA (CA-MRSA) 1. 
Human acquisition of MRSA CC398 is regarded as an occupational health risk; people in close 
contact with colonized/contaminated animals or their environment, such as farmers and 
veterinarians, are at greater risk of getting infected/colonized 1. However, carriage of MRSA CC398 
has been detected in humans without known contact to livestock animals, and it has been suggested 
that transmissions between humans occur 3. In Denmark, 164 new human clinical cases of MRSA 
CC398 were detected in Denmark in 2011, an increase of 53 and 122 cases compared to 2010 (n = 
111) and 2009 (n = 42), respectively. One hundred and thirty of these isolates belonged to spa type 
t034 of which 49 caused infections in humans 4. MRSA CC398 thus poses an increasing risk of 
human health in Denmark and other countries. 
Denmark has an annual pig production of approximately 30 million pigs and is one of the world’s 
largest exporters of pork 5,6. The most prevalent methicillin-sensitive S. aureus (MSSA) among 
Danish pigs belongs to CC398 (primarily spa type t034) 7. Until recently, pig associated MRSA had 
only been identified among CC398 in Denmark. However, a study by Agersø et al. (2012) detected 
the presence of MRSA CC30 (spa type t1333) in pigs at slaughter and it was suggested that MRSA 
CC30 may have the potential to spread among Danish pigs, as MSSA CC30 (primarily spa type 
t1333) is the second most common S. aureus in Danish pigs 8. Recently, the first cases of human 
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nasal carriage of porcine associated MRSA CC30 (t1333) were detected. Isolates were identified in 
both pig farmers and in pigs at the farm, indicating the potential of pig to human transfer  9. MRSA 
CC30 of spa type t019 is one of the most prevalent MRSA types giving rise to clinical infections 
and asymptomatic carriage in humans 10, and the presence of MRSA isolates in pigs belonging to 
the same clonal complex is of concern to the public health, since these strains might be prone to 
adapt to humans.  
MRSA CC398 isolates often lack important virulence-associated factors that are often found in 
healthcare-associated (HA)-MRSA and CA-MRSA isolates; the toxic shock syndrome toxin 
(TSST-1) has not yet been reported in CC398, and carriage of the Panton-Valentine-Leucocidin 
(PVL) has only been identified in a few cases 1,11,12. The virulence of S. aureus CC30 of porcine 
origin has to a much lesser extent been examined and so far there has been no reports of these 
virulence encoding genes in porcine S. aureus CC30 13.  
With the growing awareness of food safety, biocides are increasingly used in all stages of the meat 
production chain to reduce or inhibit growth of microorganisms and large amounts of biocides are 
used in controlling hygiene in the farm environment 14. These include quaternary ammonium 
compounds (QACs), peroxygens, chlorine compounds and aldehydes 15. The widespread use of 
biocides has led to concerns about development and emergence of microorganisms that are less-
susceptible to biocides 14. Acquired reduced susceptibility to certain biocides has been described 16. 
Examples include Staphylococcus spp. showing less susceptibility to QACs and have been isolated 
from dairy cattle and goat herds 17–19. The genetic determinants for reduced susceptibility to QACs 
are the qac genes encoding efflux pumps. Substrates of these pump systems comprise several 
cationic compounds, including the monovalent cations, such as the QAC benzalkonium chloride 
(BC) and the intercalating dye ethidium bromide (EtBr). The divalent cation chlorhexidine (CHX) 
that is widely used as an antiseptic compound at hospitals has also been found to be a substrate of 
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some QAC efflux pumps 20,21. qac genes have been found to reside on mobile genetic elements, 
such as plasmids and integrons that also encode resistance to a range of clinical important 
antimicrobial agents. In Staphylococcus spp. qac genes have been reported to co-reside with genes 
giving rise to resistance to beta-lactams (blaZ), aminoglycosides (aacD-aphD), and trimethoprim 
(dfrA) 22–26 and it has been suggested that use of QACs might give a selective advantage of qac 
positive strains and lead to co-selection of antimicrobial resistance bacteria 23,27–29.  
 The emergence of LA-MRSA and their potential to colonize and infect humans poses an important 
and increasing risk for public health. The discovery of yet another clonal lineage of LA-MRSA 
(CC30) in Danish pigs and carried by farmers is worrying. Effective use of biocides may be 
important in order to reduce/eradicate MRSA in pig herds. Therefore, we investigated porcine 
MRSA and MSSA isolates belonging to either CC398 or CC30 for their susceptibility to active 
compounds of commonly used disinfectants in pig production. These disinfectants comprise 
benzalkonium chloride (QAC), hydrogen peroxide and sodium hypochlorite (highly oxidizing 
compounds), formaldehyde (aldehyde compound) and caustic soda (strong alkaline compound) 15,30. 
Furthermore, the antimicrobial resistance profile, hemolysis properties, and the presence of TSST-1 
and PVL encoding virulence genes were investigated.  
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Material and methods 
Chemicals and reagents 
Active disinfectant compounds included in this study were: Benzalkonium chloride (BC), 50 % 
(w/w) aqueous solution (VWR); Sodium hypochlorite (SH), available chlorine 10-15 % (Sigma-
Aldrich); Formaldehyde solution (FA),  ≥ 37 % (Merck); Hydrogen peroxide (HP), ≥ 30 % (Fluka), 
and Sodium hydroxide (NaOH), ≥ 98 % (Sigma-Aldrich). Premade tryptone soya agar plates with 5 
% sheep blood (blood agar plates) were purchased from Oxoid. BBLTM Mueller-Hinton II broth 
(MHB) and agar (MHA) were from Becton, Dickinson and Company. Tryptic soy broth (TSB) and 
agar (TSA) were from Oxoid. Sheep blood was from Statens Serum Institute.  
 
Strain collection 
A total of 79 porcine S. aureus isolates were  included in this study (Table S1) and comprise 21 
MSSA and 40 MRSA belonging to CC398 and 13 MSSA and 5 MRSA belonging to CC30. 
Twenty five of the isolates were from diagnostic submissions to The National Veterinary Institute 
or The National Food Institute, Technical University of Denmark 8,31. Fifty four colonizing S. 
aureus isolates were sampled from healthy pigs (nasal swabs) at 12 different farms or from healthy 
pigs at seven different slaughter plants (nasal swabs before scalding) as part of the DANMAP 
surveillance program in 2009 8,32,33. The origin of two of the colonizing pig isolates was unknown. 
For isolates collected at slaughter plants only one sample per month was collected per Central 
Husbandry Register (CHR) number 8. Isolates originating from the same farm was collected on the 
same day, but from different animals. In one case two isolates were collected from the same pig, 
however, they belonged to CC30 and CC398, respectively (isolate 53 and 81) and were therefore 
both included in the study.  
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Species identification of S. aureus and isolation of MRSA were performed as previously described  
8,32,34,35. The presence of the mecA gene encoding methicillin resistance was confirmed by multiplex 
PCR as previously described 35. The spa-type of isolates was determined following the 
recommendations at SeqNet36 using recommended primers 7,31 or primer pair 1794 (5’-
AGACGATCCWTCAGTGAGC-3’) and 1827 (5’-TAATCCACCAAATACAGTTGTACC-3’) 8. 
Based on the amplified sequence, spa-types were assigned to each isolate using the spa plugin in 
the BioNumerics v4.6 software (Applied Maths) 7,8,31.  
 
Antimicrobial susceptibility testing 
Determination of the Minimal Inhibitory Concetration (MIC) and Minimal Bactericidal 
Concentration (MBC) of biocides 
Minimal inhibitory concentrations determination to BC (0.250 – 128 µg/ml), HP (0.00025 – 0.128 
%), SH (0.003125 – 1.6 %), FA (0.000781 – 0.4 %), and NaOH (0.003125 – 1.6 M) were 
determined as recommended by the CLSI standard 37. Selected isolates were also tested for their 
susceptibility to CHX (0.0625 – 32 µg/ml). Briefly, bacteria from over night (ON) blood agar plates 
were re-suspended in 0.9 % NaCl to a McFarland standard of 0.5 (~ 108 CFU per ml) and further 
diluted 100-fold in MHB. The size of the inoculums was determined by plating MHB cell 
suspensions on MHA plates and incubated ON at 37˚C . Working solutions of biocides were 
prepared in MHB and two-fold dilution series were prepared in 96-round bottom well microtiter 
plates (50 µl), where after 50 µl of MHB cell suspensions were transferred to the microtiter plates 
(Nunc) (~ 5 × 105 CFU per ml in wells). Wells with no biocides were included as positive growth 
controls and wells without bacteria, but containing a biocide concentration two-fold lower than the 
lowest concentration of the test interval, served as sterility controls. Plates were incubated at 37˚C 
for 16 to 20 hours in an aerobic atmosphere, after which cell growth was inspected by the eye. The 
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MIC-value was defined as the lowest concentration of the compounds giving rise to no visible 
growth. The minimal bactericidal concentration was determined following the NCCLS guideline 38 
with minor adjustments. After the MIC-values were read, taking approximately 15 min, microtiter 
plates were further incubated until a total incubation time of 24 hours was reached. Then, pellets 
were re-suspended and 10 µl where spotted on MHA plates from wells with no visible growth, 
wells containing the highest concentration of biocides and where cell growth was visible, and from 
wells including the sterility control. Plates were incubated at 37˚C and colonies were counted after 
48 h of incubation. Biocide concentrations leading to a 99.9 % reduction of viable cells was 
regarded as the MBC-value. Minimal inhibitory concentrations and MBC determinations were 
performed in duplicates and only results where duplicates showed similar results or differed only by 
2-fold was included. In the case of 2-fold variations the highest value was selected.  S. aureus 
ATCC29213 was included as control strain for reproducibility of the susceptibility testing 
procedure.  
 
Determination of the MIC of antimicrobial agents 
Susceptibility to ciprofloxacin (Cip) (0.12-8 µg/ml), erythromycin (Ery) (0.12-16 µg/ml), 
florfenicol (Ffn) (1-64 µg/ml), chloramphenicol (Chl) (2-64 µg/ml), penicillin (Pen) (0.06-16 
µg/ml), spectinomycin (Spe) (8-256 µg/ml), streptomycin (Str) (2-128 µg/ml), sulphamethoxazol 
(Smx) (8-512 µg/ml), tetracycline (Tet) (0.5-32 µg/ml), tiamulin (Tia) (0.25-32 µg/ml), and 
trimethoprim (Tmp) (1-32 µg/ml) had earlier been or were determined using the semiautomated 
Sensititre broth micodilution system (Trek Diagnostic Systems) as previously described 39. Selected 
isolates were also tested for their susceptibility to gentamicin (Gen) (0.25-16 µg/ml). Plates were 
inoculated and incubated according to the CLSI guidelines (2009) 37. S. aureus ATTC 29213 was 
used as quality control strain. The European Committee on Antimicrobial Susceptibility Testing 
Manuscript III 
9 
 
(EUCAST) epidemiological cut-off values (ECOFF) 40 were used to interpret MIC results as 
recommended by the EU Reference Laboratory for Antimicrobial Resistance (EURL-AR) 41.   
 
Genome sequencing 
Isolate 86, 88, and 89 were whole genome sequenced (WGSed). DNA purification, sample 
preparation, and sequencing on an Illumina Genome Analyzer IIx (Illumina, Inc., San Diego, CA) 
were performed as previously described 42. 
 
Ethidium bromide efflux pump assay and qacG detection 
To examine for increased efflux pump activity an ethidium bromide assay was used as described 
previously 17. Isolates were grown for 24 h at 37 °C on MHA containing EtBr (0.5 μg/ml), followed 
by inspection for fluorescence under UV light. Cells accumulating EtBr had a red fluorescence and 
cells that did not accumulate fluorescence were white and defined to include active efflux pumps. 
Strains JCM 16555 (qacA) and JCM 16556 (qacB), that overexpress efflux pumps, were included as 
controls. 
 
Detection of qacG 
Identification of QAC resistance genes in WGSed isolates showing efflux pump activity were 
performed by BLASTing nucleotide sequences of qac genes from NCBI’s homepage 
(www.ncbi.nlm.nih.gov/) with the sequences of the isolates. Furthermore, isolates found positive in 
efflux pump activity were tested for the presence of qacG by PCR with primers: qacGF: 
TTTCGTTGGAATTTGCTT and qacGR: AATGGCTTTCTCCAAATACA 27. Isolates were grown 
on TSA plates and DNA was extracted from bacterial colonies using a rapid boiling lysis protocol. 
Brieﬂy, individual bacterial colonies were suspended in 100 µl of sterile water, incubated in an 
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eppendorf microcentrifuge tube for 10 min in 100 °C and then centrifugated 10 min, 8000 rpm. A 2 
µl aliquot of the supernatant was used as the template for PCR. The volume of each reaction was 25 
µl (12.5 µl dream taq Fermentas master mix, 1 µl (100 pmol) forward primer, 1 µl (100 pmol) 
reverse primer, 2 µl DNA and 8.5 µl sterile H2O. The cycling conditions were as follows: DNA 
denaturation at 94°C for 3 min, followed by 25 cycles of 94°C for 30 s, 55°C for 30 s and 72°C for 
1 min. This was completed with an extension step of 72°C for 5 min. PCR products were analyzed 
by electrophoresis on a 1% (w/v) agarose/1× TBE gel. Primers targeting the house keeping gene glp 
were used as DNA control.  
 
lukPV and tst detection  
All isolates were screened for the virulence genes lukPV and tst using primers previously described 
(see list below). DNA extraction and the PCR program was the same as described above, except for 
the annealing temperature for tst that was set to 52 °C.    
lukPV: Luk-PV-1 ATCATTAGGTAAAATGTCTGGACATGATCCA and  
Luk-PV-2 GCATCAAGTGTATTGGATAGCAAAAGC 43. 
tst: TST-1: TST-1: AGCATCTACAAACGATAATATAAAGG and 
TST-2: CATTGTTATTTTCCAATAACCACCCG 44.  
glp dn TGG TAA AAT CGC ATG TCC AAT TC and 
glp up CTA GGA ACT GCA ATC TTA ATC C 45. 
 
Hemolysis assay 
Delta-hemolytic activities of individual bacterial isolates were assessed by cross-streaking test 
isolates perpendicular to the beta-hemolysin hyper producing S. aureus RN4220, a strain derived by 
multiple mutagenesis procedures from the parent strain NCTC8325 46, on sheep blood agar plates. 
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Hemolysis was assayed after 24 h at 37°C and again after additional 24 h at 4°C. The latter step was 
performed to evoke the “hot-cold lysis” phenomenon observed with beta-hemolysis 47. Delta-
hemolytic activity was denoted by an enhanced area of hemolysis in the intersection of RN4220 and 
test isolate streaks. 
 
Results and discussion 
In this study we tested the susceptibility of porcine S. aureus CC398 and CC30 isolates to biocides 
that are active compounds of commonly used disinfectants in pig production. In addition 
susceptibility to antimicrobial agents, the presence of active efflux pumps and important S. aureus 
virulence factors was investigated.  
 
Susceptibility to biocides and antimicrobial agents 
Susceptibility to biocides 
No standardized method exists for susceptibility testing of microorganism to biocides. It was 
therefore decided to use pre-existing methods for susceptibility testing of bacteria to antimicrobial 
agents; the CLSI Approved Standard 37 and the NCCLS Approved Guideline 38 for determining 
MIC- and MBC-values, respectively. Distributions of the MICs and MBCs of the 79 porcine S. 
aureus isolates to biocide BC, HP, SH, FH, and NaOH are shown in Figure 1. The MIC- and MBC-
values can be found in Table S1. The MIC-values were generally found to be 2 or 4 µg/ml to BC, 
0.001 or 0.002 % to HP, 0.05% to SH, 0.00625 % to FH, and 0.1 M to NaOH. The MBC-values 
were generally similar to the MIC or up to 8-fold higher. The paradoxical effect, also known as the 
eagle effect, was in some cases observed in the MBC determination of HP (see Table S1) namely 
that the number of surviving cells increased with increasing HP concentration beyond the lowest 
concentration giving rise to ≥ 99.9 % kills  38. The phenomenon is particular common for cell-wall 
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active compounds and has been described for some antimicrobial compounds (e.g. penicillin and 
aminoglycosides) 38 and also for a few isolates to CHX 48. However, in our study it was only 
observed in MBC determinations to HP. Susceptibility testing of the control strain was reproducible 
within a two-fold range and the MIC- and MBC-values were within the range of the tested isolates. 
The method used for MIC determination showed good agreement within duplicate determinations; 
duplicates were shown to have the same values in 87 to 99 % of the cases, depending on the biocide 
tested. A greater variance was observed for the MBC determinations in which duplicate values 
varied between 66 and 81 %. However, in all cases duplicate determinations did not vary more than 
2-fold. The method employed to determine the susceptibility of porcine S. aureus isolates to 
biocides in this study therefore seem to be an acceptable method. Since duplicate determinations did 
not vary more than 2-fold it may be recommended only to include one determination in 
standardization of susceptibility testing of biocides to S. aureus isolates. 
The MIC-value of S. aureus isolates to BC, HP, SH, and FH and MBC-values to BC, HP and SH 
were very similar to previous findings 28,48–52.  
The porcine S. aureus isolates were generally distributed at two or three MIC- and MBC-values, 
respectively (Figure 1). In this study reduced susceptibility to a biocide was defined as a bacterial 
strain having a MIC- as well as a MBC-value greater than the rest of the bacterial population. Based 
on this criterion no isolates showed reduced susceptibility to the tested biocides and the MIC- and 
MBC-values were widely below the recommended working concentrations. Comparing the MIC- 
and MBC-values and distributions between MSSA and MRSA and between CC398 and CC30 
isolates no noteworthy difference was observed. However, the distribution of the MIC-value to BC 
for MRSA CC30 isolates seemed to be displaced by a two-fold higher concentration (Figure 2), but 
this did not apply for the MBC distribution. 
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Susceptibility to antimicrobial agents 
The phenotypic resistance profiles and distribution of resistance of the 79 S. aureus isolates are 
presented in Table 1. The resistance patterns of the S. aureus CC398 isolates were highly variable 
and represented 23 different phenotypic resistance patterns. All of the CC398 isolates were found to 
be Tet resistant and 84% and 56% of the isolates showed resistance to Tmp and Str, respectively. 
Antimicrobial resistance to Ery (46 %), Spe (38 %) and Tia (33 %) was also frequently observed, 
whereas resistance to Cip (20%) was found to a lesser extent. Only one isolate showed resistance to 
Chl-Ffn (2 %) and Smx (2 %), respectively. Thirty-one (78 %) and 16 (76 %) of the MRSA and 
MSSA CC398 isolates, respectively, were multi-resistant (defined as resistance to three or more 
classes of antimicrobial agents other than the group of β-lactams). Overall the occurrence of 
resistance to non-beta-lactam antimicrobials was quite similar for the MRSA and MSSA CC398 
isolates, with the exception of resistance to Spe, Tmp and Str, where a higher percentage of the 
MRSA CC398 isolates were found to be resistant.  
Multi-resistance and highly variable phenotypic resistance patterns among S. aureus CC398 isolates 
have frequently been detected 12,53–55. 
The S. aureus CC30 isolates were arranged in 9 different phenotypic resistance patterns. None of 
the MSSA CC30 and one of the MRSA CC30 isolates had a multi-resistant phenotype. The group 
of MRSA CC30 isolates showed resistance to Pen (100 %), Tia (100 %), Ery (20 %), Tmp (20 %), 
and Str (100 %), whereas resistance to Pen (31 %), Tia (46 %), Ery (8 %), Tmp (8 %), Tet (15 %), 
Spe (8 %) and Str (8 %) was present in MSSA CC30 isolates. No more than 11 % of the total 
number of S. aureus CC30 isolates showed phenotypic resistance to Tet that is much lower than the 
occurrence in the CC398 isolates. The MSSA and MRSA porcine isolates belonging to CC30 have 
to a much lesser extent been described. However, in one study MRSA CC30 from pigs (n = 3) were 
found to be Tet and Ery resistant and susceptible to Chl and Cip 13. In another study MSSA CC30 
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(n = 2) showed resistance to Pen or pefloxacin (a fluoroquinolone), but were susceptible to Ery 56. 
In both studies susceptibilities were tested for multiple antimicrobials and therefore also showed a 
limited resistance phenotype.  
Some of the pig isolates within the same CC were sampled from the same farm and might therefore 
be clonal related. Also, S. aureus CC398 and CC30 isolates were only sampled from the same farm 
in one case and the resistance profiles of S. aureus pig isolates belonging to CC398 and CC30 can 
therefore not be directly measured. However, it is worth noticing that the S. aureus pig isolates 
belonging to CC398 in general seemed more resistant than the S. aureus CC30 isolates. Moreover,  
in the one case where CC398 and CC30 isolates were sampled from the same location (Farm 1) the 
two S. aureus CC398 isolates (no. 17 and 53) showed resistance to five and eight antimicrobial 
agents respectively, whereas the CC30 isolate only showed resistance to one compound. Only five 
MRSA CC30 isolates are included in this study and drawing general assumptions to this S. aureus 
type is difficult. However, when evaluating the resistance profiles of all the S. aureus pigs isolates 
resistance seems to follow the CC; MRSA isolates were more similar to the MSSA within the same 
CC than the MRSA isolates from the other CC and vice versa.   
Some of the most widely used groups of antimicrobial agents in pig production are tetracyclines, 
beta-lactamase sensitive penicillins, macrolides, pleuromutilins, penicillins with extended spectrum, 
and aminoglycosides 10. The group of amphenicols and fluoroquinolones are to a much lesser extent 
used. The occurrence of phenotypic resistance in the porcine S. aureus isolates therefore correlated 
well with the antimicrobial agents used in pig production. One exception was the high occurrence of 
Cip (fluoroquinolone compound) resistance in CC398 isolates, since only a low amount of this 
compound is used for pigs. Other environmental conditions in pig farming might therefore 
contribute to the development of Cip resistance. The SOS response has been shown to be activated 
by sub-inhibitory concentrations of antibiotics including the quinolones and β-lactams and by HP 
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57,58. Activation of the SOS response can induce mutagenesis in bacteria leading to chromosomal 
mutations giving rise to Cip resistance 59. Exposure to non-lethal doses of these compounds might 
therefore have the potential to contribute to development of Cip resistance in S. aureus pig isolates. 
However, this will need further studies to elucidate. 
In Denmark, treatment of S. aureus infections may in some cases be supplemented with a macrolide 
(personal communication, Henrik Westh, Hvidovre Hospital, Denmark). The high level of 
resistance found to the macrolide Ery in the porcine S. aureus isolates might therefore be of clinical 
relevance. 
  
Efflux pump active isolates 
Disinfectants based on QACs have various applications in veterinary medicine and play an 
important role in the control of animal disease. Efflux-mediated resistance to QACs has been 
described in S. aureus and several QAC resistance genes have been identified 60,61. Staphylococci 
including qac-genes do not always give rise to an increase in the MIC-value toward BC 21,28. The 
porcine S. aureus isolates were therefore also tested for efflux pump activity, using an EtBr assay 
on agar plates. Four MRSA CC30 isolates (85, 86, 88 and 89) showed EtBr efflux pump activity 
(Figure 3) and were found positive for the qacG gene by WGSing and PCR (isolate no. 86, 88, and 
89) and by PCR in isolate no. 85. The qacG gene has previously been identified in food-related 
staphylococci 22,28,62. QacG has a more narrow spectrum of substrates compared to the QacA efflux 
pump, encoded by qacA, which are generally found to be  associated with clinical Staphylococcus 
spp. 21. Once before the presence of a qac gene has been found in MRSA from pigs in Hong Kong. 
However, these pig associated MRSA isolates belonged to CC8 (t899), a typical S. aureus clone 
colonizing pigs in Asia 28. This study is therefore the first to report the presence of qac genes in S. 
aureus of porcine origin in Europe and in LA-MRSA belonging to CC30. Two of the strains 
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including the qacG gene were found to have higher MIC-values (8 µg/ml) compared to the 
remaining isolates, however two other isolates had similar MIC-values (4 µg/ml) as to some of the 
qacG-negative isolates. The MBC-values for qacG positive and some of the qacG-negative isolates 
were the same (8 mg/ml) and is in accordance with the study by Wong et al. (2012) 28. The presence 
of qacG only showed small or no changes in the susceptibility to BC, and still remained lower than 
the recommended working concentration of BC and might therefore not be relevant in practical 
implications. However, a study by Otter et al. (2012) showed that use of CHX for decolonization of 
MRSA gave rise to a clonal-dependent increase in MRSA isolates carrying the qacA gene (CHX is 
a substrate of QacA). This was even though the level of resistance to CHX in qacA positive isolates 
was much lower than the applied concentration 63. Incorrect use of disinfectants (e.g. over-dilution, 
reduced contact time with microorganisms, wrong temperature or pH), insufficient cleaning before 
disinfection or the presence of residual concentrations might give rise to bacterial exposure to lower 
level QAC concentrations and might also give strains, harbouring QAC resistance genes, a selective 
advantage 29. Usage of compounds that are substrates for QAC efflux pumps might therefore select 
for sub-populations carrying these genes. The susceptibility to CHX of S. aureus isolates with and 
without the qacG was determined (Table S2). qacG positive isolates were found to have 
comparable or lower MIC/MBC-values to isolates without the gene. In the study by Wong et al. 
(2013), qacG containing isolates were found to have a mean MBC-value to CHX that was slightly 
higher than the qacG negative strains (4 µg/ml vs. 6 µg/ml) 28, and was therefore outside the 
detection level in our study.  
In Denmark, treatment of S. aureus infections can be supplemented with Gen and in some cases 
with a macrolide as previously mentioned. Additional susceptibility testing of the qacG positive 
MRSA CC30 isolates to Gen showed that isolate 85 was also resistant to this compound. This is 
worrying since incorrect disinfectant procedures or the presence of residual concentrations of QACs 
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might select for MRSA strains that are resistant to clinical important antimicrobial agents. Also, qac 
genes have been found to co-exist on genetic elements, such as plasmids and integrons, with genes 
encoding resistance to important antimicrobial compounds, such as Pen, Tmp and Gen, isolated 
from clinical, animal or food-related staphylococci 22–24,26,64. Use of QACs has therefore been 
suggested also to select for antimicrobial resistance genes located on the same genetic element 29. 
The qacG gene was first described by Heir et al. (1999) and found to reside on a small plasmid 
(pST94), including two open reading frames encoding the QacG and a putative replication protein 
62. Sequence contigs including the qacG gene from the WGSed isolates (isolate no. 86, 88, and 89) 
were BLASTed against the nucleotide database at NCBI’s homepage 
(http://www.ncbi.nlm.nih.gov/) to identify the possible location of qacG. Two isolates had 99% 
identity to the full qacG corresponding to position 1532 to 1855 (GenBank accession no. Y16944) 
and one isolate had a partial sequence on the contig corresponding to position1560 to 1855, also 
with more than 99% homology. The size of the contigs varied from 2093 to 2222 bp for three of the 
isolates and the average no. of reads were approx. 75 to 130 times higher than the average number 
of reads from the WGS runs of the same isolates. The size of the contigs together with the higher 
number of reads indicates that these plasmids are probably individual plasmids rather than 
integrated on the chromosome. Moreover, on the same contigs a putative replicon were identified 
with 92 to 93% homology to rep94 of pST94. This indicates that qacG in isolate 86, 88, and 89 
reside on pST94 or a pST94-like plasmid. The qacG gene has previously been found to reside on a 
closely related pST94 plasmid isolated from bovine staphylococci 22 and have so far not been 
associated with plasmids including additional resistance genes 22,62.  
 
Virulence of isolates 
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There are a number of factors that appear to play key roles in the virulence of S. aureus. The 
accessory gene regulator (agr) locus, a well-characterized quorum-sensing two-component 
regulatory system, is a principal global virulence regulator. agr upregulates secreted proteins, 
including delta-hemolysin, and delta-hemolysin is commonly used as an indicator of agr function 
46,65. In humans acute infections it is generally proposed that full virulence requires a 
functional agr system whilst agr dysfunction is associated with chronic infections, the formation of 
small colony variants, and biofilm associated infections 65,66. Three of the tested isolates (40, 41 and 
77) were delta-toxin producing (figure 4), three isolates were not producing any toxins and the rest 
either produced alpha- and/or beta-hemolysis.   
Several studies have documented the frequency of delta-hemolysis positive and negative S. aureus 
strains and in human clinical isolates there are generally found more delta-toxin positive isolates 
than in our study 67,68.  No isolates carried the PVL genes lukF-PV and lukS-PV, or the TSST-1 
encoding gene tst. These results are consistent with other studies of porcine S. aureus CC398 12,53 
and CC30 isolates 13 (only tested for the presence of PVL genes). The TSST-1 toxin has not been 
reported in porcine S. aureus CC398 isolates and the presence of PVL genes have only been 
identified in a few cases 69. However, TSST-1 and PVL genes are commonly present in human-
associated S. aureus isolates, including S. aureus belonging to CC30 11,12,33,70–72.    
 
 
Conclusion 
In this study the presence of a qac gene, qacG, in MRSA isolates of porcine origin was for the first 
time described in Europe. These MRSA isolates belonged to CC30, a clonal complex that is often 
associated with MRSA types giving rise to clinical infections in Denmark. These findings are 
worrying, since incorrect use of or the presence of residual concentration of QACs, may contribute 
Manuscript III 
19 
 
to the spread and persistence of these isolates among Danish pigs and make the task of MRSA 
eradication more difficult. Furthermore, one of the MRSA CC30 isolates found positive for qacG 
were resistant to the clinical relevant antimicrobial agent gentamicin, sometimes used for treatment 
of S. aureus infections. Also, the high occurrence of erythromycin resistance in S. aureus CC398 
was unfortunate, since macrolides can be used for treatment of S. aureus infections. Isolates showed 
a general low haemolytic activity and were all found to be negative for the virulence genes pvl and 
tsst that are frequently observed in HA- and CA-MRSA isolates. However, virulence genes are 
commonly found on MGEs and since S. aureus are excellent at acquiring foreign DNA material, 
development of more virulent strains might just be a matter of time. Surveillance of the 
development of increased resistance to biocides and antimicrobial agents and development of more 
virulent strains among porcine S. aureus isolates is important for the public health. 
 
Acknowledgement  
This work was funded by grant 2101-08-0030 from the Program Committee for Food, Health and 
Welfare under the Danish Council for Strategic Research. The strains JCM 16555 (qacA) and JCM 
16556 (qacB) were kindly provided by Japan Collection of Microorganisms, RIKEN BRC which is 
participating in the National BioResource Project of the MEXT, Japan. We want to thank Hanne 
Mordhorst for excellent technical assistance and Henrik Hasman for help on the sequence analysis. 
 
Transparency declarations 
None to declare 
 
 
 
Manuscript III 
20 
 
References 
1. EFSA. Scientific Opinion of the Panel on Biological Hazards on a requenst from the European 
Commission on Assessment of the Public Health significance of meticillin resistant Staphylococcus 
aureus (MRSA) in animals and foods. The EFSA Journal 2009; 993: 1–73. 
2. EFSA. Analysis of the baseline survey on the prevalence of methicillin-resistant Staphylococcus 
aureus (MRSA) in holdings with breeding pigs, in the EU, 2008, Part A: MRSA prevalence 
estimates; on request from the European Commission. EFSA journal 2009; 7: 1376–. Available at: 
www.efsa.europa.eu. 
3. Smith TC, Pearson N. The emergence of Staphylococcus aureus ST398. Vector Borne Zoonotic 
Dis 2011; 11: 327–39. Available at: http://www.ncbi.nlm.nih.gov/pubmed/20925523. Accessed 
May 24, 2013. 
4. DANMAP. DANMAP 2011 - Use of antimicrobial agents and occurrence of antimicrobial 
resistance in bacteria from food animals, food and humans in Denmark. 2012. Available at: 
www.danmap.org. 
5. Danish & Food Council Agriculture. Statistics 2011 Pigmeat. 2012. Available at: 
http://www.agricultureandfood.dk/. Accessed May 30, 2013. 
6. Danish Agriculture and Food Council. Danish Agriculture and Food Council. Available at: 
http://www.agricultureandfood.dk/Danish_Agriculture_and_Food/Danish_pig_meat_industry.aspx. 
Accessed May 29, 2013. 
7. Hasman H, Moodley A, Guardabassi L, Stegger M, Skov RL, Aarestrup FM. Spa type 
distribution in Staphylococcus aureus originating from pigs, cattle and poultry. Vet Microbiol 2010; 
141: 326–31. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19833458. Accessed May 28, 
2013. 
Manuscript III 
21 
 
8. Agersø Y, Hasman H, Cavaco LM, Pedersen K, Aarestrup FM. Study of methicillin resistant 
Staphylococcus aureus (MRSA) in Danish pigs at slaughter and in imported retail meat reveals a 
novel MRSA type in slaughter pigs. Vet Microbiol 2012; 157: 246–50. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/22245403. Accessed May 29, 2013. 
9. Larsen J, Agersø Y, Mordhorst H, Dalhoff V, Jensen V., Skov R. Emergence of porcine-origin 
methicillin-resistan and -susceptible Staphylococcus aureus ST433 in humans. In prep. 
10. DANMAP. DANMAP 2011 - Use of antimicrobial agents and occurence of antimicrobial 
resistance in bacteria from food animals, food, and humans in Denmark. 2012: ISSN 1600–2032. 
Available at: www.danmap.org. 
11. DANMAP. DANMAP 2010 - Use of antimicrobial agents and occurrence of antimicrobial 
resistance in bacteria from food animals, food and humans in Denmark. 2011. Available at: 
www.danmap.org. 
12. Argudín M a, Tenhagen B, Fetsch A, et al. Virulence and resistance determinants of German 
Staphylococcus aureus ST398 isolates from nonhuman sources. Appl Environ Microbiol 2011; 77: 
3052–60. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3126402&tool=pmcentrez&rendertype
=abstract. Accessed May 29, 2013. 
13. Pomba C, Hasman H, Cavaco LM, Da Fonseca JD, Aarestrup FM. First description of 
meticillin-resistant Staphylococcus aureus (MRSA) CC30 and CC398 from swine in Portugal. Int J 
Antimicrob Agents 2009; 34: 193–4. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19359145. 
Accessed May 29, 2013. 
14. Langsrud S, Sidhu MS, Heir E, Holck AL. Bacterial disinfectant resistance—a challenge for the 
food industry. Int Biodeterior Biodegradation 2003; 51: 283–90. Available at: 
http://linkinghub.elsevier.com/retrieve/pii/S0964830503000398. Accessed May 29, 2013. 
Manuscript III 
22 
 
15. Sørensen AI., Lundsby K, Larsen L., Wingstrand A. Karakteristik af danske 
slagtesvinebesætninger 2007-2008. Økologisk, frilands- og konventionel produktion. 2011. 
Available at: www.food.dtu.dk. 
16. McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clin 
Microbiol Rev 1999; 12: 147–79. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=88911&tool=pmcentrez&rendertype=ab
stract. 
17. Sundheim G, Hagtvedt T, Dainty R. Resistance of meat associated staphylococci to a 
quarternary ammonium compound. Food Microbiol 1992; 9: 161–7. 
18. Heir E, Sundheim G, Holck a L. Resistance to quaternary ammonium compounds in 
Staphylococcus spp. isolated from the food industry and nucleotide sequence of the resistance 
plasmid pST827. J Appl Microbiol 1995; 79: 149–56. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/7592110. 
19. Heir E, Sundheim G, Holck a L. Identification and characterization of quaternary ammonium 
compound resistant staphylococci from the food industry. Int J Food Microbiol 1999; 48: 211–9. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/10443540. 
20. Lassen C, Skårup S, Sonja HM, Kjølholt J. Inventory of Biocides used in Denmark. 
Environmental project no. 585 2001. 2001. 
21. Jaglic Z, Cervinkova D. Genetic basis of resistance to quaternary ammonium compounds–the 
qac genes and their role: a review. Vet Med 2012; 2012: 275–81. Available at: 
http://vri.cz/docs/vetmed/57-6-275.pdf. Accessed May 29, 2013. 
22. Bjorland J, Steinum T, Kvitle B, Sunde M, Heir E, Waage S. Widespread Distribution of 
Disinfectant Resistance Genes among Staphylococci of Bovine and Caprine Origin in Norway. J 
Clin Microbiol 2005; 43: 4363–8. 
Manuscript III 
23 
 
23. Sidhu MS, Heir E, Sørum H, Holck A. Genetic linkage between resistance to quaternary 
ammonium compounds and beta-lactam antibiotics in food-related Staphylococcus spp. Microb 
Drug Resist 2001; 7: 363–71. Available at: http://www.ncbi.nlm.nih.gov/pubmed/11822776. 
24. Sidhu MS, Heir E, Leegaard T, Wiger K, Holck A. Frequency of Disinfectant Resistance Genes 
and Genetic Linkage with β -Lactamase Transposon Tn 552 among Clinical Staphylococci. 
Antimicrob Agents Chemother 2002; 46: 2797–803. 
25. Anthonisen I, Sunde M, Steinum TM, Sidhu MS, Sørum H. Organization of the Antiseptic 
Resistance Gene qacA and Tn 552 -Related β -Lactamase Genes in Multidrug- Resistant 
Staphylococcus haemolyticus Strains of Animal and Human Origins. Antimicrob Agents Chemother 
2002; 46: 3606–12. 
26. Byrne ME, Gillespie MT, Skurray R a. Molecular analysis of a gentamicin resistance 
transposonlike element on plasmids isolated from North American Staphylococcus aureus strains. 
Antimicrobial agents and chemotherapy 1990; 34: 2106–13. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=172007&tool=pmcentrez&rendertype=a
bstract. 
27. Smith K, Gemmell CG, Hunter IS. The association between biocide tolerance and the presence 
or absence of qac genes among hospital-acquired and community-acquired MRSA isolates. J 
Antimicrob Chemother 2008; 61: 78–84. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/17981834. Accessed May 29, 2013. 
28. Wong TZ, Zhang M, O’Donoghue M, Boost M. Presence of antiseptic resistance genes in 
porcine methicillin-resistant Staphylococcus aureus. Vet Microbiol 2013; 162: 977–9. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/23164812. Accessed May 29, 2013. 
29. Hegstad K, Langsrud S, Lunestad BT, Scheie AA, Sunde M, Yazdankhah SP. Does the wide 
use of quaternary ammonium compounds enhance the selection and spread of antimicrobial 
Manuscript III 
24 
 
resistance and thus threaten our health? Microb Drug Resist 2010; 16: 91–104. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/20370507. 
30. Videncenter for svineproduktion. Desinfektion. 2013. Available at: 
http://vsp.lf.dk/Viden/Sundhed og forebyggelse/Rengoring_desinfektion/Desinfektion.aspx. 
Accessed May 30, 2013. 
31. De Vries LE, Christensen H, Skov RL, Aarestrup FM, Agersø Y. Diversity of the tetracycline 
resistance gene tet(M) and identification of Tn916- and Tn5801-like (Tn6014) transposons in 
Staphylococcus aureus from humans and animals. J Antimicrob Chemother 2009; 64: 490–500. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/19531603. Accessed May 28, 2013. 
32. Hasman H, Moodley A, Guardabassi L, Stegger M, Skov RL, Aarestrup FM. Spa type 
distribution in Staphylococcus aureus originating from pigs, cattle and poultry. Vet Microbiol 2010; 
141: 326–31. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19833458. Accessed May 28, 
2013. 
33. McAdam PR, Templeton KE, Edwards GF, et al. Molecular tracing of the emergence, 
adaptation, and transmission of hospital-associated methicillin-resistant Staphylococcus aureus. 
Proceedings of the National Academy of Sciences of the United States of America 2012; 109: 9107–
12. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3384211&tool=pmcentrez&rendertype
=abstract. Accessed May 26, 2013. 
34. Aarestrup F., Wegener H., Rosdahl V., Jensen N. Staphylococcal and other Bacterial Species 
Associated with Intramammary Infections in Danish Dairy Herds. Acta vet scand 1995; 36: 475–87. 
35. Maes N, Magdalena J, Rottiers S, Gheldre Y De, Struelens MJ. Evaluation of a Triplex PCR 
Assay To Discriminate Staphylococcus aureus from Coagulase-Negative Staphylococci and 
Determine Methicillin Resistance from Blood Cultures. J Clin Microbiol 2002; 40: 1514–7. 
Manuscript III 
25 
 
36. Anon. No Title. Available at: www.SegNet.org. 
37. CLSI. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow 
Aerobically; Approved Standard - Eighth Edition. CLSI document M07-A8. Wayne, PA: Clinical 
and Laboratory Standards Institute. 2009. 
38. NCCLS. Methods for Dertermining Bactericidal Activity of Antimicrobial Agents; Approved 
Guideline. NCCLS document M26-A. 1999. 
39. Aarestrup FM, Agersø Y, Ahrens P, JŁrgensen JC, Madsen M, Jensen LB. Antimicrobial 
susceptibility and presence of resistance genes in staphylococci from poultry. Vet Microbiol 2000; 
74: 353–64. Available at: http://www.ncbi.nlm.nih.gov/pubmed/10831857. 
40. European Committee on Antimicrobial Susceptibility Testing (EUCAST). No Title. Available 
at: http://www.eucast.org/. Accessed October 25, 2012. 
41. (EURL-AR) ERL for AR. No Title. Available at: www.eurl-ar.eu. Accessed October 25, 2012. 
42. Price LB, Stegger M, Hasman H, et al. Staphylococcus aureus CC398: Host Adaptation and 
Emergence of Methicillin Resistance in Livestock. MBio 2012; 3: 1–7. 
43. Lina G, Piémont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin-
producing Staphylococcus aureus in primary skin infections and pneumonia. Clinical infectious 
diseases: an official publication of the Infectious Diseases Society of America 1999; 29: 1128–32. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/10524952. 
44. Argudín M a, Mendoza MC, González-Hevia M a, Bances M, Guerra B, Rodicio MR. 
Genotypes, exotoxin gene content, and antimicrobial resistance of Staphylococcus aureus strains 
recovered from foods and food handlers. Appl Environ Microbiol 2012; 78: 2930–5. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3318794&tool=pmcentrez&rendertype
=abstract. Accessed May 29, 2013. 
45. Anon. MLSTnet. Available at: http://www.mlst.net/. 
Manuscript III 
26 
 
46. Traber K, Novick R. A slipped-mispairing mutation in AgrA of laboratory strains and clinical 
isolates results in delayed activation of agr and failure to translate δ - and α -haemolysins. Mol 
Microbiol 2006; 59: 1519–30. 
47. Adhikari RP, Arvidson S, Novick RP. A nonsense mutation in agrA accounts for the defect in 
agr expression and the avirulence of Staphylococcus aureus 8325-4 traP::kan. Infect Immun 2007; 
75: 4534–40. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1951176&tool=pmcentrez&rendertype
=abstract. Accessed May 29, 2013. 
48. Pitt TL, Gaston M a, Hoffman PN. In vitro susceptibility of hospital isolates of various bacterial 
genera to chlorhexidine. J Hosp Infect 1983; 4: 173–6. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/6195226. 
49. Aarestrup FM, Hasman H. Susceptibility of different bacterial species isolated from food 
animals to copper sulphate, zinc chloride and antimicrobial substances used for disinfection. Vet 
Microbiol 2004; 100: 83–9. Available at: http://www.ncbi.nlm.nih.gov/pubmed/15135516. 
Accessed August 17, 2012. 
50. Jaglic Z, Cervinkoá D, Vlková H, E M, G K, V B. Bacterial Biofilms Resist Oxidising Agents 
Due to the Presence of Organic Matter. Czech J Food Sci 2012; 30: 178–87. 
51. Suller MTE, Russell AD. Antibiotic and biocide resistance in methicillin-resistant 
Staphylococcus aureus and vancomycin-resistant enterococcus. J Hosp Infect 1999; 43: 281–91. 
52. Otero MC, Nader-Macías ME. Inhibition of Staphylococcus aureus by H2O2-producing 
Lactobacillus gasseri isolated from the vaginal tract of cattle. Anim Reprod Sci 2006; 96: 35–46. 
Available at: http://www.ncbi.nlm.nih.gov/pubmed/16386389. Accessed May 29, 2013. 
53. Kadlec K, Ehricht R, Monecke S, et al. Diversity of antimicrobial resistance pheno- and 
genotypes of methicillin-resistant Staphylococcus aureus ST398 from diseased swine. J Antimicrob 
Manuscript III 
27 
 
Chemother 2009; 64: 1156–64. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19808235. 
Accessed May 29, 2013. 
54. Crombé F, Willems G, Dispas M, et al. Prevalence and antimicrobial susceptibility of 
methicillin-resistant Staphylococcus aureus among pigs in Belgium. Microb Drug Resist 2012; 18: 
125–31. Available at: http://www.ncbi.nlm.nih.gov/pubmed/22088147. Accessed May 29, 2013. 
55. Oppliger A, Moreillon P, Charrière N, Giddey M, Morisset D, Sakwinska O. Antimicrobial 
resistance of Staphylococcus aureus strains acquired by pig farmers from pigs. Appl Environ 
Microbiol 2012; 78: 8010–4. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3485952&tool=pmcentrez&rendertype
=abstract. Accessed May 29, 2013. 
56. Armand-lefevre L, Ruimy R, Andremont A. Clonal Comparison of Staphylococcus aureus 
Isolates from Healthy Pig Farmers , Human Controls , and Pigs. Emerging Infect Dis 2005; 11: 
711–4. 
57. Foster PL. Stress-induced mutagenesis in bacteria. Crit Rev Biochem Mol Biol 2007; 42: 373–97. 
Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2747772&tool=pmcentrez&rendertype
=abstract. Accessed May 28, 2013. 
58. Chang W, Small DA, Toghrol F, Bentley E, Bentley WE. Global Transcriptome Analysis of 
Staphylococcus aureus Response to Hydrogen Peroxide. J Bacteriol 2006; 188: 1648–59. 
59. Cirz RT, Chin JK, Andes DR, De Crécy-Lagard V, Craig W a, Romesberg FE. Inhibition of 
mutation and combating the evolution of antibiotic resistance. PLoS Biol 2005; 3: e176. Available 
at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1088971&tool=pmcentrez&rendertype
=abstract. Accessed May 28, 2013. 
Manuscript III 
28 
 
60. Bjorland J, Sunde M, Waage S. Plasmid-Borne smr Gene Causes Resistance to Quaternary 
Ammonium Compounds in Bovine Staphylococcus aureus. J Clin Microbiol 2001; 39: 3999–4004. 
61. Bjorland J, Steinum T, Sunde M, Heir E. Novel Plasmid-Borne Gene qacJ Mediates Resistance 
to Quaternary Ammonium Compounds in Equine Staphylococcus aureus , Staphylococcus 
simulans , and Staphylococcus intermedius. Antimicrob Agents Chemother 2003; 47: 3046–52. 
62. Heir E, Sundheim G, Holck a L. The qacG gene on plasmid pST94 confers resistance to 
quaternary ammonium compounds in staphylococci isolated from the food industry. J Appl 
Microbiol 1999; 86: 378–88. Available at: http://www.ncbi.nlm.nih.gov/pubmed/10196743. 
63. Otter J a, Patel A, Cliff PR, Halligan EP, Tosas O, Edgeworth JD. Selection for qacA carriage in 
CC22, but not CC30, methicillin-resistant Staphylococcus aureus bloodstream infection isolates 
during a successful institutional infection control programme. J Antimicrob Chemother 2013; 68: 
992–9. Available at: http://www.ncbi.nlm.nih.gov/pubmed/23288405. Accessed May 29, 2013. 
64. Weigel LM, Clewell DB, Gill SR, et al. Genetic analysis of a high-level vancomycin-resistant 
isolate of Staphylococcus aureus. Science (New York, NY) 2003; 302: 1569–71. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/14645850. Accessed May 29, 2013. 
65. Traber KE, Lee E, Benson S, et al. agr function in clinical Staphylococcus aureus isolates. 
Microbiology (Reading, Engl) 2008; 154: 2265–74. Available at: 
http://www.ncbi.nlm.nih.gov/pubmed/18667559. Accessed May 29, 2013. 
66. Somerville GA, Cockayne A, Dürr M, et al. Synthesis and Deformylation of Staphylococcus 
aureus δ -Toxin Are Linked to Tricarboxylic Acid Cycle Activity. J Bacteriol 2003; 185: 6686–94. 
67. Gagnaire J, Dauwalder O, Boisset S, et al. Detection of Staphylococcus aureus delta-toxin 
production by whole-cell MALDI-TOF mass spectrometry. PLoS ONE 2012; 7: e40660. Available 
at: 
Manuscript III 
29 
 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3391297&tool=pmcentrez&rendertype
=abstract. Accessed May 30, 2013. 
68. Sharma-Kuinkel BK, Ahn SH, Rude TH, et al. Presence of genes encoding panton-valentine 
leukocidin is not the primary determinant of outcome in patients with hospital-acquired pneumonia 
due to Staphylococcus aureus. J Clin Microbiol 2012; 50: 848–56. Available at: 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3295120&tool=pmcentrez&rendertype
=abstract. Accessed May 26, 2013. 
69. Belkum A Van, Melles DC, Peeters JK, Leeuwen WB Van, Spalburg E, Neeling AJ De. 
Methicillin-Resistant and -Susceptible Staphylococcus aureus Sequence Type 398 in Pigs and 
Humans. Emerging Infectious Diseases 2008; 14: 479–83. 
70. EFSA. Scientific Opinion of the Panel on Biological Hazards on a request from the European 
Commission on Assessment of the Public Health significance of meticillin resistant Staphylococcus 
aureus (MRSA) in animals and foods. The EFSA Journal 2009; 993: 1–73. 
71. Bartels MD, Boye K, Larsen AR, Skov R, Westh H. Rapid Increase of Genetically Diverse 
Methicillin-Resistant Staphylococus aureus, Copenhagen, Denmark. Emerging Infect Dis 2007; 13: 
1533–40. 
72. Diep BA, Sensabaugh GF, Somboona NS, Carleton HA. Widespread Skin and Soft-Tissue 
Infections Due to Two Methicillin-Resistant Staphylococcus aureus Strains Harboring the Genes 
for Panton-Valentine Leucocidin. J Clin Microbiol 2004; 42: 2080–4.  
 
 
Table and figures 
Manuscript III 
30 
 
 
 
 
0 
20 
40 
60 
80 
1 2 4 8 16 
N
um
be
r 
of
 is
ol
at
e 
µg/ml 
Benzalkonium chloride 
MIC 
MBC 
0 
20 
40 
60 
80 
0.001 0.002 0.004 0.008 0.016 
N
um
be
r 
of
 is
ol
at
es
 
% 
Hydrogen peroxide 
MIC 
MBC 
0 
20 
40 
60 
80 
0.025 0.05 0.1 0.2 0.4 
N
um
be
r 
of
 is
ol
at
es
 
% available chlorine 
Sodium hypochlorite 
MIC 
MBC 
Manuscript III 
31 
 
 
 
Figure 1. Distributions of the minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) of 
the 79 S. aureus pig isolates. 
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Figure 2. Distribution of the minimal inhibitory concentration (MIC) and bactericidal concentration (MBC) to 
benzalkonium chloride (BC) of MRSA and MSSA S. aureus pig isolates belonging to clonal complex (CC) 398 and 30. 
 
Table 1. Phenotypic resistance profile (A) and distribution of resistances (B) in the 79 S. aureus pig isolates. CHL; 
chloramphenicol, CIP; ciprofloxacin, ERY; erythromycin, FFN; florfenicol, PEN; penicillin, SPE; spectinomycin, STR; 
streptomycin, SMX; sulphamethoxazol, TET; tetracycline, TIA; tiamulin, TMP; trimethoprim.  
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4 D PEN, TET, TMP, SXT, STR R14 
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7 D PEN, TET R10 
8 D PEN, TET, TMP, SXT R13 
9 D PEN, ERY, TET R3 
10 D PEN, TIA, ERY, TET, STR R21 
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12 D ERY, TET R1 
13 D PEN, TET, TMP R11 
14 D PEN, TIA, ERY, TET, SPE, TMP, STR R20 
15 D TIA, ERY, TET R30 
16 D PEN, TIA, TET, SPE, TMP R27 
17 F1 PEN, TIA, TET, CIP, TMP R26 
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18 F2 PEN, TIA, TET, SPE, TMP, STR R28 
19 F3 PEN, ERY, TET, CIP, TMP R4 
20 F3 PEN, ERY, TET, CIP, TMP R4 
21 F3 PEN, ERY, TET, CIP, TMP R4 
M
R
SA
 C
C
39
8 
22 S4 PEN, ERY, TET, TMP, STR R8 
23 S4 PEN, TET, CIP, FFN, CHL, TMP, SXT R10 
24 S3 PEN, TET R9 
25 S5 PEN, TET, TMP,SXT R15 
27 N PEN, TET, TMP R11 
28 N PEN, TIA, TET, SPE, TMP, SXT R29 
29 S6 PEN, ERY, TET, TMP, STR R8 
30 S6 PEN, ERY, TET, SPE, TMP, SXT R7 
31 S7 PEN, TIA, ERY, TET, SPE, STR R18 
32 S5 PEN, TET R9 
33 F4 PEN, TET, TMP, STR R12 
34 F5 PEN, TET, TMP, STR R12 
35 F6 PEN, TET, TMP R11 
37 F7 PEN, ERY, TET, SPE, TMP, STR R6 
38 F7 PEN, ERY, TET, SPE, TMP, STR R6 
39 F7 PEN, ERY, TET, SPE, TMP, STR R6 
40 F7 PEN, ERY, TET, TMP, STR R8 
41 F7 PEN, ERY, TET, SPE, TMP, STR R6 
42 F7 PEN, ERY, TET, SPE, TMP R5 
43 F7 PEN, ERY, TET, SPE, TMP, STR R6 
44 F4 PEN, TET, TMP R11 
45 F4 PEN, TET, TMP R11 
46 F4 PEN, TET, TMP, STR R12 
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48 F4 PEN, TET, TMP R11 
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50 F4 PEN, TET, TMP, STR R12 
51 F4 PEN, TET, TMP R11 
52 F4 PEN, TET, TMP, STR R12 
53 F1 PEN, TIA, ERY, TET, SPE, TMP, SMX, STR R19 
54 F2 PEN, TIA, TET, SPE, TMP, STR R28 
55 F2 PEN, TIA, ERY, TET, SPE, TMP, STR R20 
56 F8 PEN, TET, TMP, STR R12 
57 F9 PEN, TIA, ERY, TET, CIP, SPE, TMP, STR R16 
58 F9 PEN, TIA, ERY, TET, CIP, SPE, TMP, SXT, STR R17 
59 F9 PEN, TIA, ERY, TET, CIP, SPE, TMP, STR R16 
60 F11 PEN, TIA, TET, CIP, SPE, TMP, STR R24 
61 F10 PEN, TIA, ERY, TET, CIP, SPE, TMP, SXT, STR R17 
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Figure 3. Ethidium bromide efflux activity assay. Isolates were grown for 24 h at 37 °C on TSA containing EtBr (1 
µg/ml), followed by inspection for fluorescence under UV light. Strains JCM 16555 (qacA) and JCM 16556 (qacB), 
that overexpress efflux pumps, were included as controls 
85 86 87 88 89 
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Figure 4. Hemolytic activity of S. aureus on sheep blood. RN4220, a strong beta-hemolysin producer, is streaked 
vertically and isolates horizontally. Beta-hemolysin forms a tubid zone of hemolysis surrounding the vertical streak of 
RN4220. Delta-hemolysis and beta-hemolysis are synergistic, producing a clear hemolysis where they intersect.    
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Table S1. Collection of isolates included in this study. D; diagnostic submission, F; farm, N; no information, S; slaughter house. 
  Isolate no. Year Sample Source spa-type 
M
SS
A
 C
C
39
8 
1 2000 Clinical D t034 
2 2000 Clinical D t034 
3 2001 Clinical D t034 
4 2001 Clinical D t034 
5 2002 Clinical D t034 
6 2002 Clinical D t034 
7 2002 Clinical D t011 
8 2002 Clinical D t034 
9 2002 Clinical D t034 
10 2002 Clinical D t034 
11 2003 Clinical D t034 
12 2003 Clinical D t034 
13 2004 Clinical D t011 
14 2004 Clinical D t034 
15 2004 Clinical D t571 
16 2005 Clinical D t034 
17 2007 Colonization F1 t034 
18 2007 Colonization F2 t034 
19 2007 Colonization F3 t034 
20 2007 Colonization F3 t034 
21 2007 Colonization F3 t034 
M
R
SA
 C
C
39
8 
22 2009 Colonization S4 t034 
23 2009 Colonization S4 t034 
24 2009 Colonization S3 t034 
25 2009 Colonization S5 t034 
27 2009 Colonization N t034 
28 2009 Colonization N t034 
29 2009 Colonization S6 t034 
30 2009 Colonization S6 t034 
31 2009 Colonization S7 t011 
32 2009 Colonization S5 t011 
33 2007 Colonization F4 t108 
34 2007 Colonization F5 t034 
35 2007 Colonization F6 t318 
37 2007 Colonization F7 t034 
38 2007 Colonization F7 t034 
39 2007 Colonization F7 t034 
40 2007 Colonization F7 t034 
41 2007 Colonization F7 t034 
42 2007 Colonization F7 t034 
43 2007 Colonization F7 t034 
44 2007 Colonization F4 t034 
45 2007 Colonization F4 t034 
46 2007 Colonization F4 t034 
47 2007 Colonization F4 t034 
48 2007 Colonization F4 t034 
49 2007 Colonization F4 t034 
50 2007 Colonization F4 t034 
51 2007 Colonization F4 t034 
52 2007 Colonization F4 t034 
53 2007 Colonization F1 t034 
54 2007 Colonization F2 t034 
55 2007 Colonization F2 t034 
56 2007 Colonization F8 t034 
57 2008 Colonization F9 t034 
58 2008 Colonization F9 t034 
59 2008 Colonization F9 t034 
60 2008 Colonization F11 t034 
61 2008 Colonization F10 t034 
62 2008 Colonization F10 t034 
63 2008 Colonization F10 t034 
M
SS
A
 C
C
30
 
72 2007 Colonization S1 t1333 
73 2007 Colonization S1 t1333 
74 2000 Clinical D t1333 
75 2000 Clinical D t1333 
76 2000 Clinical D t1333 
77 2000 Clinical D t1333 
78 2001 Clinical D t1333 
79 2002 Clinical D t1333 
80 2002 Clinical D t1333 
81 2007 Colonization F1 t1333 
82 2002 Clinical D t1333 
83 2007 Colonization S2 t1333 
84 2001 Clinical D t1333 
M
R
SA
 C
C
30
 85 2011 Colonization F12 t1333 
86 2009 Colonization S3 t1333 
87 2009 Colonization S3 t1333 
88 2009 Colonization S3 t1333 
89 2009 Colonization S3 t1333 
 
Table S2. The MIC- and MBC-values of the 79 S. aureus pig isolates to benzalkonium chloride (BC), hydrogen peroxide (HP), 
sodium hypochlorite (SH), formaldehyde (FH), caustic soda (NaOH), and chlorhexidine digluconate (CHX).  
  
BC (µg/ml) HP (%) SH (%) a FH (%) NaOH (%) CHX (µg/ml) 
  Isolate no. MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC 
M
SS
A
 C
C
39
8 
1 2 8 0.002 0.002 0.05 0.1 0.00625 0.0125 0.1 0.1 2 4 
2 2 4 0.002 0.008 0.05 0.1 0.00625 0.0125 0.1 0.1 ND ND 
3 2 4 0.001 0.008 0.05 0.2 0.00625 0.0125 0.1 0.1 ND ND 
4 2 4 0.001 0.008 0.05 0.2 0.00625 0.0125 0.1 0.1 ND ND 
5 2 4 0.001 0.004 0.05 0.2 0.00625 0.0125 0.05 0.1 ND ND 
6 2 4 0.001 0.008 0.05 0.2 0.00625 0.0125 0.1 0.1 ND ND 
7 2 4 0.002 0.004 0.05 0.1 0.00625 0.0125 0.1 0.1 ND ND 
8 2 4 0.002 0.008* 0.05 0.2 0.00625 0.025 0.05 0.1 ND ND 
9 2 4 0.001 0.008 0.05 0.2 0.00625 0.025 0.1 0.1 ND ND 
10 2 4 0.001 0.008 0.05 0.2 0.00625 0.0125 0.1 0.1 ND ND 
11 2 4 0.001 0.008* 0.05 0.2 0.00625 0.0125 0.1 0.2 ND ND 
12 2 4 0.001 0.008* 0.05 0.2 0.00625 0.025 0.1 0.1 ND ND 
13 2 8 0.001 0.004 0.05 0.4 0.00625 0.0125 0.1 0.1 ND ND 
14 4 4 0.001 0.004 0.05 0.4 0.00625 0.0125 0.1 0.1 2 8 
15 4 4 0.001 0.008 0.05 0.2 0.00625 0.0125 0.1 0.1 2 2 
16 4 8 0.001 ND 0.05 ND 0.00625 0.0125 0.1 0.2 2 4 
17 2 8 0.002 0.008* 0.05 0.2 0.0125 0.025 0.1 0.1 ND ND 
18 4 8 0.001 0.004 0.05 0.2 0.0125 0.025 0.1 0.1 ND ND 
19 4 8 0.001 0.008* 0.05 0.4 0.00625 0.0125 0.2 0.2 4 8 
20 4 4 0.001 0.004 0.05 0.4 0.00625 0.0125 0.1 0.2 2 4 
21 4 8 0.002 0.008 0.05 0.4 0.00625 0.0125 0.2 0.2 ND ND 
M
R
SA
 C
C
39
8 
22 2 4 0.001 0.002 0.05 0.2 0.00625 0.0125 0.1 0.1 ND ND 
23 2 4 0.001 0.002 0.05 0.2 0.00625 0.0125 0.1 0.1 ND ND 
24 2 8 0.001 0.004* 0.05 0.2 0.00625 0.0125 0.1 0.1 ND ND 
25 4 4 0.002 0.002 0.05 0.2 0.00625 0.0125 0.1 0.2 ND ND 
27 2 4 0.002 0.004 0.05 0.2 0.00625 0.0125 0.1 0.1 ND ND 
28 2 4 0.002 0.004 0.05 0.2 0.00625 0.0125 0.1 0.1 ND ND 
29 2 4 0.002 0.008 0.05 0.2 0.00625 0.0125 0.1 0.1 ND ND 
30 2 4 0.001 0.004 0.05 0.1 0.00625 0.0125 0.05 0.1 ND ND 
31 2 4 0.002 0.008* 0.05 0.2 0.00625 0.0125 0.1 0.1 ND ND 
32 2 8 0.002 0.008 0.05 0.2 0.00625 0.025 0.1 0.2 ND ND 
33 2 16 0.002 0.004* 0.05 0.1 0.00625 0.0125 0.1 0.1 ND ND 
34 2 4 0.002 0.008 0.05 0.2 0.00625 0.0125 0.1 0.1 2 4 
35 2 4 0.002 0.004 0.05 0.1 0.00625 0.0125 0.1 0.1 ND ND 
37 2 4 0.001 0.008* 0.05 0.4 0.00625 0.0125 0.1 0.1 ND ND 
38 2 4 0.002 0.008 0.05 0.4 0.0125 0.0125 0.1 0.1 ND ND 
39 2 4 0.002 0.008* 0.05 0.4 0.0125 0.025 0.1 0.2 ND ND 
40 2 8 0.001 0.008 0.05 0.4 0.0125 0.0125 0.1 0.1 ND ND 
41 4 8 0.002 0.008 0.05 0.4 0.00625 0.0125 0.1 0.2 2 4 
42 2 8 0.001 0.008* 0.05 0.2 0.00625 0.0125 0.1 0.2 ND ND 
43 1 2 0.002 0.002 0.05 0.2 0.00625 0.0125 0.025 0.1 ND ND 
44 2 8 0.002 0.008 0.1 0.4 0.00625 0.0125 0.1 0.2 ND ND 
45 2 8 0.002 0.008 0.05 0.4 0.00625 0.025 0.1 0.2 ND ND 
46 2 4 0.001 0.008 0.05 0.4 0.00625 0.0125 0.1 0.2 ND ND 
47 4 4 0.001 0.008 0.05 0.4 0.00625 0.0125 0.1 0.2 ND ND 
48 2 8 0.001 0.008 0.1 0.2 0.00625 0.0125 0.1 0.1 ND ND 
49 2 8 0.001 0.008 0.05 0.2 0.00625 0.025 0.1 0.1 ND ND 
50 2 8 0.002 0.008 0.1 0.2 0.0125 0.025 0.1 0.2 ND ND 
51 2 8 0.002 0.008 0.05 0.2 0.00625 0.0125 0.1 0.1 ND ND 
52 2 4 0.002 0.004 0.05 0.2 0.0125 0.025 0.1 0.1 ND ND 
53 2 4 0.001 0.004 0.05 0.2 0.00625 0.0125 0.05 0.1 ND ND 
54 4 4 0.001 0.008 0.05 0.4 0.00625 0.0125 0.1 0.2 4 4 
55 2 4 0.001 0.008 0.05 0.4 0.00625 0.0125 0.1 0.1 ND ND 
56 4 4 0.002 0.004 0.025 0.1 0.00625 0.0125 0.1 0.1 ND ND 
57 
4 4 0.001 0.008 0.05 0.2 0.00625 0.025 0.1 0.1 ND ND 
58 4 8 0.001 0.008 0.05 0.2 0.00625 0.025 0.1 0.1 ND ND 
59 
2 4 0.001 0.008* 0.05 0.2 0.00625 0.025 0.1 0.2 ND ND 
60 4 8 0.001 0.016 0.025 0.2 0.00625 0.025 0.1 0.1 ND ND 
61 4 4 0.001 0.008* 0.05 0.2 0.00625 0.0125 0.1 0.2 2 4 
62 4 8 0.001 0.008* 0.05 0.2 0.00625 0.025 0.1 0.2 2 4 
63 4 8 0.001 0.008 0.025 0.2 0.00625 0.025 0.1 0.1 2 4 
M
SS
A
 C
C
30
 
72 2 4 0.002 0.004 0.05 0.1 0.00625 0.0125 0.1 0.1 ND ND 
73 2 2 0.002 0.004 0.05 0.1 0.00625 0.0125 0.1 0.1 ND ND 
74 2 4 0.002 0.008* 0.05 0.1 0.00625 0.025 0.1 0.1 ND ND 
75 2 4 0.001 0.008 0.05 0.4 0.00625 0.0125 0.1 0.1 ND ND 
76 2 4 0.001 0.002 0.05 0.1 0.00313 0.00625 0.05 0.1 ND ND 
77 4 4 0.001 0.008* 0.05 0.2 0.00625 0.0125 0.05 0.1 4 4 
78 4 8 0.001 0.008* 0.05 0.2 0.00625 0.0125 0.1 0.1 ND ND 
79 2 4 0.002 0.008* 0.05 0.2 0.00625 0.025 0.1 0.1 ND ND 
80 2 4 0.001 0.002 0.05 0.1 0.00625 0.0125 0.1 0.1 ND ND 
81 2 4 0.002 0.002 0.05 0.1 0.00625 0.025 0.1 0.1 ND ND 
82 4 4 0.001 0.002 0.05 0.1 0.00625 0.0125 0.1 0.1 ND ND 
83 4 4 0.001 0.008* 0.05 0.1 0.00625 0.0125 0.1 0.1 2 4 
84 2 4 0.001 0.002 0.05 0.05 0.00625 0.025 0.1 0.1 ND ND 
M
R
SA
 C
C
30
 85 4 8 0.002 0.008* 0.05 0.1 0.00625 0.0125 0.1 0.1 2 4 
86 4 8 0.002 0.002 0.05 0.05 0.00625 0.0125 0.1 0.1 2 4 
87 2 4 0.002 0.008* 0.05 0.2 0.00625 0.025 0.1 0.1 2 4 
88 8 8 0.002 0.008* 0.05 0.1 0.00625 0.0125 0.1 0.1 2 2 
89 8 8 0.002 0.008 0.05 0.2 0.00625 0.0125 0.1 0.2 2 2 
* Paradoxical effect observed, a SH: Available chlorine 
              
